bibliography books€¦ · insufficiency and hemorrhage of the brain stem and cerebellum....
TRANSCRIPT
1
BIBLIOGRAPHY BOOKS 1. Meyer JS, Gastaut H (Eds): Cerebral Anoxia and the Electroencephalogram.
Proceedings of the Colloquium on Cerebral Anoxia, Marseilles, France, Springfield: CC Thomas, 1961, 617 pp.
2. Loeb C, Meyer JS: Strokes Due to Vertebrobasilar Disease. Infarction, Vascular
Insufficiency and Hemorrhage of the Brain Stem and Cerebellum. Springfield: CC Thomas, 1965, 307 pp.
3. Meyer JS, Lechner H, Eichhorn O, (Eds): Research on the Cerebral Circulation.
Proceedings of the Third International Salzburg Conference. Springfield: CC Thomas, 1969, 408 pp.
4. Gilroy J, Meyer JS: Medical Neurology: New York, MacMillan, 1969,720 pp. 5. Meyer, JS, Reivich M, Lechner H, Eichhorn 0 (Eds): Research on the Cerebral
Circulation. Proceedings of the Fourth International Salzburg Conference. Springfield: CC Thomas, 1970,297 pp.
6. Meyer JS, Schade JP (Eds): Cerebral Blood Flow. Progress in Brain Research,
Vol. 35. Amsterdam: Elsevier, 1972,437 pp. 7. Meyer JS, Reivich M, Lechner H, Eichhorn 0 (Eds): Research on the Cerebral
Circulation. Proceedings of the Fifth International Salzburg Conference. Springfield: CC Thomas, 1972,475 pp.
8. Meyer JS, Lechner H, Reivich M, Eichhorn 0 (Eds): Cerebral Vascular Disease.
Proceedings of the Sixth International Salzburg Conference, 1972. Stuttgart: George Thieme Verlag, 1974, 280 pp.
9. Gilroy J, Meyer JS: Neurologia Medica. (Medical Neurology), Spanish Edition.
Rosario, Argentina: La Medica 1974,965 pp. 10. Meyer JS (Ed): Modern Concepts of Cerebrovascular Disease. New York:
Spectrum Publications, Inc., 1975, 181 pp. Spanish Edition, Editorial Marin, S.A., 1977.
11. Gilroy J, Meyer JS: Medical Neurology, second edition. New York, MacMillan,
1975, 769 pp. (included in American College of Physicians revised "Library for Internists", March, 1976; and cited in Trial magazine, the official journal of the American Trial Lawyers Association, April, 1976.
2
12. Meyer JS, Lechner H, Reivich M (Eds): Cerebral Vascular Disease. Proceedings of the Eighth International Conference, Salzburg, 1974, Stuttgart: George Thieme Verlag, 1976 205 pp.
13. Meyer JS, Lechner H, Reivich M (Eds): Cerebral Vascular Disease. Proceedings of
the Eighth International Salzburg Conference, September 22-25, 1976. Amsterdam: Excerpta medica Foundation, 1978, 281 pp.
14. Deshmukh VD, Meyer JS: Noninvasive Measurement of Regional Cerebral Blood
Flow in Man. New York: Spectrum Publications, 1978, 250 pp. 15. Gilroy J, Meyer JS: Neurologia Medica (Italian Edition). Piccin Editore: Padova, Italy,
1978, 748 pp. 16. Meyer JS (Ed): Modem Concepts of Cerebrovascular Disease. (Spanish Edition).
Barcelona, Spain: Editorial Marin, S.A., 1977, 177 pp. 17. Meyer JS, Lechner H, Reivich M, Oft E, Aranibar A (Eds): Cerebrovascular Disease
2. Proceedings of the Ninth Salzburg Conference, Sept. 27-30, 1978. Excerpta Medica: Amsterdam-Oxford, 1979, 383 pp.
18. Gilroy J, Meyer JS: Medical Neurology. Third Edition. New York: MacMillan, 1979. 19. Meyer JS, Shaw TG (Eds): Diagnosis and Management of Stroke and TlAs.
Addison-Wesley Publishing Co., Menlo Park, California, 1982. 20. Meyer JS, Lechner H, Reivich M, Ott EO, Aranibar A (Eds): Cerebral Vascular
Disease 3. Tenth Salzburg Conference, Excerpta Medica, Amsterdam, 1980. 21. Meyer JS, Lechner H, Reivich M, Ott EO: Cerebral Vascular Disease 4. Word
Federation of neurology, Eleventh Salzburg Conference, International Congress Series 616, Excerpta Medica, Amsterdam, 1983.
22. Meyer JS, Lechner H, Reivich M, Ott EO: Cerebral Vascular Disease 5. World
Federation of Neurology, Twelfth Salzburg Conference, International Congress Series 687, Excerpta Medica, Amsterdam, 1985.
23. Lechner H, Meyer JS, Ott EO (Eds): Cerebrovascular Disease- Research and
Clinical Management. World Federation of Neurology, Elsevier, Amsterdam, New York, Oxford, 1986, 350 pp.
24. Meyer JS, Lechner H, Ott EO, Reivich M: Cerebral Vascular Disease 6. World Federation of Neurology, Thirteenth Salzburg Conference, International Congress Series, Excerpta Medica, Amsterdam, International Congress Series 738, 320 pp, 1987. 25. Meyer JS, Lechner H, Marshall J, Toole JF (Eds): Vascular and Multi-Infarct Dementia, Futura Publishing Co., Mount Kisco, New York, 276 pp., 1988. 4:1
3
26. Meyer JS, Lechner H, Reivich M, Toole JF (Eds): Cerebral Vascular Disease 7. World Federation of Neurology, Fourteenth Salzburg Conference, International Congress Series, 858 Excerpta Medica, Amsterdam, 304 pages, 1989. 27. Meyer JS, Lechner H, Marshall J, Toole J (Eds): Demenza, Vascolare e Multi- inartale. Italian Edition. Gino Micarelli, editore, Roma, Italy, 1989. 28. Meyer JS, Lechner H, Toole JF (Eds): Cerebrovascular Disease 8. World Federation of Neurology, Fifteenth Salzburg Conference, International Congress Series, 975 Excerpta Medica, Amsterdam, 1-23'), 1989. 29. Meyer JS, Rauch GM, Lechner H. Loeb C, Toole JF (Eds): Vascular Dementia,
Futura Publishing Co., Armonk, New York, 2001, 310 pages.
4
PUBLICATIONS 1. Meyer JS. Histological picture of cerebral oedema. McGill Med J 1945; 14:293-302. 2. Meyer JS. The thalamus. McGill Med J 1947; 16:299-313. 3. Meyer JS. Effects of diencephalic injury on consciousness. McGill University,
Masters Thesis, 1948. 4. Meyer JS, Hunter J. Behavior deficits following diencephalic lesions. Neurology
1952;2:112-130. Reprinted in Year Book of Neuro Neurosurg and Psychiat 1962. 5. Meyer JS, Foley JM. The encephalopathy produced by extracts of eosinophil and
bone marrow. J Neuropath Exp Neurol 1953;12:349-362. Trans Amer Neurol Assn 1952.
6. Denny-Brown D, Meyer JS, Horenstein S. The significance of perceptual rivalry
resulting from parietal lesion. Brain 1952;75:433-471. 7. Brown EF, Meyer JS. Pheochromocytoma with rupture of an intracranial aneurysm.
New Eng J Med 1952;247:671-672. 8. Meyer JS, Foley JM, Campagna-Pinto D. Granulomatous angiitis of the meninges
in sarcoidosis. Arch Neurol Psychiat 1953;69:587-600. 9. Denny-Brown D, Meyer JS, Fang HCH. Effects of vascular occlusion on cortical
oxygen tension. Fifth International Neurol Cong, Lisbon 1953. 10. Progress Reports to Bureau of Medicine and Surgery, Department of the Navy.
a) Report on U.S. Navy Head Injury Project, Acute Phase. Report to Surgeon General, October 1, 1953.
b) Research Project N.M. 007088.11. Clinical Studies of the Reaction to Injury,
December 31, 1953.
c) Research Project N.M. 007091.09. Physiological Studies of the Reaction of the Brain to Injury.
11. Meyer JS, Fang HC, Denny-Brown D. Polarographic study of cerebral collateral
circulation. Arch Neurol Psychiat 1954;72:296-312.
12. Meyer JS, Mortel E. Experimental studies of brain injury. Arch Neurol Psychiat 1955;74:215-217. (Abstract)
13. Meyer JS, Denny-Brown D. Polarographic study of cerebral collateral circulation.
Arch Neurol Psychiat 1954;72:296-312.
5
14. Meyer JS, Denny-Brown D. Studies of cerebral circulation in brain injury. 11. Cerebral Concussion. EEG Clin Neurophysiol 1955;7:529-544.
15. Meyer JS, Baxter D. A case of porphyria with manifestations like delirium tremens.
Boston Society of Psychiatry and Neurology 1955. 16. Meyer JS. Studies of cerebral circulation in brain injury. Ill. Cerebral contusion,
laceration and brain stem injury. EEG Clin Neurophysiol 1956;8:107-116. 17. Meyer JS, Leiderman H, Denny-Brown D. Electroencephalographic study of
insufficiency of the basilar and carotid arteries in man. Neurol 1956;6-.455-477. 18. Meyer JS, Leiderman H, Struzziero RC. An electroencephalographic study of
cerebrovascular hemodynamics in man. EEG Clin Neurophysiol 1956;8:524-525. 19. Meyer JS, Leiderman H, Denny-Brown D. Electroencephalographic testing of
insufficiency of the basilar and carotid arteries in man by use of the tilt table. Trans Amer Neurol Assn 1956.
20. Meyer JS. Studies of cerebral circulation in brain injury. IV. Ischemia and hypoxemia
of the brain stem and respiratory center. EEG Clin Neurophysiol 1957;9:83-100. Reprinted in Brain and Behavior. 1. Mood, States, and Mind, Pribram KH, ed. Penguin Books, 1969:311-338.
21. Meyer JS, Hunter J. Effects of hypothermia on local blood flow and metabolism
during cerebral ischemia and hypoxia. J Neurosurg 1957;14:210-227. 22. Meyer JS, Hunter J. Polarographic study of cortical blood flow in man. J Neurosurg
1957; 14:382-399. 23. Meyer JS, Denny-Brown D. The cerebral collateral circulation. 1. Factors influencing
collateral blood flow. Neurol 1957;7:447-458. 24. Meyer JS, Denny-Brown D. The cerebral collateral circulation. 2. Production of
cerebral infarction by ischemic anoxia and the reversibility of early stages. Neurol 1957;7:567-579.
25. Meyer JS, Wagner W, Kane CA, Reinmuth OM. Electroencephalographic evaluation
of treatment in obstructive disease of the basilar and carotid arteries. Neurol 1957;7:765-776.
26. Hunter J, Meyer JS. Studies of the protective effect of hypothermia against anoxia in
cerebral tissue. First Congress of Neurological Sciences, Brussels 1957. 27. Meyer JS. Discussion of An experimental study of the interrelationships of cerebral
oxygen tension, EEG and intravascular pressure in dogs during hemorrhagic hypotension with and without adrenolytic or ganglionic blocking agents. Presented by P Bloor. Harvey Cushing Society, Detroit 1957.
6
28. Meyer JS, Chason JL. Diseases of the basilar artery. The pathogenesis of syndromes due to ischemia and infarction of brain stem and occipital lobes. Bull Wayne State Univ and Detroit Receiving Hosp 1958,5:2-8.
29. Meyer JS. Localized changes in properties of the blood and effects of anticoagulant
drugs in experimental cerebral infarction. New Eng J Med 1958;278:151-159. 30. Meyer JS. Circulatory changes following occlusion of the middle cerebral artery and
their relation to function. JNeurosurgl958;15:653-673. 31. Meyer JS. Importance of ischemic damage to small vessels in experimental cerebral
infarction. J Neuropath Exp Neurol 1958;17:571-585. 32. Meyer JS, Portnoy HD. Localized cerebral hypoglycemia simulating stroke. A clinical
and experimental study. Neurol 1958;8:601-614. 33. Meyer JS. Theory and rationale of anticoagulant therapy in occlusive cerebral
vascular disease. Radiology 1958;70:815-825. 34. Meyer JS. Discussion of Experimental Cerebrovascular Disease and Dysfunction. In:
Wright IS, Millikan CH, eds. Cerebral Vascular Diseases. Second Princeton Conf. New York:Grune &Stratton, 1958:58-60.
35. Meyer JS. Discussion of Central Neurogenic Hyperventilation in Man. Trans Amer
Neurol Assn 1958. 36. Meyer JS, Waltz AG, Hess JW, Zak B. Serum lipid and cholesterol levels in
cerebrovascular disease. Arch Neurol 1959; 1:303-311. 37. Meyer JS, Greifenstein F, Devault H. A new drug causing symptoms of sensory
deprivation. Neurological, electroencephalographic and pharmacological effects of Seryl. J Nerv Dis 1959;129:54-61.
38. Meyer JS, Portnoy HD. Post-epileptic paralysis, a clinical and experimental study.
Brain 1959;82:162-185. 39. Meyer JS, Waltz AG. Effects of changes in composition of plasma on blood flow. 1.
Lipid and lipid fractions. Neurol 1959;9:728-740. 40. Meyer JS. Changing concepts in childhood neurology. Medical Times 1959;
87:743-459. 41. Rodin EA, Luby ED, Meyer JS. Electroencephalographic findings associated with
Seryl infusion. EEG Clin Neurophysiol 1959;11:796-798. 42. Waltz AG, Meyer JS. Effects of changes in composition of plasma on pial blood flow.
2. High molecular weight substances, blood constituents and tonicity. Neurol 1959;9:815-825.
7
43. Barron DW, Meyer JS, Schwimmer B. Present status of neurosyphilis in a large city hospital. J Mich Med Soc 1959;58-.1477-1482.
44. Meyer JS, Sheehan S, Bauer RB. An arteriographic study of cerebrovascular
disease in man. 1. Stenosis and occlusion of the vertebral-basilar arterial system. Arch Neurol 1960;2:27-45.
45. Dickson LG, Morita Y, Cowsert EJ, Graves J, Meyer JS. Neurological,
electroencephalographic, and heredo-familial aspects of pseudohypoparathyro id ism and pseudo-pseudohypoparathyroidism. J Neurol Neurosurg Psychiat 1960;23:3339.
46. Meyer JS, Gotoh F. Method for measuring local changes in cerebral metabolism and
blood flow. Physiologist 1960;3:113. 47. Sikov MR, Meyer JS, Resta CF, Lofstrom JE. Neurological disorders produced by
prenatal x-irradiation of the rat. Radiat Res 1960,12:151. (Abstract) 48. Meyer JS, Gotoh F. Hyperventilation and the electroencephalogram. Recording brain
oxygen and carbon tensions, Ph, EEG, and blood flow during hyperventilation. Trans Amer Neurol Assn 1960; 155-160.
49. Meyer JS, Barron DW. Apraxia of gait: a clinicophysiological study. Brain
1960;83:261-284. 50. Meyer JS, Gotoh F. Messung von Anderugen des Blutstroms und des Stoffwechsels
in umschriebenen Himgebieten. (Measurement of changes in blood flow and metabolism of circumscribed areas of the brain. Survey of methods and principles.) Word Neurol 1960;1:316-333.
51. Herndon RM, Meyer JS, Johnson JF, Landers J. Treatment of cerebrovascular
thrombosis with fibrinolysin. Preliminary report. Amer J Cardio 1960;6:540-545. 52. Meyer JS, Gotoh F. Metabolic and electroencephalographic effects of
hyperventilation. Experimental studies of brain oxygen and carbon dioxide tension, pH, EEG, and blood flow during hyperventilation. Arch Neurol 1960;3:539-552. Abstracted in Year Book of Neurology, Neurosurgery and Psychiatry, 1961-62.
53. Meyer JS, Waltz AG. Arterial oxygen saturation and alveolar carbon dioxide during
electroencephalography. 1. Comparison of hyperventilation and induced hypoxia in subjects without brain disease. Arch Neurol 1960;2:631-643.
54. Meyer JS, Waltz AG, Gotoh F. Pathogenesis of cerebral vasospasm in hypertensive
encephalopathy. 1. Effects of acute increases in intraluminal blood pressure on pial blood flow. Neurol 1960;10-.735-744.
55. Meyer JS, Waltz AG, Gotoh F. Pathogenesis of cerebral vasospasm in hypertensive
encephalopathy. [I. The nature of increased irritability of smooth muscle of pial arterioles in renal hypertension. Neurol 1960;10:859-867.
8
56. Zacharoupoulos G, Gotoh F, Meyer JS. Simple method for continuous recording of
alveolar oxygen concentration with the EEG. EEG Clin Neurophysiol 1960;12:917-919.
57. Sheehan S, Bauer RN, Meyer JS. Vertebral artery compression in cervical
spondylosis. Arteriographic demonstration during life of vertebral artery insufficiency due to rotation and extension of the neck. Neurol 1960;10:968-986.
58. Herndon RM, Meyer JS, Johnson JF Fibrinolysin therapy in thrombotic diseases of
the nervous system. J Mich Med Soc 1960;59:1684-1692. 59. Bauer RB, Meyer JS. Clinical evaluation of Elipten. A new anticonvulsant drug for
epilepsy. J Mich Mid Soc 1960;59:1829-1832. 60. Meyer JS, Gotoh F. Interaction of cerebral hemodynamics and metabolism.
International Conf on Vasc Dis of the Brain. Neurol 1961;11(2):46-65. 61. Gotoh F, Tazaki Y, Meyer JS. Transport of gases through brain and their
extravascular vasomotor action. Exp Neurol 1961;4:48-58. 62. Meyer JS, Bauer RB. Medical treatment of spontaneous intracranial hemorrhage by
the use of hypotensive drugs. Neurol 1961;12:36-47. 63. Gotoh F, Meyer JS. A combined electrode for recording absolute tensions of oxygen
and carbon dioxide from small areas of tissue. EEG Clin Neurophysiol 1961;13:119-122.
64. Bauer RB, Sheehan S, Meyer JS. Arteriographic study of cerebrovascular disease in
man. 11. Cerebral symptoms due to kinking, tortuosity and compression of carotid and vertebral arteries in the neck. Arch Neurol 1961-4:119-131.
65. Meyer JS. Neurological approach to comatose patients. Med Ann Rec
1961;54:249-250. 66. Meyer JS, Gotoh F. Pathogenesis of coma. Clinical and metabolic considerations.
Int J Neurol 1961;2:281-298. 67. Bauer RB, Wechsler N, Meyer JS. Carotid compression and rotation of the head in
occlusive vertebral artery disease. Relation to carotid sinus sensitivity. Ann Intern Med 1961;55:283-291.
68. Meyer JS, Gotoh F, Tazaki Y. Inhibitory action of acetazolamide (Diamox) in seizure
activity. EEG Clin Neurophysiol 1961;13:316. (Abstract) 69. Meyer JS, Bauer RB, Wechsler N. EEG disorders resulting from deficits in circulation
of the brain. Med Ann Rec 1961;54:334-336.
9
70. Meyer JS. Personality. Derek Ernest Denny-Brown, OBE, MD (NZ) D Phil (Oxford), LLD (hon Wayne), Dr. Hon Causa (Brazil), FACP Int J Neurol 1961;2:393-397.
71. Meyer JS, Gotoh F, Tazaki Y. C02 narcosis. An experimental study. Neurol 196 1;
11: 524-537. 72. Meyer JS. Occlusive cerebrovascular disease. Pathogenesis and treatment. Amer J
Med 1961;30:577-588. 73. Meyer JS, Gotoh F, Tazaki Y. Demonstration of cerebral arterial thrombolysis by
fibrinolytic agents. Thromb Diath Hemorrh 1961;5:606. (Abstract) 74. Meyer JS, Gotoh F, Tazaki Y. Inhibitory action of carbon dioxide and acetazolamide
in seizure activity. EEG Clin Neurophysiol 1961;13:762-775. 75. Meyer JS, Gotoh F, Tazaki Y. Continuous recording of arterial P02, PC02, pH and
02 saturation in vivo. J Appl Physiol 1961;16:896-902. 76. Gomez MR, Gotham JE, Meyer JS. Effect of sodium glutamate on leucine-induced
hypoglycemia: clinical and electroencephalographic study. Pediatrics 1961;28:935-942.
77. Meyer JS, Gotham J, Tazaki Y, Gotoh F. Card iorespi ratory syndrome of extreme
obesity with papilledema. Report of a fatal case with electroencephalographic, metabolic, and necropsy studies. Neurol 1961;11:950-958.
78. Meyer JS, Gotoh F, Tazaki Y, Hamaguchi K. The physiopathogenesis of
electroencephalographic changes in circulatory and respiratory disturbances. Seventh International Neurol Cong, Rome 1961.
79. Meyer JS, Gotoh F, Tazaki Y, Hamaguchi K. Sodium and potassium activity of living
brain. Relation to EEG and active sodium transport. Trans Amer Neurol Assn 1961;86:17-22.
80. Herndon RM, Nelson A, Johnson JF, Meyer JS. Thrombolytic treatment in
cerebrovascular thrombosis. In: Anticoagulants and Fibrinolysin. Ontario Heart Assn Symp. New York:MacMillan, 1961:153-164.
81. Meyer JS, Waltz AG. Relation of cerebral anoxia to functional and
electroencephalographic abnormality. In- Cerebral Anoxia and the Electroencephalogram. Meyer JS, Gastaut H, eds. Springfield: Charles C. Thomas, 1961:307-328.
82. Meyer JS, Waltz AG. Arterial oxygen saturation and alveolar carbon dioxide during
electroencephalography. Comparison of hyperventilation and induced hypoxia in subjects with cerebral vascular disease. In: Meyer JS, Gastaut H, eds. Cerebral Anoxia and the Electroencephalogram. Springfield: Charles Thomas, 1961:329-342.
10
83. Meyer JS. Changes in cerebral blood flow resulting from vascular occlusion. In: Fields WS, ed. Pathogenesis and Treatment of Cerebrovascular Disease. Springfield: Charles Thomas, 1961:88-104.
84. Meyer JS. The value of electroencephalography in diagnosis of cerebrovascular
disease. In: Fields WS, ed. Pathogenesis and Treatment of Cerebrovascular Disease. Springfield: Charles Thomas, 1961:182-191.
85. Gastaut H, Fishgold H, Meyer JS. Conclusions of the international colloquium on
anoxia and the EEG. In: Meyer JS, Gastaut H, eds. Cerebral Anoxia and the Electroencephalogram. Springfield: Charles Thomas, 1961:599-617.
86. Meyer JS. Arteriography - Indications. In: Millikan CH, Siekert RG, Whisnant JP, eds.
Cerebral Vascular Diseases. Third Princeton Conf. New York-.Grune & Stratton, 1961:21-25.
87. Meyer JS, Hemdon RM, Gotoh G, Tazaki Y, Nelson JN, Johnson JF. Therapeutic
thrombolysis. In: Millikan CH, Siekert RG, Whisnant JP, eds. Cerebral Vascular Diseases. Third Princeton Conf. New York: Grune & Stratton, 1961:160-178.
88. Meyer JS, Gotoh F, Tazaki Y. Circulation and metabolism following experimental
cerebral embolism. J Neuropath Exp Neurol 1962;21:4-24. 89. Perez-Boda C, Meyer JS. Non-specific evoked response (NSER). Acta Neurol Lat
Amer 1962;8:33-40. 90. Gotoh F, Tazaki Y, Hamaguchi K, Meyer JS. Continuous recording of sodium and
potassium ionic activity of blood and brain in situ. J Neurochem 1962;9:81-97. 91. Sikov MR, Resta CF, Lofstrom JE, Meyer JS. Neurological deficits in the rat resulting
from x-irradiation in utero. Exp Neurol 1962;5-.131-138. 92. Dilenge D, David M, Meyer JS. L'atteinte des vaisseaux du cou dans les syndromes
de vasculopathie cerebrale. Neuro-Chirugie 1962;8:168-174. 93. Gotham JE, Gilroy J, Meyer JS. Studies of cerebral circulation time in man. 1.
Normal values and alterations with cerebral vascular disease and tumor in arm-to-retinal circulation time. J Neurol Neurosurg Psychiat 1962;25:292-302.
94. Gilroy J, Meyer JS. Auscultation of the neck in collusive cerebrovascular disease.
Circulation 1962;25:300-310. 95. Meyer JS, Gotoh F, Tazaki Y, Hamaguchi K, Ishikawa S, Nouailhat F, Symon L.
Regional cerebral blood flow and metabolism in vivo. Effects of anoxia, hypoglycemia, ischemia, acidosis, alkalosis, and alterations of blood PC02. Arch Neurol 1962;7:560-581.
96. Meyer JS, Herndon RM. Bilateral infarction of the pyramidal tracts in man. Neurology
1962;12:637-642.
11
97. Bauer RB, Sheehan S, Wechsler N, Meyer JS. Arteriographic sites, incidence and
treatment of arteriosclerotic cerebrovascular lesions. Neurol 1962; 12:698-711. 98. Vulpe M, Meyer JS, Goodman M. Optic neuritis and encephalomyelitis in monkey
produced with human optic nerve. Nature 1962;196.-901-902. 99. MeyerJS. Lysis of cerebrovascular blood clots. NYJMedl962;62-.3750-3753. 100. Meyer JS. Clinical, circulatory and metabolic studies in cerebrovascular disease
Roma-Siena 1971. Basel: S Karger, 1972:465-473. 101. Sikorski JB, Gilroy J, Meyer JS. Clostridium perfringes (gas bacillus) septicemia and
purulent meningitis. Harper Hosp Bull 1963;21-.38-42. 102. Bauer RB, Meyer JS, McMorrow KJ. Nerve conduction times in neurologic diagnosis.
Evidence of neuropathic component in some cases of spinocerebellar degeneration. Amer J Phys Med 1963;42:166-174.
103. Symon L, Ishikawa S, Lavy S, Meyer JS. Quantitative measurement of cephalic
blood flow in the monkey. A study of vascular occlusion in the neck using electromagnetic flow meters. J Neurosurg 1963;20:199-218.
104. Meyer JS. Ischemic cerebrovascular disease (stroke). Clinical investigation and
management. J Amer Med Assn 1963; 183:237-240. 105. Symon L, Ishikawa S, Meyer JS. Cerebral arterial pressure changes and
development of leptomeningeal collateral circulation. Neurol 1963;13:237-250. 106. Meyer JS, Perez-Borja C. Review of Rheoencephalography: A Method for the
Continuous Registration of Cerebrovascular Changes by Fritz L. Jenkner. EEG Clin Neurophysiol 1963;15:346-347.
107. Gomez MR, Whitten CF, Nolke A, Bernstein J, Meyer JS. Aneurysmal malformation
of the great vein of Galen causing heart failure in early infancy. Report of five cases. Pediatrics 1963;31:400-411.
108. Johnson JF, Barnhart MI, Gilroy J, Meyer JS. Plasma changes during fibrinolytic
therapy. Vox Sang 1963;8:484-488. 109. Gilroy J, Bauer RB, Krabbenhoft KL, Meyer JS. Cerebral circulation time in cerebral
vascular disease measured by serial angiography. Amer J Roentgen 1963;90:490-505.
110. Gilroy J, Meyer JS. Compression of subclavian artery as a cause of ischemic
brachial neuropathy. Brain 1963;86:733-746.
12
111. Gotham JIF, Wein H, Meyer JS. Clinical studies of neuropathy due to macroglobulinemia (Waldenstrom's syndrome). Canada Med Assn J 1963;89:806-809. Abstracted in Year Book of Neurology, Neurosurgery and Psychiatry 1964.
112. Meyer JS, Gilroy J, Barnhart MI, Johnson JF Therapeutic thrombolysis in cerebral
thromboembolism. Double-blind evaluation of intravenous plasmin therapy in carotid and middle cerebral artery occlusion. Neurol 1963;13:927-937.
113. Meyer JS, Ishikawa S, Lee TK, Thai A. Quantitative measurement of cerebral blood
flow with electromagnetic flow meters. Recording of internal jugular venous flow of monkey and man. Trans Amer Neurol Assn 1963,88:78-83.
114. Meyer JS. Review of Selective Vulnerability of the Brain in Hypoxemia, Schade JP,
McMeneney WH, Davis FA, eds. J Amer Med Assn 1964-187:466. 115. Gilroy J, Meyer JS. Pituitary insufficiency with cerebrovascular symptoms. A new
clinical syndrome. New Eng J Med 1963;169:1115-1119. Abstracted in Mod Med 1964;32:93-94.
116. Henderson R, Gilroy J, Huber P, Meyer JS. Landry-Guillain Barre syndrome with
cranial nerve involvement (polyneuritis cranialis). Harper Hosp Bull 1964;22:59-62. 117. Meyer JS, Perez-Borja C. Electroencephalogram (EEG) in the diagnosis of seizures
and other spells in pediatric neurology. Pediat Diag 1964;6:45-60. 118. Perez-Boda C, Meyer JS. A critical evaluation of Rheoencephalography in control
subjects and in proven cases of cerebrovascular disease. J Neurol Neurosurg Psychiat 1964;27:66-72.
119. Meyer JS, Kypros GP, Gilroy J. Hyperuricemia, gout and cerebrovascular disease.
W Virginia Med J 1964;60:150-153. 120. Meyer JS, Gotoh F. Continuous recording of cerebral metabolism, internal jugular
flow and EEG in man. Trans Amer Neurol Assn 1964;89:151-156. 121. Meyer JS. Clinical, circulating and metabolic studies in cerebrovascular disease
proven by arteriography. J Neuroradiol, Paris 1962. Ann Radiol 1963;6:15-22. 122. Meyer JS. Discussion of What is the Place of Anticoagulants in the Treatment of
Cerebrovascular Disease. Mod Med 1964;32:246-280. 123. Bauer RB, Gilroy J, Meyer JS. A controlled study of surgical treatment of
cerebrovascular disease. Neurol 1964; 14:257. (Abstract) 124. Meyer JS. Acute Stroke. Biochemical and therapeutic studies. Minn Med
1964;47:265-271.
13
125. Fischer-Williams M, Telerman-Toppet N, Meyer JS. Clinico-EEG correlation with arterial and jugular venous biochemical studies in acute neurological disorder. Brain 1964;87:281-306. Abstracted in EEG Clin Neurophysiol, American EEG Society Meeting 1964.
126. Meyer JS, Magee K Current views concerning the etiology, pathophysiology, and
treatment of Parkinson's disease. J Neuropsychology 1960;5:284-290. Abstracted in Med Digest 1965.
127. Lavy S, Ishikawa S, Symon L, Meyer JS. The effects of anoxia on the internal carotid
blood flow and brain metabolism in the monkey. EEG Clin Neurophysiol 1964;16:309-310. (Abstract) Cited in Proceedings of the Israel EEG Society 1964.
128. Meyer JS, Gilroy J. The defect of ACTH secretion in the syndrome of pituitary
insufficiency with cerebrovascular symptoms. Letter to the Editor, New Eng J Med 1964;270:317-318.
129. Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase
therapy in progressive stroke. J Amer Med Assn 1964; 189:373. 130. Meyer JS. Medical treatment of cerebrovascular disease. Second National
Conference on Cardiovascular Disease Heart Circulation 1964;1:430-432. 131. Meyer JS, Ishikawa S, Lee TK Electromagnetic measurements of internal jugular
venous flow in the monkey. Effect of epilepsy and other procedures. J Neurosurg 1964;21:524-539.
132. Meyer JS. Review of Brain Function and Metabolic Disorders. Neurologic Effects of
Changes in Hydrogen Ion Concentration, by Barry Wyke. EEG Clin Neurophysiol 1964; 16:535.
133. Meyer JS, Gotoh F. Continuous recording of arterial and jugular venous blood gas
tension with EEG in man. EEG Clin Neurophysiol 1964,17:608. (Abstract) 134. Henderson HR, Gilroy J, Meyer JS. Pituitary function in patients with cerebrovascular
disease (stroke). Med Times 1964;92:1261-1266. 135. Meyer JS, Gilroy J. Obstruction of the cerebral arteries. In: Current Therapy, 16 th
Edition. Philadelphia: WB Saunders, 1964:509-512. 136. Meyer JS, Gotoh F, Nara N, Handa J. Recording cerebral blood flow and metabolism
by electromagnetic, thermovelocity, local dilution, and arterio-venous difference methods. In: Eichhorn 0, Lechner H, Auell KH, eds. Scientific and Clinical Research on the Cerebral Circulation, Second International Symposium Salzburg, Vienna: Druck and Verlag, 1964:25-39.
14
137. Meyer JS. a) Report of the Stroke Subcommittee, President's Commission of Heart Disease, Cancer and Stroke. Hearings before the Subcommittee of Health and the Committee of Labor and Public Welfare, United States Senate, February 9-10, 1965, 89' Congress, First Session, Bill L-596 "Combating Heart Disease, Cancer and Stroke", Washington, D.C.: U. S. Government Printing Office, 1965, 43:669, pp. 136-139, 193-199. b) Stroke: Report of the Subcommittee and Recommendations to the President. In: A National Program to Conquer Heart Disease, Cancer and Stroke. Washington, D.C.:U.S. Government Printing Office, 1965;2:129-136.
138. Huber P, Meyer JS, Handa J, Ishikawa S. Electromagnetic flowmeter study of carotid
and vertebral blood flow during intracranial hypertension. Acta Neurochir (Vienna) 1965; 13:37-63.
139. Hamaguchi K, Gotoh F, Ishikawa S, Tazaki Y, Meyer JS. Effects of neuroactive
drugs on cerebral metabolism and ionic activity in electroencephalogram. Int J Neuropsych 1965;1:28-40.
140. Ishikawa S, Handa J, Meyer JS, Huber P. Hemodynamics of the circle of Willis and
leptomeningeal anastomoses. An electromagnetic flow meter study of intracranial arterial occlusion in the monkey. J Neurol Neurosurg Psychiat 1965;28:124-136.
141. Lambert EH, Kane C, Rowland LP, Newman MK, Meyer JS. Symposium on muscle
disease. Arch Phys Med 1965;46(l):146-159. 142. Meyer JS, Handa J, Huber P, Yoshida K. Effect of hypotension on internal and
external carotid blood flow. Demonstration of a homeostatic mechanism peculiar to cerebral vessels and its importance in cerebrovascular occlusion. J Neurosurg 1965;23:191-198. Abstracted in Review of Surgery 1966.
143. Perez-Borja C, Meyer JS. Electroencephalographic monitoring during reconstructive
surgery of the neck vessels. EEG Clin Neurophysiol 1965; 18:162169. 144. Gotham J, Meyer JS, Gilroy J, Bauer RB. Observations on cerebrospinal fluid
rhinorrhea and pneumocephalus. Ann Otol 1965;74-.215-233. 145. Handa J, Meyer JS, Yoshida K. Regional pharmacological responses of the vertebral
and internal carotid arteries. J Pharmacol Exp Ther 1965;152:251-264. 146. Gotoh F, Meyer JS. Cerebral vascular reactivity in man: Influence of arterial gas
tension on effective cerebral perfusion. Neurol 1965;15:268. (Abstract) 147. Bauer RB, Meyer JS, Gotham JE, Gilroy J. Results of surgery in patients with
reversible ischemic neurological deficit and completed stroke. Neurol 1965; 15:269. (Abstract)
148. Handa J, Meyer JS, Gotham JE, Gilroy J. Time course of development of cerebral
collateral circulation. Experimental study of carotid occlusion in the monkey by electromagnetic flow meters. Vas Dis 1965;2:271-282.
15
149. Meyer JS, Gotoh F, Favale E. Effects of carotid compression on cerebral metabolism and electroencephalogram. EEG Clin Neurophysiol 1965;19-362-376.
150. Gotoh F, Meyer JS, Takagi Y. Cerebral effects of hyperventilation in man. Arch
Neurol 1965;12:410-423. 151. Meyer JS. Testimony concerning regional medical complexes in the case of heart
disease, cancer, and stroke. Committee on Interstate and Foreign Commerce, Mr. Harris, Chairman. Records of the Congress of the United States House of Representatives, July 22, 1965.
152. Meyer JS. Surgical treatment of strokes. Results of a controlled study. Med Trib
1965. 153. Handa J, Ishikawa S, Huber P, Meyer JS. Experimental production of the If subclavian
steal". Electromagnetic flow measurements in the monkey. Surgery 1965;58:703-712.
154. Meyer JS, Gotoh F, Ebihara S, Tomita M. Effects of anoxia on cerebral metabolism
and electrolytes in man. Neurol 1965;15:892-901. Abstracted in 154. Mod Med 1966;34:198.
155. Meyer JS, Gotoh F, Gilroy J, Nara N. Improvement in brain oxygenation and clinical
improvement in patients with strokes treated with papaverine hydrochloride. J Amer Med Assn 1965; 194:957-96 1.
156. Meyer JS, Gotoh F. Cerebral metabolism during epileptic seizures in man. Trans
Amer Neurol Assn 1965;90:23-29. 157. Meyer JS, Gilroy J, Barnhard MI, Johnson JF. Therapeutic thrombolysis in cerebral
thrombo-embolism. Randomized evaluation of intravenous streptokinase. In: Millikan CH, Siekert R, Whisnant J, eds. Cerebral Vascular Diseases. Fourth Princeton Conference. New York:Grune & Stratton, 1965. Canada Med Assn J 1963;89:806-809. Abstracted in Year Book of Neurology, Neurosurgery and Psychiatry 1964.
158. Meyer JS. Pathophysiological basis of the EEG. In: EEG, Second Advanced Course
in Electroencephalography. Salzburg: Vertag der Wiener Medizinischen Akademie, 1965:34-35.
159. Meyer JS, Gotoh F, Favale E. Cerebral metabolism during epileptic seizures in man.
EEG Clin Neurophysiol 1966;21:10-22. 160. Gotoh F, Meyer JS, Ebihara S. Continuous recording of human cerebral blood flow
and metabolism. Methods for electronic monitoring of arterial and venous gases and electrolytes. Med Res Engin 1966;5:13-19. (Amer J Med Electronics)
161. Meyer JS, Gotoh F, Takagi Y, Kakimi R. Cerebral hemodynamics, blood gases, and
electrolytes during breath-holding and Valsalva maneuver. Circ 1966;3334(2):35-48.
16
162. Gotoh F, Meyer JS, Tomita M. Carbonic anhydrase inhibition and cerebral venous
blood gases and ions in man. Demonstration of increased oxygen availability to ischemic brain. Arch Intern Med 1966; 117:39-46.
163. Gotoh F, Meyer JS, Tomita M, Akiyama M. The hydrogen method for recording
cerebral blood flow. Trans Amer Neurol Assn 1966-91-.80-83. 164. Gilroy J, Meyer JS. Hypopituitarism with cerebral ischemia. Mod Med 1966;52:9394. 165. Meyer JS, Akiyama M, Yoshitake S, Gotoh F. Monitoring cerebral blood flow, oxygen,
glucose, lactate, an ammonia metabolism. Circ 1966;33-34(2):170. (Abstract) 166. Meyer JS, Gotoh F, Ebihara S. Influence of cerebrovascular disease and state of
consciousness on cerebral metabolism. Amer J Geriat 1966;14:205-220. Reprinted in Year Book of Anesthesiology 1967.
167. Meyer JS, Gotoh F, Tomita M, Akiyama M. Automatic recording of cerebral blood flow by
the nitrous oxide method without blood loss. Neurol 1966;16:305. (Abstract) 168. Gilroy J, Meyer JS, Bauer RB, Vulpe M, Greenwood D. Clinical, biochemical and
neurophysiological studies of chronic interstitial hypertropic polyneuropathy. Am J Med 1966;40:368-383.
169. Meyer JS, Gotoh F, Tomita M. Acute respiratory acidemia. Correlation of jugular blood
composition with electroencephalogram during C02 narcosis. Neurol 1966; 16:463-474. Reprinted in Year Book of Medicine 1967.
170. Gotoh F, Meyer JS, Tomita M. Hydrogen method for determining cerebral blood flow in
man. Arch Neurol 1966; 15;549-559. 171. Yoshida K, Meyer JS, Sakamoto K, Handa J. Autoregulation of cerebral blood flow.
Electromagnetic flow measurements during acute hypertension in the monkey. Circulation Res 1966;19:726-738.
172. Handa J, Meyer JS, Sakamoto K. Blood pressure changes induced by subclavian
injection of methylglucamine diatrizoate (Renografin@). Amer J Roentgen 1966;98:914-921.
173. Meyer JS, Gotoh F, Tomia M. Cerebral metabolism during arousal and mental activity in
stroke patients. Amer J Geriat 1966;14:986-1012. 174. Handa J, Yoshida K, Meyer JS. Hemodynamic effects of subclavian and innominate
artery ligation. Surg 1966;59:1069-1078. 175. Meyer JS. The neurological examination, diagnosis and prevention of strokes. In:
DeForest RD, ed. Proceedings of the National Stroke Congress. Springfield: Charles C. Thomas, 1966:65-70.
17
176. Meyer JS, Gotoh F, Tomita M, Akiyama M. New techniques for recording cerebral blood flow and metabolism in subjects with cerebrovascular disease. In: Millikan CH, Siekert RG, Whisnant JP, eds. Cerebral Vascular Diseases. Fifth Princeton Conference. New York:Grune &Stratton, 1966:147-166.
177. Gilroy J, Meyer JS. Controlled evaluation of cerebral vasodilator drugs in the
progressive stroke. In: Millikan CH, Siekert RG, Whisnant JP, eds. Cerebral Vascular Disease. Fifth Princeton Conference. New York:Grune & Stratton, 1966:197-209.
178. Bauer RB, Meyer JS, Gotham JE, Gilroy J. A controlled study of surgical treatment
of cerebrovascular diseases. Forty-two months experience with 183 cases. In: Millikan CH, Siekert RG, Whisnant JP, eds. Cerebral Vascular Disease. Fifth Princeton Conference. New York:Grune &Stratton, 1966:254-272.
179. Meyer JS, Herndon RM, Johnson JF, Barnhart M. Treatment of cerebrovascular
thrombosis with plasmin and plasminogen activators. In: Association for Research in Nervous and Mental Disease: Cerebrovascular Disease. Baltimore: Williams & Wilkins, 1966:373-398.
180. Meyer JS. Testimony on Neurology and Blindness (Stroke). Departments of Labor
and Health, Education and Welfare appropriations for 1967. Hearings before a subcommittee of the Committee on Appropriations, House of Representatives, 89th Congress, 2 nd Session, Congressman John E. Fogarty, Chairman. Washington, D.C.:U.S. Government Printing Office, 1966-150-153.
181. Meyer JS. Testimony as a citizen's witness on behalf of the needs of the National
Institute of Neurological Diseases and Blindness, April 25, 1967. Hearings before a Subcommittee on Appropriations, House of Representatives, 90 th Congress, First Session, Congressman Daniel J. Flood, Chairman. Washington, D.C.:U.S. Government Printing Office, 1967:201-205.
182. Meyer JS, Gotoh F, Takagi Y. Inhalations of oxygen and carbon dioxide. Effect on
composition of cerebral venous blood. Arch Intern Med 1967; 119:4-15. 183. Meyer JS, Handa J. Cerebral blood flow and metabolism during experimental
hyperthermia. Minn Med 1967;50:37-44. 184. Meyer JS, Sawada T, Kitamura A, Toyoda M. Improved cerebral blood flow after
control of hypertension in stroke. Trans Amer Neurol Assn 1967-92:79-84. 185. Boulos RS, Gilroy J, Meyer JS. Technique of cerebral angiography in children. Amer
J Roentgen 1967; 101: 121-127. 186. Meyer JS. Medical treatment of the progressive stroke. J Amer Med Assn
1967;199:120. (Editorial)
18
187. Meyer JS, Sawada T, Kitamura A, Toyoda M. Cerebral anaerobic glycolysis demonstrated by measuring cerebral glucose, lactate and pyruvate metabolism in human subjects with stroke. Circ 1967;36(2):187-188. (Abstract)
188. Meyer JS, Gotoh F, Akiyama M, Yoshitake S. Monitoring cerebral blood flow, oxygen
and glucose metabolism. Analysis of cerebral metabolic disorder in stroke and some therapeutic trials in human volunteers. Circ 1967,36:197-211.
189. Meyer JS, Eadia GA, Ericsson AD, Hobbler SW, MacMahon HR. A pilot study of
antihypertensive therapy in cerebrovascular disease. Amer J Geriat 1967;15:313321. 190. Meyer JS, Sakamoto K, Akiyama M, Yoshida K, Yoshitake S. Monitoring cerebral
blood flow, metabolism and EEG. EEG Clin Neurophysiol 1967;23:497-508. 191. Meyer JS, Yoshida K, Sakamoto K. Autonomic control of cerebral blood flow
measured by electromagnetic flowmeters. Neuro11967;17:638-648. 192. Meyer JS, Gotoh F, Akiyama M, Yoshitake S. Monitoring cerebral blood flow,
oxygen, glucose, lactate and ammonia metabolism. Experimental trials in animals. Circ Res 1967;21:649-660.
193. Meyer JS, Gotoh F, Akiyama M, Yoshitake S. Autonomic recording of cerebral blood
flow by nitrous oxide inhalation without blood loss. Neurol 1967; 17:838-853. 194. Gilroy J, Meyer JS. Cerebral vascular disease and endocrine disorders. In: Bajusz E,
ed. An Introduction to Clinical Neuroendocrinology. Basel: S Karger, 1967:340355. 195. Meyer JS, Bauer RB, Rayson GE. Natural history of extracranial cerebrovascular
insufficiency. In: Brest AN, Moyer JH, eds. Atherosclerotic Vascular Disease. New York: Appleton-Century-Croft, 1967:433-444.
196. Meyer JS. Medico-legal considerations following trauma to the head and neck. In:
Belli MM, ed. Trial and Tort Trends. Belli Seminar 1967. Vienna, Virginia: Coiner Publications, 1968:214-240.
197. Bauer RB, Boulos RS, Meyer JS. Natural history and surgical treatment of occlusive
cerebrovascular disease evaluated by serial arteriography. Amer J Roentgen 1968;104:1-17.
198. Meyer JS, Gilroy J. Regulation and adjustment of the cerebral circulation. Dis Chest
1968;53:30-40. 199. Basu DB, Gilroy J, Meyer JS. Intermittent cortico-steroid treatment of demyelinating
diseases in children. Mich Med 1968;67:474-481. 200. Meyer JS, Sawada T, Kitamura A, Toyoda M. Cerebral blood flow after control of
hypertension in stroke. Neurol 1968;18:772-781.
19
201. Fields WS, North RR, Hass WK, Galbraith JG, Wylie EF, Ratinov G, Burns MH, MacDonald MC, Meyer JS. Joint study of extracranial arterial occlusion as a cause of stroke. 1. Organization of study and survey of patient population. J Amer Med Assn 1968;203:955-960.
202. Meyer JS, Sawada T, Kitamura A, Toyoda M. Cerebral oxygen, glucose, lactate and
pyruvate metabolism in stroke. Therapeutic considerations. Circ 1968;37:1036-1048. 203. Meyer JS, Toyoda M, Shinohara Y, Kitamura A, Ryu T, Wiederholt 1, Guiraud B.
Regional cerebral blood flow (carotid perfusion) measured by clearance of hydrogen from cerebral venous blood. Scand J Clin Lab Invest 1968;22(102):XI:G. Abstracted in Trans Amer Neurol Assn 1968.
204. Meyer JS. The nature of high oxygen tensions in bordering zones of cerebral
ischemia. Scan J Clin Lab Invest 1968-22(102):XVI:A. 205. Meyer JS, Ericsson AD. Definition and classification of cerebrovascular disease. In:
Borhani NO, Meyer JS, eds. Medical Basis for Comprehensive Community Stroke Programs, Special Task Force of the Joint Council's Subcommittee on Cerebrovascular Disease, National Heart Institute and National Institute of Neurological Diseases and Blindness 1968.
206. Borhani NO, Meyer JS, eds. Medical Basis for Comprehensive Community Stroke
Programs. Special Task Force of the Joint Council's Subcommittee on Cerebrovascular Disease, National Heart Institute and National Institute of Neurological Diseases and Blindness 1968.
207. Barnhart MI, Gilroy J, Meyer JS. Platelet function in acute stroke treated with
Rheomacrodex. Clinical and pharmacological studies of dextrans. Texas Heart Assn 1968.
208. Barnhart MI, Vettraino A, Gilroy J, Meyer JS. Platelet changes during
cerebrovascular thrombosis. 12' Cong of the International Society of Hematology. NewYork, 1968:197. (Abstract)
209. Meyer JS. Testimony on behalf of the needs of the National Institute of Neurological
Diseases and Blindness. Hearings before a subcommittee of the Committee on Appropriations, House of Representatives, Congressman Flood, Chairman, April 25,1968.
210. Meyer JS, Sawada T, Toyoda M, Kitamura A. Anaerobic cerebral metabolism
induced by ischemia. Relation to hyperventilation and cerebrovascular disease in man. In: Toole JF, Siekert RG, Whisnant JP, eds. Cerebral Vascular Disease, Sixth Princeton Conference. New York:Grune & Stratton, 1968:111-122.
211. Meyer JS, Nomura F, Sakamoto K, Kondo A. Effect of stimulation of the brain stem
reticular formation on cerebral blood flow and oxygen consumption. EEG Clin Neurophysiol 1969;26:125-132.
20
212. Gilroy J, Barnhart MI, Meyer JS. Treatment of acute stroke with dextran 40. J Amer Med Assn 1969;210:292-298. Abstracted in Modern Medicine 1970.
213. Meyer JS, Shinohara Y, Kanda T, Fukuuchi Y, Ericsson AD, Rodprasert P.
Hemispheric blood flow and metabolism in neurological disease - a note on the metabolic accompaniments of diaschisis. Trans Amer Neurol Assn 1969;94:303307.
214. Meyer JS, Wiederholt IC, Toyoda M, Ryu T, Shinohara Y, Guiraud B. A new method
for continuous sampling of cerebral venous blood without extracranial contamination in man. Bilateral transbrachial catheterization of the cerebral venous sinuses. Neurol 1969; 19:353-358. Abstracted in Modern Medicine 1970.
215. Bauer RB, Meyer JS, Fields WS, Remington R, MacDonald MC, Callen P. Joint
study of extracranial arterial occlusion. 111. Progress report of controlled study of long-term survival in patients with and without operation. J Amer Med Assn 1969;208:509-518.
216. Meyer JS. Testimony on behalf on the needs of the National Institute of Neurological
Diseases and Stroke. Hearings before a Subcommittee of the Committee on Appropriations, House of Representatives, Congressman Flood, Chairman, May 22, 1969.
217. Gotoh F, Meyer JS, Takagi Y. Cerebral venous and arterial blood gases during
Chyne-Stokes respiration. Amer J Med 1969;47:534-545. 218. Shinohara Y, Meyer JS, Kitamura A, Toyoda M, Ryu T. Measurement of cerebral
hemispheric blood flow by intracarotid injection of hydrogen gas. Validation of the method in the monkey. Circ Res 1969;25:735-745.
219. Meyer JS, Gotoh F. Clinical and physiological tests on metabolism and blood flow in
the brain. In: Mchedlishvilli GI, ed. Correlation of Blood Supply with Metabolism and Function. 2nd International Symposium. Tbilisi: Metsniereba, 1969.
220. Meyer JS, Ryu T, Toyoda M, Shinohara Y, Eiderholt 1, Guiraud B. Evidence for a
Pasteur effect regulating cerebral blood oxygen and carbohydrate metabolism in man. Neurol 1969;19:954-962.
221. Meyer JS, Kondo A, Nomura F, Sakamoto K, Teraura T. Cerebral hemodynamics
and metabolism following brain trauma. Demonstration of luxury perfusion following brain stem laceration. In: Brock M, Fieschi C, Ingvar DH, Lassen NA, Schurmann K, eds. Cerebral Blood Flow. Berlin- Springer-Verlag, 1969:199-201.
222. Loeb C, Meyer JS. Pontine syndromes. In: Vinken PJ, Bruyn GW, eds. Handbook of
Clinical Neurology. Amsterdam: North-Holland Publishing, 1969;2:238-271. 223. Meyer JS, Shinohara Y, Kanda T, Fukuuchi Y, Rodprasert P, Ericsson AD. A new
method for measuring hemispheric blood flow and metabolism in man. International Congress Series No. 193. Amsterdam: Excerpta Medica Foundation, 1969:252. (Abstract)
21
224. Tomita M, Meyer JS, Gotoh F. Desaturation of hydrogen gas from human brain after
inhalation. In: Meyer JS, Lechner H, Eichhorn 0, eds. Research on the Cerebral Circulation. Third Salzburg Conference. Springfield: Charles C. Thomas, 1969:145-172.
225. Meyer JS. Clinical investigations of the nature and treatment of cerebral metabolic
disorders resulting from cerebral ischemia and anoxia. In: Locke S, ed. Modern Neurology. Boston: Little, Brown & Co., 1969:483-490.
226. Toyoda M, Meyer JS. Effects of cerebral ischemia, seizures, and anoxia on arterial
concentrations of catecholamines. Cardiovasc Res Cent Bull 1969;8-.59-74. 227. Meyer JS. Statement presented before the Subcommittee on Health. United States
Senate, Senator Ralph Yarborough, Chairman, February 18, 1970. 228. Szewcykowski J, Meyer JS, Kondo A, Nomura F, Teraura T. Effects of ergot
alkaloids (hydergine) on cerebral hemodynamics and oxygen consumption in monkeys. J Neurol Sci 1970;10:25-31.
229. Meyer JS. Newer concepts of cerebral vascular disease. Med Clin N.A.
1970;54:349-360. 230. Meyer JS, Kondo A, Nomura F, Sakamoto K, Teraura T. Cerebral hemodynamics
and metabolism following experimental head injury. J Neurosurg 1970;32:304-319. 231. Meyer JS, Ryu T, Shinohara Y, Toyoda M, Wiederholt 1, Guiraud B. Effects of
altering oxygen delivery and cerebral blood flow independently on cerebral metabolism in stroke. In: Meyer JS, Lechner H, Eichhorn 0, eds. Research on the Cerebral Circulation. Fourth Salzburg Conference. Springfield: Charles C. Thomas, 1979:223-236.
232. Fields WS, Maslenikov V, Meyer JS, Hass WK Remington R, MacDonald M. Joint
study of extracranial arterial occlusion. V. Progress reports of prognosis in operated and non-operated patients with transient cerebral ischemic attacks and cervical carotid artery lesions. J Amer Med Assn 1970;211:1993-2003.
233. Meyer JS. Statement before the Subcommittee of the Committee on Appropriations
for Labor and Health, Education and Welfare, House of Representatives, Congressman Daniel Flood, Chairman, Washington, D.C., June 9, 1970, 879-889.
234. Meyer JS, Kondo A, Szewcykowski J, Nomura F, Teraura T. The effect of a new
drug (Hexo-bendine) on cerebral hemodynamics and oxygen consumption. J Neurol Sci 1970;1:137-145.
235. Meyer JS, Shinohara Y, Kanda T, Fukuuchi Y, Kok N, Ericsson AD. Abnormal
hemispheric blood flow and metabolism despite normal angiograms in patients with stroke. Stroke 1970;1:219-223.
22
236. Meyer JS, Ericsson AD. Diagnosis and prevention of acute stroke. Sandoz Panorama 1970;8:4-8.
237. Meyer JS, Shinohara Y, Kanda T, Fukuuchi Y, Ericsson A, Kok N. Diaschisis
resulting from acute unilateral cerebral infarction: Quantitative evidence for man. Arch Neurol 1970;23:241-247.
238. Teraura T, Meyer JS, Hashi K, Marx P, Sakamoto K, Sterman-Marinchescu. Acute
brain swelling following temporary occlusion of four vessels in the monkey. Circ 1970;41-42(3):108. (Abstract)
239. Meyer JS, Bauer RB, Rivera-Olmos VM, Nolan DC, Lerner AM. Herpes virus
hominis, neurological manifestations and use of idoxuridine. Arch Neurol 1970;23:438-450.
240. Meyer JS, Binns PM, Ericsson AD, Vulpe M. Sphenopalatine ganglionectomy for
cluster headache. Arch Otolaryng 1970192:475-484. 241. Welch KMA, Meyer JS. Control of cerebral blood flow. Letter to the Editor. Lancet
1970;2:1316. 242. Meyer JS, Kanda T, Shinohara Y, Fukuuchi Y. Changes in cerebrospinal fluid
sodium and potassium concentrations during seizure activity. Neurol 1970;20:1179-1184.
243. Meyer JS, Kanda T, Shinohara Y, Fukuuchi Y, Ericsson AD, Kok NK. Effect of
hexobendine on cerebral blood flow and metabolism in cerebrovascular disease. Neurol 1970;20:375. (Abstract)
244. Meyer JS, Shinohara Y. A method for measuring hemispheric blood flow and
metabolism. Stroke 1970;1:419-431. 245. Meyer JS, Teraura T. Central neurogenic control of cerebral blood flow. Trans Amer
Neurol Assn 1970;95:15-20. 246. Meyer JS, Toyoda M. Studies of rapid changes in cerebral circulation and
metabolism during arousal and rapid eye movement sleep in man. In: Zulch KF, ed. Cerebral Circulation and Stroke. Berlin: Springer-Verlag, 1971:156-163.
247. Feifar Z, Hatano S, Meyer JS, et al. Cerebrovascular Diseases: Prevention,
Treatment, and Rehabilitation. Report of WHO meeting. World Health Organization technical report series No. 469. In: Langfitt TW, McHenry LC Jr, Reivich M, Wollman H, eds. Cerebral Circulation and Metabolism. New York: Springer-Verlag, 1975:336-338.
248. Meyer JS, Marx P. Cerebral autoregulation and dysautoregulation and their relation
to cerebral vascular symptoms. Current Concepts of Cerebrovasc Dis (Stroke) 1971; 6:Jan-Feb.
23
249. Meyer JS. Review of methods of measuring cerebral blood flow and metabolism. In: Stocker G, Kuhn RA, Hall P, Becker G, van der Veen E, eds. Assessment in Cerebrovascular Insufficiency. Wurzburg Stuttgart: George Thieme, 1971136-140.
250. DeBakey ME, Noon GP, Diethrich EG, Meyer JS. Diagnosis and treatment of
cerebrovascular insufficiency. Brochure accompanying exhibit. Baylor College of Medicine 1971.
251. Meyer JS, Teraura T, Sakamoto K, Kondo A. Central neurogenic control of cerebral
blood flow. Neurol 1971;21:247-262. 252. Suzuki M, Fukuuchi Y, Shimazu K, Meyer JS. Experimental atherosclerosis of the
cerebral arteries in dogs. 11. A study on cerebral blood flow. Amer J Path 1971;62:33a. (Abstract)
253. Meyer JS, Fukuuchi Y, Kanda T, Shimazu K. New method for measuring regional
cerebral blood flow by the use of implanted electrodes, with comments on "intracerebral steal". Neurol 1971;21:401. (Abstract)
254. Meyer JS. Stroke-past, present and future: a personal view. Stroke 1971;2:95-100. 255. Meyer JS, Fukuuchi Y, Kanda T, Shimazu K. Regional measurements of cerebral
blood flow and metabolism using intracarotid injection of hydrogen, with comments on intracerebral steal. In: Ross-Russell RW, ed. Brain and Blood Flow. Fourth International Symposium on the Regulation of Cerebral Blood Flow. London:Pitman Medical and Scientific Publishing, 1971:71-79.
256. Meyer JS, Fukuuchi Y, Kanda T, Shimazu K. Interactions between cerebral
metabolism and blood flow. In: Ross-Russel RW, ed. Brain and Blood Flow. Fourth International Symposium on the Regulation of Cerebral Blood Flow. London:Pitman Medical and Scientific Publishing, 1971:156-163.
257. Barnhart MI, Gilroy J, Meyer JS. Dextran 40 in cerebrovascular thrombosis. Thromb
Diath Hemorrh 1971;(40):321-344. 258. Meyer JS, Teraura T, Sakamoto K, Hashi K. The effect of Pavabid@ (oral
papaverine) on cerebral blood flow and metabolism in the monkey. Cerebrovasc Res Cent Bull 1971;9:105-129.
259. Meyer JS, Kanda T, Shinohara Y, Fukuuchi Y, Shimazu K, Ericsson AD, Gordon WH
Jr. Effect of hexobendine on cerebral hemispheric blood flow and metabolism. Preliminary clinical observations concerning its use in ischemic cerebrovascular disease. Neurol 1971;21:691-702.
260. Meyer JS, Kanda T, Fukuuchi Y, Shimazu K, Dennis EW, Ericsson AD. Clinical
prognosis correlated with hemispheric blood flow in cerebral infarction. Stroke 1971;2:383-394.
24
261. Rosenstock HA, Simons DG, Meyer JS. Chronic manganism. Neurologic and laboratory studies during treatment with Levodopa. J Amer Med Assn 1971;217:1354-1361.
262. Meyer JS, Kanda T, Shinohara Y, Fukuuchi Y. Effects of anoxia on cerebrospinal
fluid sodium and potassium concentrations. Neurol 1971;21:889-895. 263. Kannel WB, Blaisell FW, Gifford R, Hass W, McDowell F, Meyer JS, Seltser R. Risk
factors in stroke due to cerebral infarction. Stroke 1971;2-.428-432. 264. Meyer J, Charney J, Rivera V, Mathew N. Treatment of cerebral edema due to acute
cerebral infarction with glycerol. Lancet 1971;2:993-997. Abstracted in Mod Med 1972;40:72. Abstracted in Family Circle, March 1972. Reprinted in Year Book of Drug Therapy 1972. Reprinted in Year Book of Neurology and Neurosurgery 1972. Abstracted in International Conference, Salzburg, 1972. Stuttgart: George Thieme, 1973:264-271.
265. Meyer JS, Fukuuchi Y, Shimazu K, Ohuchi T, Mathew NT, Ericsson AD. Treatment
of cerebral infarction with hyperosmolar agents(glycerol and mannitol). Circ 1971;43-44(2):96. (Abstract)
266. Meyer JS, Charney JZ, Rivera VM, Mathew NT. Cerebral embolization: prospective
clinical analysis of 42 cases. Stroke 1971;2:541-554. 267. Mathew N, Meyer J, Bell R, Ericsson A. New method for measuring regional cerebral
blood flow and blood volume in man using the gamma camera. Trans Amer Neurol Assn 1971;96:273-275.
268. Shimazu K, Fukuuchi Y, Meyer JS, Suzuki M. Experimental cerebral atherosclerosis
in the dog. Ill. Effects of carbon dioxide on the cerebral blood flow. AHA 44h Scientific Sessions, Anaheim, November 1971. Circ 1971;43-44(ill):25. (Abstract)
269. Meyer JS, Welch KMA. Relationship of cerebral blood flow and metabolism to
neurological symptoms. In: Meyer JS, Schade JP, eds. Cerebral Blood Flow, Progress in Brain Research, Volume 35. Amsterdam: Elsevier, 1972:285-347.
270. Hashi K, Meyer JS, Shinmaru S, Welch KMA, Teraura T. Hemodynamic and
metabolic changes in experimental subarachnoid hemorrhage. Panminerva Med 1971;13:191. (Abstract) Eur Neurol 1972;8:32-37. In: Fieschi C, ed. Cerebral Blood Flow and Intracranial Pressure. 5h International Symposium on Cerebral Blood Flow Regulation, Acid-Base and Energy Metabolism in Acute Brain Injuries. Roma-Siena 1971. Base[: S Karger, 1972:414-419.
271. Meyer JS, Fukuuchi Y, Shimazu K, Mathew NT, Ohuchi T. Effects of cerebral
compression by a mass lesion on regional cerebral blood flow. Panminerva Med 1971;13:195. (Abstract) Eur Neurol 1972-8:83-91. In: Fieshci C, ed. Cerebral Blood Flow and Intracranial Pressure. 5th InternationalSymposiumm on Cerebral Blood Flow Regulation, Acid-Base and Energy Metabolism in Acute Brain Injuries. Basel:S Karger, 1970:4-8.
25
272. Meyer JS, Mathew NT, Fukuuchi Y, Teraura T, Shimazu K, Charney JZ. Importance
of therapeutic control of cerebral edema by medical means in vascular diseases of the brain. In: Third Asian andOceanicn Congress of Neurology. Bombay, 1971 (abstract). In: First All-India Workshop-Conference on Stroke, November 1971, Vellore, India, Christian Medical College Hospital, 1971, 82-91. Indian Council of Medical Research, New Delhi, 1973, 76-83.
273. BelIRL, Mathew NT, Ericsson AD, Meyer JS, Johnson PC. Quantitative cerebral
blood flow with the gamma camera and magnetic tape. A comparative study of intracarotid injection of 133Xenon and 99m technetium pertechnetate. J Nuclear Med 1971;12:338. (Abstract)
274. Meyer JS, Fukuuchi Y, Shimazu K, Ohuchi T, Ericsson AD. Abnormal hemispheric
blood flow and metabolism in cerebrovascular disease. 1. Disordered patterns of hemispheric metabolism. Stroke 1972;3:141-156.
275. Meyer JS, Fukuuchi Y, Shimazu K, Ohuchi T, Ericsson AD. Abnormal hemispheric
blood flow and metabolism in cerebrovascular disease. 11. Therapeutic trials with 5%CO2 inhalation, hyperventilation, and intravenous infusion of THAM and Mannitol. Stroke 1972;3:157-167.
276. Meyer JS, Fukuuchi Y, Shimazu K, Ohuchi T, Ericsson AD. Effect of intravenous
infusion of glycerol on hemispheric blood flow and metabolism in patients with acute cerebral infarction. Stroke 1972;3:168-180.
277. Meyer JS, Stoica E, Giri NY, Shimazu K. Cerebral metabolic changes accompanying
ischemia of the brain. In:Prociram of the Journees Internationales de Circulation Cerebrale, Toulouse, France, April, 1972 (abstract). In: Geraud J, Lazorthes G, Bes A, eds. L'iscehmie Cerebrale dans le Territoire Carotidien, Toulouse: Fournie Press, 1973:211-226.
278. Meyer JS, Shimazu K, Fukuuchi Y, Ohuchi T, Okamoto S, Koto A, Ericsson AD.
Cerebral dysautoregulation in central neurogenic orthostatic hypotension (Shy-Drager syndrome). Neurol 1972;22:407. (Abstract) Neurol 1973;23:262-273.
279. Meyer JS, Guirand B, Bauer R. Clinical and pathophysiological considerations of
atherosclerotic and thrombotic disease of the carotid arteries. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: North Holland, 1972-.327-365.
280. Welch KMA, Meyer JS, Kwant S. Estimation of levels of serotonin and 5-
hydroxyindoles in whole blood by auto-analytical procedure. Observations on the blood-brain barrier. 1972 Technicon International Congress. J Neurochem 1972;19:1079-1087. Reprinted in Advances in Automated Analysis.
281. Meyer JS, Fukuuchi Y, Kanda T, Shimazu K. Regional cerebral blood flow measured
by intracarotid injection of hydrogen. Comparison of impaired regional vasomotor capacitance from cerebral infarction versus compression. Neurol 1972;22:571-584.
26
282. Teraura T, Meyer JS, Sakamoto K, Hashi K, Marx P, Sterman-Marinchesu C,
Shinmaru S. Hemodynamic and metabolic concomitants of brain swelling and cerebral edema due to experimental cerebral infarction. J Neurosurg 1972,36:728-744.
283. Welch KMA, Meyer JS, Teraura T, Hashi K, Shinmaru S. Ischemic anoxia and
cerebral serotonin levels. J Neurol Sci 1972;16:85-92. Abstracted in Stroke 1973;4:105.
284. Meyer JS, Ericsson AD. Cerebral circulation and metabolism in neurological
disorders. Part 1. Coma. Part 11. Cerebrovascular disease. In: Carpi A, ed. International Encyclopedia of Pharmacology and Therapeutics. Oxford: Pergamon Press Ltd., 1972:253-296.
285. Hashi K, Meyer JS, Shinmaru S, Welch KMA, Teraura T. Cerebral hemodynamic
and metabolic changes after experimental subarachnoid hemorrhage. J Neurol Sci 1972;17:1-14.
286. Hashi K, Meyer JS, Shinmaru S, Welch KMA, Teraura T. Changes in cerebral
vasomotor reactivity to C02 and autoregulation following experimental subarachnoid hemorrhage. J Neurol Sci 1972; 17:15-22.
287. Hashi K, Meyer JS, Shinmaru S, Welch KMA, Teraura T. Effect of glycerol and
intracarotid phenoxybenzamine on cerebral hemodynamics and metabolism after experimental subarachnoid hemorrhage, J Neurol Sci 1972;17.-23-28.
288. Mathew NT, Meyer JS, Bell R, Johnson PC, Neblett PC. Regional cerebral blood
flow and blood volume measured with the gamma camera. Neuroradiol 1972-4-.133-140.
289. Meyer JS, Perusquia E, Infante E. Blepharospasm: A rare sign of corticostriatobular
release. Trans Amer Neurol Assn 1972;97:311-312. 290. Shinmaru S, Ohuchi T, Meyer JS, Teraura T. Catheter-mounted oxygen electrode for
monitoring oxygen tension. Cardiovasc Res Cent Bull 1972;10:111-122. 291. Mathew NT, Meyer JS, Rivera VM, Charney JZ, Hartmann A. Double-blind
evaluation of gycerol therapy in acute cerebral infarction. Lancet 1972;2:1327-29. Abstracted in Mod Med 1973:41:73.
292. Meyer JS, Teraura T, Marx P, Hashi K, Akamoto K. Brain swelling due to
experimental cerebral infarction. Changes in vasomotor capacitance and effects of intravenous glycerol. Brain 1972;95:833-852.
293. Marx P, Teraura T, Hashi K, Meyer JS. The movement of chloride ions during
cerebral ischemia. In: Meyer JS, Reivich M, Lechner H, Eichhorn 0, eds. Research on the Cerebral Circulation. Fifth Salzburg Conference. Springfield: Charles C. Thomas, 1972:146-154.
27
294. Meyer JS, Fields WS. A controlled therapeutic trial of carotid endarterectomy versus
non-surgical treatment in occlusive cerebrovascular disease. Five-year follow-up of patients with transient neurologic deficits. In: Meyer JS, Reivich M, Lechner H, Eichhorn 0, eds. Research on the Cerebral Circulation. Fifth Salzburg Conference. Springfield: Charles C. Thomas, 1972:396-400.
295. Mathew NT, Meyer JS, Rivera VM. Glycerol in acute cerebral infarction. Letter to the
Editor, Lancet 1972;1:204. 296. Meyer JS, Mathew NT, Shimazu K. Clinical management of cerebral ischemia. In:
McDowell FH, Brennan RW, eds. Cerebral Vascular Disease. Eight Conference. New York:Grune &Stratton, 1973:191-204.
297. Meyer JS, Mathew NT. Current status of the gamma camera for clinical diagnosis of
cerebrovascular disorders. Formal discussion of Dr. Richard Janeway's paper. In: McDowell FH, Brennan RW, eds. Cerebral Vascular Disease. Eighth Conference. New York:Grune &Stratton, 1973:274-275.
298. Meyer JS. Summary of the Sixth Salzburg Conference on Cerebral Vascular
Disease, September 27 to October 1, 1972, Salzburg, Austria. (Special Article) Stroke 1973;4:1-6.
299. Welch KMA, Hashi K, Meyer JS. Reconsideration of the role of serotonin in
subarachnoid hemorrhage. Australian Assn of Neurologists 1973;9:155-164. 300. Giri NY, Reddy YS, Meyer JS. Endogenous phosphorylation of calcium binding
protein isolated from brain actomyosin. Federation Proceedings 1973;32:429. (Abstract)
301. Pilgeram LO, von dem Bussche G, Meyer JS, Gotto A. Abnormalities in clotting and
thrombolysis as risk factor for stroke. Federation Proceedings 1973;32:314. (Abstract)
302. Meyer JS, Shimazu K, Fukuuchi Y, Ohuchi T, Okamoto S, Koto A, Ericsson AD.
Impaired neurogenic cerebrovascular control in dysautoregulation after stroke. Stroke 1973;4:169-186.
303. Meyer JS, Shimazu K, Okamoto S, Koto A, Ohuchi T, Sari A, Ericsson AD. Effects of
alpha adrenergic blockage on autoregulation and chemical vasomotor control of CBF in stroke. Stroke 1973-4:187-200.
304. Dodson RD, Hashi K, Meyer JS. The effect of glycerol and intracarotid
phenoxybenzamine after experimental subarachnoid hemorrhage. An ultrastructural study. Acta Neuropath 1973;24:1 -11.
305. Suzuki M, Fukuuchi Y, Shimazu K, Kim HS, Meyer JS. Cerebral atherosclerosis in
the dog. 11. Cerebral Circulation. Arch Pathoi 1973;96:14-17.
28
306. Meyer JS, Stoica E, Pascu 1, Shimazu K, Hartmann A. Catecholamine concentrations in CBF and plasma of patients with cerebral infarction and hemorrhage. Brain 1973;96:277-288.
307. Stoica E, Meyer JS, Kawamura Y, Hiromoto H, Hashi K, Aoyagi M, Pascu 1. Central
neurogenic control of cerebral circulation: Effects of intravertebral injection of pyrithioxin on cerebral blood flow and metabolism. Neurol 1973-23:687-698.
308, Meyer JS, Okamoto S, Shimazu K, Koto A, Itoh Y, Sari A, Giri NY, Ericsson AD. The
question of uncoupling of cerebral oxidative phosphorylation in acute cerebral infarction. Stroke 1973;4:378. (Abstract) In: Langfitt TW, McHenry LC Jr, Reivich M, Wollman H, eds. Cerebral Circulation and Metabolism. New York: SpringerVerlag, 1975:528-532.
309. Mathew NT, Meyer JS, Hartmann A. Effect of alpha and beta adrenergic blocking
agents on regional cerebral blood flow and C02 responsiveness in patients with cerebrovascular disease. Stroke 1973;4:372. (Abstract) In: Langfitt TW, McHenry LC Jr, Reivich M, Wollman H, eds. Cerebral Circulation and Metabolism. New York: Springer-Verlag, 1975:336-338.
310. Hartmann A, Aoyagi M, Giri NY, Mathew NT, Meyer JS. Effect of cyclic AMP on
regional cerebral blood flow in normal baboons. Stroke 1973;4:357. (Abstract) In: Langfift TW, McHenry LC Jr, Reivich M, Wollman H, eds. Cerebral Circulation & Metabolism. New York: Springer-Verlag, 1975:336-338.
311. Mathew NT, Meyer JS. Natural history and pathogenesis of transient ischemic global
amnesia (TGA). Circ 1973;48(IV):97. (Abstract) 312. Meyer JS, Shimazu K, Okamoto S, Koto A, Itoh Y, Sari A, Giri NY, Ericsson AD. The
question of uncoupling of cerebral oxidative phosphorylation in acute cerebral infarction. Excerpta Medica, Tenth International Congress of Neurology 1973;296:185. (Abstract)
313. Rivera VM, Meyer JS, Mathew NT. Vasodilator therapy. Controlled trials in acute and
chronic cerebrovascular disease. Excerpta Medica, Tenth International Congress of Neurology 1973;296:216. (Abstract)
314. Hartmann A, Aoyagi M, Giri NY, Mathew NT, Meyer JS. The effect od dibutyl cyclic
AMP on regional cerebral blood flow in the baboon. Excerpta Medica, Tenth International Congress of Neurology 1973-296:151. (Abstract)
315. Mathew NT, Meyer JS, Hartmann A. Diagnosis and treatment of complicating factors
in subarachnoid hemorrhage. Evaluation by a new approach. Neurol 1973;23:397. (Abstract)
316. Welch KMA, Hashi K Meyer JS. Cerebrovascular response to intracarotid injection
of serotonin before and after middle cerebral artery occlusion. J Neurol Neurosurg Psychiat 1973;36:724-735.
29
317. Mathew NT, Meyer JS, Hartmann A. Diagnosis and treatment of subarachnoid and
intracerebral hemorrhage analyzed by regional cerebral blood flow measurements. In: Meyer JS, Lechner H, Reivich M, Eichhorn 0, eds. Cerebral Vascular Disease. Sixth International Salzburg Conference. Stuttgart: George Thieme, 1973:176-183.
318. Meyer JS. Summary of the Sixth Salzburg conference on Cerebral Vascular
Disease. In: Meyer JS, Lechner H, Reivich M, Eichhorn 0, eds. Cerebral Vascular Disease. New York: Springer-Verlag, 1975:224-227.
319. Meyer JS, Shimazu K, Okamoto S, Koto A, Itoh Y, Sari A, Ericsson AD. Two
separate mechanisms controlling cerebral blood flow: Effect of alpha adrenergic blockade on cerebral autoregulation and chemical vasomotor control. Trans Amer Neurol Assn 1973;98:284-286.
320. Meyer JS, Mathew NT. Medical management in cerebral ischemia. In: Ingelfinger F,
Ebert RV, Finland M, Reiman AS, eds. Controversy in Internal Medicine, Volume 2. Philadelphia:WB Saunders, 1974:771-786.
321. Meyer JS, Shimazu K, Ohuchi T, Okamoto S, Koto A, Fukuuchi Y, Ericsson AD.
Cerebral metabolic effects of glycerol infusion in diabetics with stroke. J Neurol Sci 1974;21:1-22.
322. Meyer JS, Mathew NT, Hartmann A, Rivera VM. Orally administered betahistine and
regional cerebral blood flow in cerebrovascular disease. J Clin Pharmacol 1974;14:280-289.
323. Mathew NT, Meyer JS, Hartmann A. Diagnosis and treatment of factors complicating
subarachnoid hemorrhage. Neuroradiol 1974;6:236-245. 324. Welch KMA, Meyer JS, Okamoto S, Mathew NT, Rivera VM, Bond J. Glycerol-
induced hemolysis; letter to the editor. Lancet 1974;1:416-417. 325. Meyer JS, Okamoto S, Sari A, Koto A, Itoh Y, Ericsson AD. Effects of beta-
adrenergic blockage on cerebral autoregulation and chemical vasomotor control in patients with stroke. Stroke 1974-5:167-179.
326. Meyer JS, Okamoto S, Shimazu K, Koto A, Ohuchi T, Sari A, Ericsson AD. Cerebral
metabolic changes during treatment of subacute cerebral infarction by alpha and beta adrenergic blockage with phenoxybenzamine and propranolol. Stroke 1974;5:180-195.
327. Meyer JS, Ott EO, Aoyagi M, Kawamura Y, Tagashira Y, Matsuda M, Achari AN. In
migraine. In: Ingvar DH, Lassen NA, eds. Cerebral function, metabolism and circulation. Copenhagen: Munksgaard Press, 1977:196-197.
30
328. Betz E, Kok N, Mchedlishvili G, Meyer JS, Pocchiari F. Influence on the EEG of certain physiological states and other parameters, Part B. In: Cooper R, ed. Physiological correlates of EEG, Volume 7. In: Remond A, ed. Handbook of electroencephalography and clinical neurophysiology. Amsterdam.. Elsevier, 1974.
329. Rivera VM, Meyer JS, Baer PE, Faibish GM, Mathew NT, Hartmann A.
Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride. JAGS 1974-722:397-406.
330. Mathew NT, Meyer JS. Pathogenesis and natural history of transient global
amnesia. Stroke 1974;5:303-311. 331. Welch KIVIA, Meyer JS, Chee ANC. Significance of altered cerebral arteriovenous
blood levels of cyclic AMP after cerebral infarction in man. Program of the Society for Neurosciences, Fourth Annual Meeting, St. Louis, 1974:472. (Abstract)
332. Itoh Y, Meyer JS, Miyakawa Y, Ishihara N, Ott EO, Achari AN, Mathew NT. The
question of vasospasm versus breakthrough in the pathogenesis of hypertensive encephalopathy. Circ 1974;50(3):90. (Abstract)
333. Matsuda M, Meyer JS, Ott EO, Aoyagi M, Tagashira Y. Cholinergic influence on
autoregulation and C02 responsiveness of the brain. Circ 1974;50(3):90. (Abstract) 334. Oft EO, Mathew NT, Meyer JS. Redistribution of regional cerebral blood flow after
glycerol infusion in acute cerebral infarction. Neurol 1974;24-.1117-1126. 335. Meyer JS, Welch KMA, Okamoto S, Shimazu K. Disordered neurotransmitter
function. Demonstration by measurement of norepinephrine and 5hydroxytryptamine in CSF of patients with recent cerebral infarction. Brain 1974;97:655-664.
336. Meyer JS. Cerebral blood flow studies in stroke. MCV Quar 1974; 10(3):123-127. 337. Meyer JS. Clinical advances in the diagnosis of cerebral vascular disease. MCV
Quar 1974; 10(3):124-138. 338. Kawamura Y, Meyer JS, Hiromoto H, Aoyagi M, Hashi K. Neurogenic control of
cerebral blood flow in the baboon. Effects of alpha adrenergic blockade with phenoxybenzamine on cerebral autoregulation and vasomotor reactivity to changes in PaC02. Stroke 1974;5:747-758.
339. Tulleken CAF, Meyer JS, Ott EO, Abraham J, Dodson RF. Brain tissue pressure
gradients in experimental infarction and space occupying lesions. Clin Neurol Neurosurg 1974;77:198-121.
340. Mathew NT, Hartmann A, Meyer JS. Diagnostic evaluation of normal pressure
hydrocephalus. Trans Amer Neurol Assn 1974;99:227-229.
31
341. Welch KMA, Meyer JS, Okamoto S, Itoh Y, Sakaki S, Miyakawa Y, Ericsson AD, Chabi E, Chee ANC. Beneficial effects of glycerol in cerebral infarction - osmotic or metabolic? Trans Amer Neurol Assn 1974;99:262-265.
342. Mathew NT, Hartmann A, Meyer JS, Ott EO. The importance of "CSF pressure-
regional cerebral blood flow dysautoregulation" in the pathogenesis of normal pressure hydrocephalus. In: Lundberg N, Ponten U, Brock M, eds. Intracranial pressure, Volume 11. Berlin, Heidelberg, New York: Springer Verlag, 1975:145149.
343. Tulleken CAF, Meyer JS, Ott EO, Abraham J, Dodson RF. Brain tissue pressure
gradients in experimental infarction recorded by multiple wick-type transducers. In: Lundberg N, Ponten U, Brock M, eds. Intracranial pressure, Volume 11. Berlin, Heidelberg, New YYork: SpringerVerlag, 1975:224-227.
344. Ott EO, Abraham J, Meyer JS, Achari AN, Chee ANC, Mathew NT. Disordered
cholinergic neuro-transmission and dysautoregulation after acute cerebral infarction. Stroke 1975;6:172-180.
345. Meyer JS. Summary of the Seventh Salzburg International Conference on Cerebral
Vascular Disease, September 25-29, 1974. Special Article. Stroke 1975-6:190215. 346. Welch KMA, Meyer JS, Chee ANC. Evidence for disordered cyclic AMP metabolism
in patients with cerebral infarction. EEuropeNeurol 1975; 13:144-154. 347. Mathew NT, Davis D, Meyer JS, Chandar K. Hyperlipoproteinemia in occlusive
cerebrovascular disease. JAMA 1975;232:262-266. 348. Meyer JS, Itoh Y, Okamoto S, Welch KMA, Mathew NT, Ott EO, Sakaki S, Miyakawa
Y, Chabi E, Ericsson AD. Circulatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction. Circ 1975;51:701-702.
349. Meyer JS, Rivera VM. Stroke. The Methodist Hospital Journal, 1975; February: 4-5. 350. Mathew NT, Hrastnik F, Meyer JS, Itoh Y, Miyakawa Y, Ishihara N. "Breakthrough"
versus angiospasm in the pathogenesis of hypertensive encephalopathy. Stroke 1975;6:225.
351. Deshmukh VD, Meyer JS, Aoyagi M, Matsuda M, Tagashira Y, Mathew NT, Hrastnik
F, Achari AN. Evidence for cholinergic neurogenic influence on cerebral blood flow. Stroke 1975;6:226.
352. Achari AN, Meyer JS, Abraham J, Ott EO, Migliore PJ, Tagashira Y. Cholinesterase
activity in the brain following acute cerebral infarction. Stroke 1975;6:226. 353. Welch KMA, Chabi E, Meyer JS, Buckingham J. The effect of ischemia on
catecholamine and 5-hydroxytryptamine levels in the cerebral cortex of gerbils - influence o fp-chlorophenylalanine. Proceedings of the 6th meeting of the American Society for Neurochemistry, Mexico City 1975;6:157.
32
354. Abraham J, Oft EO, Aoyagi M, Tagashira Y, Achari AN, Meyer JS. Regional cerebral blood flow changes after bilateral external carotid artery ligation in acute experimental infarction. J Neurol Neurosurg Psychiat 1975;38:77-88.
355. Meyer JS. Summary of the International Round Table Conference on Platelet
Aggregation in the Pathogenesis of Cerebrovascular Disorders. Special Article. Stroke 1975;6:239-244.
356. Hoff HF, Gotto AM, Meyer JS. Localization of low density lipoproteins in
atherosclerotic extra- and intracranial arteries from normo- and hyperlipidemics.J Neuropath Exp Neuro 1975;34:89.
357. Mathew NT, Meyer JS, Achari AN. Hyperlipidemic neuropathy and dementia. Neurol
1975;25:353 358. Mathew NT, Meyer JS, Ott EO. Increased cerebral blood volume in benign
intracranial hypertension. Neurol 1975;25:646-649. 359. Perez FI, Rivera VM, Meyer JS, Gay JRA, Taylor R, Mathew NT. Analysis of
intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. J Neurol Neurosurg Psychiat 1975;38:533-540.
360. Meyer JS. Evidence for neurogenic control of cerebral circulation. In: Langfift TW,
McHenry LC Jr, Reivich M, Wollman H, eds. Cerebral circulation and metabolism. New York: Springer Verlag, 1975:545-547.
361. Ott EO, Abraham J, Meyer JS, Tulleken CAF, Mathew NT, Achari AN, Aoyagi M.
Regional cerebral blood flow measured by the gamma camera after direct injection of 133 Xe into the distal stump of the occluded middle cerebral artery. Stroke 1975;6:376-381.
362. Welch KMA, Chabi E, Bartosh K, AcharVS, Meyer JS. Cerebrospinal fluid gamma-
aminobutyric acid (GABA) in migraine. Brit Med J 1975;3:516-517. 363. Mathew NT, Meyer JS, Hartmann A, Ott EO. Abnormal cerebrospinal fluid-blood flow
dynamics. Implications in diagnosis, treatment, and prognosis in normal pressure hydrocephalus. Arch Neurol 1975;32:657-664.
364. Hoff HF, Heideman CL, Noon GP, Meyer JS. Localization of apo-lipoproteins in
human carotid artery plaques. Stroke 1975;6:531-534. 365. Meyer JS. Discussion of Dr. A. Murray Harper's paper "Autonomic control of CBF.
In: Whisnant JP, Sandok BA, eds. Cerebral vascular diseases, ninth conference. New York:Grune &Stratton, 1975:42-43.
366. Welch KMA, Meyer JS, Chabi E, Buckingham J. The effect of ischemia on
catecholamine and 5-hydroxytryptamine levels in the cerebral cortex of gerbils: influence of parachlorophenyla Ian i ne (PCPA). In: Harper AM, Jennett WB, Miller
33
JD, Rowan JO, eds. Blood flow and metabolism in the brain. Edinburgh, London, New York:Churchill Livingstone, 1975:3.18-3.22.
367. Mathew NT, Meyer JS, Hrastnik F. Vasospasm versus "breakthrough" in the
pathogenesis of hypertensive encephalopathy. In: Harper AM, Jennett WB, Miller JD, Rowan JO, eds. Blood flow and metabolism in the brain. Edinburgh, London, New York: Churchill, Livingstone, 1975:5.17-5.21.
368. Deshmukh VD, Meyer JS, Aoyagi M, Matsuda M, Tagashira Y. Evidence for
cholinergic influences on cerebral blood flow and metabolism. in: Harper AM, Jennett WB, Miller JD, Rowan JO, eds. Blood flow and metabolism in the brain. Edinburgh, London, New York: Churchill, Livingstone, 1975:4.3-4.4.
369. Millikan CH, Meyer JS, et al. A classification and outline of cerebrovascular disease,
Volume 11. A report by an ad hoc committee, advisory council for the National Institute of Neurological and Communicative Disorders and Stroke. Stroke 1975;6:565-616.
370. Kawamura Y, Meyer JS, Hiromoto H, Aoyagi M, Tahashira Y, Ott EO. Neurogenic
control of cerebral blood flow in the baboon. Effects of the cholinergic inhibitory agent, atropine, on cerebral autoregulation and vasomotor reactivity to changes in PaC02. J Neurosurg 1975;43:676-688.
371. Aoyagi M, Meyer JS, Deshmukh VD, Ott EO, Tagashira Y, Kawamura Y, Matsuda
M, Achari AN, Chee ANC. Central cholinergic control of cerebral blood flow in the baboon. Effect of cholinesterase inhibition with neostigmine on autoregulation and C02 responsiveness. J Neurosurg 1975;43:689-705.
372. Welch KMA, Meyer JS, Chee ANC. Effects of cerebral infarction in man on cyclic
AMP levels in CSF and blood. In: Drummond GI, Greengard P, Robison GA, eds. Advances in cyclic nucleotide research, Volume 5, second international conference on cyclic AMP. New York:Raven Press, 1975:814.
373. Welch KMA, Chabi E, Achar VS, Bartosh K, Meyer JS. GABA in human CSF; the
significance of measurement in neurological disease. Society for Neuroscience, Volume 1, Bethesda, Maryland, 1975-.324.
374. Meyer JS. Medical and surgical treatment of cerebrovascular disease. In: Meyer JS,
ed. Modern concepts of cerebrovascular disease. New York:Spectrum Publications Inc., 1975:159-177.
375. Rivera VM, Meyer JS. Dementia and cerebrovascular disease. In: Meyer JS, ed.
Modern concepts of cerebrovascular disease. New York:Spectrum Publications, Inc., 1975:135-158.
376. Welch KMA, Meyer JS. Disordered cerebral metabolism after cerebral ischemia and
infarction - therapeutic implications. In: Meyer JS, eds. Modern concepts of cerebrovascular disease. New York: Spectrum Publications, Inc., 1975:87-112.
34
377. Mathew NT, Meyer JS. Regional cerebral blood flow in the diagnosis of vascular headache. Headache 1976;15:252-260.
378. Scheinberg P, Meyer JS, Reivich M, Sundt TM Jr, Waltz AG. XIII. Cerebral
circulation and metabolism in stroke. Cerebral circulation and metabolism in stroke study group. Stroke 1976;7:211-234.
379. Meyer JS, Miyakawa Y, Welch KMA, Itoh Y, Ishihara N, Chabi E, Neil J, Bartosh K,
Ericsson AD. Influence of adrenergic receptor blockage on circulatory and metabolic effects of disordered neurotransmitter function in stroke patients. Stroke 1976;7:158-167.
380. Meyer JS. Book review: The mystery of the mind by Wilder Penfield, The Island
Packet, April 1, 1978:31. 381 Mathew NT, Hrastnik F, Meyer JS, Itoh Y, Miyakawa Y, Ishihara N. Is the
pathogenesis of hypertensive encephalopathy due to angiospasm of "breakthrough"? Trans Amer Neurol Assn 1975; 100:220-222.
382. Meyer JS, Miyakawa Y, Ishihara N, Itoh Y, Welch KMA, Ericsson AD. Effects of
combined administration of alpha and beta adrenergic blockade on cerebral circulation and metabolism in cerebral infarction. Trans Amer Neurol Assn 1975; 100:223-225.
383. Welch KMA, Meyer JS, Chabi E, Miyakawa Y, Itoh Y, Ishihara N, Chee ANC.
Tyrosine uptake and neurotransmitter synthesis in ischemic brain after administration of alpha and beta adrenergic blocking agents to man. Amer Neurol Assn 1975;100:256-259.
384. Welch KMA, Nell J, Chabi E, Mathew NT, Neblett CR, Meyer JS. Cyclic nucleotide
studies in migraine. Neurol 1976;26:380-381. 385. Deshmukh SV, Meyer JS. Platelet dysfunction in migraine and effect of self
medication with aspirin. Stroke 1976;7:11. 386. Meyer JS, Miyakawa Y, Welch KMA, Deshmukh VD, Ishihara N, Itoh Y, Mathew NT,
Ericsson AD. Effect of CSF removal on CBF and metabolism in patients with stroke and Alzheimer's disease. Stroke 1976;7:8.
387. Welch KIVIA, Chabi E, Nell J, Bartosh K, Meyer JS. Similarities in biochemical
effects of cerebral ischemia in patients with cerebrovascular disease and migraine. Stroke 1976;7:4-5.
388. Deshmukh SV, Meyer JS. Cyclic changes in platelet dynamics in migraine. Neurol
1976;26:347. 389. Mathew NT, Meyer JS, Welch KMA, Neblett Cr. Abnormal CT scans in migraine.
Neurol 1976;26:380.
35
390. Aoyagi M, Deshmukh VD, Meyer JS, Kawamura Y, Tagashira Y. Effect of beta-adrenergic blockage with propanolol on cerebral blood flow, autoregulation and C02 responsiveness. Stroke 1976;7:291-295.
391. Meyer JS, Mathew NT, Hartmann A. Cerebral blood flow and metabolism changes in
the epilepsies and during cerebral anoxia, ischemia and edema. In: Himwich HE, ed. Brain metabolism and cerebral disorders, second edition. New York:Spectrum Publications Inc, 1976:207-229.
392. Meyer JS, Welch KMA, Titus JL, Suzuki M, Kim HS, Perez Fl, Mathew NT, Gedye
JL, Hrastnik F, Miyakawa Y, Achar VS, Dodson RF. Neurotransmitter failure in cerebral infarction and dementia. In: Terry RD, Gershon E, eds. The neurobiology of aging. New York:Raven Press, 1976:121-138.
393. Mathew NT, Meyer JS, Achari AN, Dodson RF Hyperlipidemic neuropathy and
dementia. Eur Neurol 1976; 14:370-382. 394. Achar VS, Welch KMA, Chabi E, Bartosh K, Meyer JS. Cerebrospinal fluid gamma-
aminobutyric acid (GABA) in neurological disease. Neurol 1976;26:777-780. 395. Ott EO, Meyer JS, Mathew NT, Okamoto S, Itoh Y, Sakaki S, Miyakawa Y.
Correlation between concurrent measurements of hemispheric blood flow measured by hydrogen and regional cerebral blood flow measured by xenon 133 clearance in patients with recent cerebral infarction. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:123-127.
396. Hartmann A, Mathew NT, Meyer JS. Quantitation of collateral cross-filling in internal
carotid artery occlusion. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:132-136.
397. Rivera VM, Meyer JS, Baer PE, Faibish GM, Mathew NT. Vertebrobasilar
insufficiency as a cause of dementia. Controlled therapeutic trial with betahistine- HCL. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, 7 International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:112-118.
398. Itoh Y, Meyer JS, Okamoto S, Sakaki S, Miyakawa Y, Mathew NT, Ericsson AD. A
critical appraisal of the question of "breakthrough" of cerebral autoregulation in patients with hypertensive stroke. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, Vh International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:5-12.
399. Baer PE, Faibish GM, Meyer JS, Mathew NT, Rivera VM. Neuropsychological
correlates of hemispheric and regional cerebral blood flow in dementia. In.. Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, 7 th International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:100-106.
36
400. Hoff HF, Meyer JS, Gotto AM. Localization of low density lipoproteins in atherosclerotic extra- and intracranial arteries from normo- and hyperlipemics. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease, 7 th International Salzburg Conference, 1974. Stuttgart: George Thieme, 1976:170-173.
401. Matsuda M, Meyer JS, Deshmukh VD, Tagashira Y. Effect of acetylcholine on
cerebral circulation. J Neurosurg 1976;45:423-431. 402. Welch KMA, Meyer JS. Disordered neurotransmitter function in cerebral ischemia.
Formal discussion. In: Scheinberg P, ed. Cerebral vascular disease, 1 oth Princeton Conference. New York:Raven Press, 1976:173-178.
403. Meyer JS, Deshmukh VD, Welch KMA. Experimental studies concerned with the
pathogenesis of cerebral ischemia and infarction with possible relevance to the patient with stroke. In: Ross Russell RW, ed. Cerebral arterial disease. Edinburgh: Churchill Livingstone, 1976:57-84.
404. Mathew NT, Meyer JS, Welch KMA, Neblett CR. Abnormal CT scans in migraine.
Headache 1977;16:272-279. 405. Deshmukh SV, Meyer JS, Mouche RJ. Platelet dysfunction in migraine. Effect of
self-medication with aspirin. Thrombos Haemostas 1977;36:319-324. 406. Meyer JS, Miyakawa Y, Ishihara N, Itoh Y, Naritomi H, Mathew NT, Welch KMA,
Deshmukh VD, Ericsson AD. Effect of CSF removal on CBF and metabolism in patients with Alzheimers disease versus recent stroke. Stroke 1977;8.-44-50.
407. Meyer JS. Summary of the 8th International Salzburg Conference on Cerebral
Vascular Disease, Salzburg, Austria, September 22-25, 1977. 408. Hsu MC, Deshmukh VD, Meyer JS, Miyakawa Y, Ishihara N, Naritomi H, Dodson RF
Acute and chronic cerebral multi-infarction in the baboon using a modified Microfil embolization model. Stroke 1977-8:134.
409. Meyer JS, Deshmukh VD, Ishihara N, Naritomi H, Hsu MC, Pollack PG. Noninvasive
measurement of rCBF in man: Effects of X-ray correction, age and hemispheric differences. Stroke 1977;8-.139.
410. Perez Fl, Stump DA, Wray RE, Gay JRA, Bannon MR, Meyer JS. Automated
behavioral assessment system: Precise measurement of memory performance in cerebrovascular disease. Stroke 1977;8:140.
411. Meyer JS. On TIAs and strokes - their follow-up. Executive Health Report 1977;
13:5. 412. Perez FI, Mathew NT, Stump DA, Meyer JS. Regional cerebral blood flow statistical
patterns and psychological performance in multi-infarct dementia and Alzheimer's disease. Canad J Neurol Sci 1977;4:53-62.
37
413. Deshmukh SV, Meyer JS. Platelet dysfunction as a risk factor in cerebrovascular disease. Stroke 1977;8:3-4.
414. Tagashira Y, Meyer JS, Matsuda M, Chee ANC, Chabi E, Welch KMA. Effects of
cyclic AMP and dibutyryl cyclic AMP on cerebral hemodynamics; and metabolism in the baboon. J Neurosurg 1977-46:484-493.
415. Ishihara N, Meyer JS, Deshmukh VD, Hsu MC. Non-invasive measurement of
regional cerebral blood flow (rCBF) in man: Normal values, effect of age, cerebral dominance and activation. Neurol 1977-27:401.
416. Meyer JS, Naritomi H, Deshmukh VID, Pollack P. Non-invasive regional cerebral
blood flow (rCBF) measurements in cerebral infarction and TIAs due to carotid and vertebrobasilar disease. Neurol 1977-27:402.
417. Sakai F, Meyer JS, Deshmukh VD, Naritomi H. Non-invasive 133 Xe inhalation
measurements of regional cerebral blood flow (rCBF) in migraine and recurrent headaches. Neurol 1977;27:404.
418. Miyakawa Y, Meyer JS, Ishihara N, Naritomi H, Nakai K, Hsu MC, Deshmukh VD.
Effect of cerebrospinal fluid removal on cerebral blood flow and metabolism in the baboon. Influence of tyrosine infusion and cerebral metabolism on CSFP-autoregulation. Stroke 1977-8:346-351.
419. Welch KMA, Chabi E, Buckingham J, Bergin B, Achar VD, Meyer JS. Catecholamine
and 5-hydroxytryptamine levels in ischemic brain: Influence of pchlorophenylalanine. Stroke 1977;8:341-346.
420. Meyer JS, Welch KMA, Deshmukh VD, Perez Fl, Jacob RH, Haufrect DB, Mathew
NT, Morrell RM. Therapeutic trial of neurotransmitter precursor amino acids in multi-infarct dementia and Alzheimer's diseases. JAGS 1977-25:289-298.
421. Sakai P, Meyer JS, Naritomi H. Non-invasive 133Xe inhalation measurements of
rCBF. In: Ladurner G, Oft E, eds. Transient Ischemic Attacks. 5 1h International Symposium for Coordination of the Neurological Sciences. Graz, Austria. Berne, Switzerland: Huber Publishing Co., 1978.
422. Meyer JS, Sakai F, Deshmukh VID, Ishihara N, Naritomi H, Pollack P. Testing
cerebrovascular functional reserve using 133 Xe inhalation measurements of rCBF in health and disease. In: lngvar DH, Lassen NA, eds. Cerebral function, metabolism and circulation. Copenhagen: Munksgaard Press, 1977:476-477.
423. Naritomi H, Meyer JS, Deshmukh VD, Pollack P. Non-invasive measurement of
regional cerebral blood flow in TIAs and stroke due to carotid and vertebrobasilar disease. In: Ingvar DH, Lassen NA, eds. Cerebral function, metabolism and circulation. Copenhagen: Munksgaard Press, 1977:474-475.
38
424. Deshmukh SV, Meyer JS. Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine. Headache 1977;17-101-108. (Winner of the 1977 Harold G. Wolff Award)
425. Sakai F, Meyer JS, Hsu MC, Jacob RH, Prost J, Deshmukh VD, Ishihara N, Naritomi
H, Pollack P. EEG correlated with non-invasive measurement of regional cerebral blood flow in epilepsy and narcolepsy. Ann Neurol 1977;1:501.
426. Katzman R, Clasen R, Klatzo L, Meyer JS, Pappius HM, Waltz AG. XV brain edema
in stroke. Study group on brain edema in stroke. Stroke 1977;8:509-540. 427. Nakai K, Welch KMA, Meyer JS. Critical cerebral blood flow in production of
hemiparesis after unilateral carotid occlusion in the gerbil. N Neurol Neurosurg Psychiat 1977;40:595-599.
428. Meyer JS, Oft EO, Aoyagi M, Kawamura Y, Tahashira Y, Matsuda M, Achari A.
Double cholinergic and adrenergic functional control of cerebral blood flow. Budapest:Akademiai Kiado, 1977:119-135.
429. Meyer JS, Welch KMA, Buckingham J. Contribution of platelet aggregation and
serotonin release to progressive cerebral infarction. In: Agnoli A, Fazio C eds. 3" International Congress of Sleep Research. Tokyo, 1979:211.
430. Meyer JS. Cholinergic influences on cerebral blood flow as measured by means of
electromagnetic flow meters. In: Owman C, Edvinsson L, eds. Neurogenic control of brain circulation. International Symposium, Wenner-Gren Vol 30. Oxford;NewYork:Pergamon Press, 1977-.273-281.
431. Claghorn JL, Mathew RJ, Larger JW, Meyer JS. Effect of biofeedback-induced
changes in skin temperature on non-invasive regional cerebral blood flow in normal subjects. Society for Neurosciences, Vol 3. Bethesda, Maryland, 1977:19-55.
432. Mathew NT, Hartmann A, Meyer JS. The use of regional cerebral blood flow
measured with the gamma camera in neurological diagnosis. Int J Neurol 1977; 11: 194-205.
433. Meyer JS. Hemorrhagic cerebrovascular syndromes. In: Toole JF, ed. Clinical
concepts of neurological disorders. Baltimore: Williams & Wilkins, 1977:238-254. 434. Meyer JS, Deshmukh VD, Mathew NT, Naritomi H, Ishihara N, Sakai F, Hsu MC,
Pollack P, Bishop L, Perez Fl, Gedye JL. Non-invasive 133 Xe inhalation measurements of regional cerebral blood flow in dementia. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease. 8' International Salzburg Conference, September 22-25, 1976. Amsterdam: Excerpta Medica Foundation, 1978:179-183.
435. Mathew NT, Sarala PK, Meyer JS. Computer assisted tomography in the differential
diagnosis of dementia. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease. 8th International Salzburg Conference, September 2225, 1976. Amsterdam: Excerpta Medica Foundation, 1978:14-17.
39
436. Naritomi H, Meyer JS, Sakai F, Yamaguchi F, Pollack P. Regional cerebral
dysautoregulation in pathogenesis of TlAs within the vertebrobasilar arterial system. Stroke 1978;9:109.
437. Kite LD, Meyer JS, Gedye JL. Sulfinpyrazone and aspirin therapy compared on
platelet function in completed stroke and vertebral basilar insufficiency. Stroke 1978;9:109.
438. Perez Fl, Mathew NT, Stump DA, Meyer JS. Cerebral blood flow and psychological
correlates in Alzheimer's disease and multi-infarct dementia. In: Meyer JS, Lechner H, Reivich M, eds. Cerebral vascular disease. 8th International Salzburg Conference, September 22-25, 1976. Amsterdam: Excerpta Medica Foundation, 1978:35-39.
439. Welch KMA, Chabi E, Nell J, Bartosh K, Meyer JS, Mathew NT. Similarities in
biochemical effects of cerebral ischemia in patients with cerebrovascular disease and migraine. In: Greene R, ed. Current concepts in migraine research. New York:Raven Press, 1978:187.
440. Sakai F, Meyer JS, Hsu MC, Naritomi H, Karacan 1. Regional cerebral blood flow in
narcoleptics and normal volunteers during sleep and wakefulness. Sleep Research 1977;6:56.
441. Juge 0, Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Shaw T. Critique of rCBF
measurements recorded from brain stem and cerebellar areas by 133Xe inhalation. Neurol 1978;28:342.
442. Meyer JS, Sakai F, Karacan 1, Naritomi H, Yamaguchi F, Shaw T. Regional cerebral
blood flow during sleep and wakefulness compared in normal volunteers and patients with narcolepsy.
443. Meyer JS, Ishihara N, Deshmukh VD, Naritomi H, Sakai F, Hsu MC, Pollack P-.
Improved method for noninvasive measurement of regional cerebral blood flow by "Xenon inhalation. Part 1: Description of method and normal values obtained in healthy volunteers. Stroke 1978,9:195-205.
444. Meyer JS: Improved method for noninvasive measurement of regional cerebral
blood flow by 133Xenon inhalation. Part II: Measurements in health and disease. Stroke 1978;9:205-210.
445. Meyer Js. Recent validation of 133 Xe inhalation (Letter to the Editor). Stroke
1978;9:272. 446. Meyer JS, Sakai F, Naritomi H, Grant P. Normal and abnormal patterns of
cerebrovascular reserve tested by 133Xe inhalation. Arch Neurol 1978;35:350-359.
40
447. Sakai F, Meyer JS, Hsu MC, Jacob R, Frost J, Deshmukh VD, Ishihara N, Naritomi H, Pollack P. EEG correlated with non-invasive measurement of regional cerebral blood flow in epilepsy and narcolepsy. In: Scheinberg P, ed. Transactions of the American Neurological Association. New York: Springer-Verlag, 1977:73-74.
448. Sakai F, Meyer JS. Regional cerebral hemodynamics during migraine and cluster
headaches measured by the 133Xe inhalation method. Headache 1978; 18:122-132. 13th Harold G. Wolff Award Winner.
449. Sakai F, Meyer JS, Naritomi H, Hsu MC. Regional cerebral blood flow and EEG in
patients with epilepsy. Arch Neurol 1978;35:648-657. 450. Ishihara N, Naritomi H, Meyer JS, Dodson RF, Deshmukh VD. Differences in the
time course of regional cerebral hemodynamics of gray and white matter during experimental hypertension. J Neurol Sci 1978;38:97-111.
451. Largen JW, Mathew RJ, Dobbins K, Meyer JS, Claghorn JL. Skin temperature self-
regulation and non-invasive regional cerebral blood flow. Headache 1978;18:203-210.
452. Mathew RF, Largen JW, Claghorn JL, Dobbins K, Meyer JS. Relationship between
volitional alteration in skin temperature and regional cerebral blood flow in normal subjects. In: Biofeedback Society of America, Vh Annual Meeting, March 3-7, 1978, Albuquerque, New Mexico 1978:40-42. Abstracted in Biofeedback and Self Regulation 1978;3:236.
453. Meyer JS, Deshmukh VD, Ishihara N. Cerebral steal syndromes. In: Lechner H,
Ladurner G, Ott E, eds. Transient ischemic attacks. 5h International Symposium for Coordination of the Neurological Sciences, Graz, Austria. Berne, Switzerland: Huber Publishing Co., 1978.
454. Sakai F, Meyer JS, Karacan 1, Yamaguchi F, Yamamoto M. Narcolepsy: regional cerebral blood flow during sleep and wakefulness. Neurol 1979;29:61-67. 455. Shaw TG, Meyer JS. Double blind trial of oral papaverine therapy in chronic
cerebrovascular ischemia. Angiology 1978;29:839-851. 456. Meyer JS. Clinical applications of non-invasive measurements of cerebral blood flow.
In: Deller JJ, ed. Eisenhower Medical Center, Fall, 1978, Nuclear Medicine for the Primary Care Physician, 1979:60-71.
457. Meyer JS, Naritomi H, Sakai F. Non-invasive measurements of regional blood flow in
patients with cerebrovascular disorders. In: Mrsulja BB, ed. Pathophysiology of cerebral energy metabolism. New York:Plenum Press, 1979:253-255.
458. Meyer JS, Sakai F, Naritomi H. Regional cerebral blood flow in man during different
stages of wakefulness and sleep. In: Mrsulja BB, ed. Pathophysiology of cerebral energy metabolism. New York:Plenum Press, 1979:433-440.
41
459. Naritomi H, Sakai F, Meyer JS. Pathogenesis of transient ischemic attacks within the vertebrobasilar arterial system. Arch Neurol 1979;36:121-128.
460. Yamamoto M, Meyer JS, Yamaguchi F, Sakai F, Jacoby R. Effect of chronic spinal
cord transaction on cerebral hemodynamics. Neurol 1979;29:562. 461. Yamaguchi F, Meyer JS, Yamamoto M, Sakai F, Shaw T. Cerebral vasomotor
responsiveness to 5% C02 inhalation and behavioral activation in Alzheimer's disease, multi-infarct dementia and normal aging. Neurol 1979;29:562-563.
462. Meyer JS, Sakai F, Karacan 1, Derman S, Yamaguchi F, Yamamoto M. Regional
cerebral hemodynamics during normal and abnormal sleep (stages I-IV) and REM. Neurol 1979;29:562.
463. Sakai F, Meyer JS, Yamaguchi F, Yamamoto M, Shaw T. 133Xe inhalation method
for measuring cerebral blood flow in conscious baboons. Stroke 1979;10:310-318. 464. Meyer JS, Hass WK. Summary of the 9' International Salzburg Conference on
Cerebrovascular Disease, Salzburg, Austria, September 27-30, 1978. Stroke 1979; 10: 113-116.
465. Sakai F, Meyer JS, Shaw T, Kelly D, Yamaguchi F, Yamamoto M. Regional cerebral
blood flow measured by 133 Xe inhalation in tracheotomized and laryngectomized men and women. J Neurol Sci 1979;41:247-253.
466. Largen JW, Mathew RJ, Dobbins K, Meyer JS, Sakai F, Claghorn JL. The effect of
direction of skin temperature self-regulation on migraine activity and regional cerebral blood flow. In: Biofeedback Society of America, 1011 Annual Meeting, 1978, San Diego, California. Denver, Colorado: Biofeedback Society of America, 1979:76-78.
467. Meyer JS, Sakai F, Karacan 1, Derman S, Yamamoto M. Regional cerebral
hemodynamics during normal and abnormal human sleep (stages I-IV and REM). In: Gotoh F, Nagai H, Tazaki Y, eds. Cerebral blood flow and metabolism. 9 th
International Symposium on CBF and Metabolism. Japan:Acta Neurologica Scandinavica, 1979:2-3.
468. Shaw TG, Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Mortel K. Effects of
normal aging versus risk factors for stroke on regional cerebral blood flow (rCBF). In: Gotoh F, Nagai H, Tazaki Y, eds. Cerebral blood flow and metabolism. 9 th
International Symposium on CBF and Metabolism. Japan:Acta Neurologica Scandinavica, 1979:462-463.
469. Yamaguchi F, Meyer JS, Sakai F, Yamamoto M. Effects of normal aging on cerebral
blood vasoconstrictive responses to hypocapnia with demonstration of ischemic threshold. In: Gotoh F, Nagai H, Tazaki Y, eds. Cerebral blood flow and metabolism. 9d' International Symposium on CBF and Metabolism. Japan:Acta Neurologica Scandinavica, 1979:88-89.
42
470. Sakai F, Meyer JS, Yamamoto M, Yamaguchi F. Testing abnormal cerebral vasomotor reactivity in migraine and cluster headaches. In: Gotoh F, Nagai H, Tazaki Y, eds. Cerebral blood flow and metabolism. 9th International Symposium on CBF and Metabolism. Japan:Acta Neurologica Scandinavica, 1979:542-543.
471. Naritomi H, Meyer JS, Sakai F, Yamaguchi F, Shaw T. Effects of advancing age on
regional cerebral blood flow. Studies in normal subjects and subjects with risk factors for atherothrombotic stroke. Arch Neurol 1979;36:410-416.
472. Meyer JS, Naritomi H, Sakai F, Ishihara N, Hsu MC, Grant P. Regional cerebral
blood flow, diaschisis and steal after stroke. Neurol Res 1979;1:155-173. 473. Juge 0, Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Shaw T. Critical appraisal
of cerebral blood flow measured from brain stem and cerebellar regions after `Xe inhalation in humans. Stroke 1979;10:428-437.
474. Sakai F, Meyer JS, Yamaguchi F, Yamamoto M, Shaw T, Juge 0. Validation studies
of the 133Xe inhalation method for measuring brain stem-cerebellar blood flow in baboons and humans. In: Meyer JS, Lechner H, Reivich M, Ott E, Aranibar A, eds. Cerebrovascular Disease 2. 9' Salzburg Conference, September 27-30, 1978. Amsterdam/Oxford:Excerpta Medica, 1979:12-18.
475. Shaw TG, Meyer JS, Sakai F, Yamaguchi F, Yamamoto M. Double blind trial of oral
papaverine in chronic cerebrovascular ischemia. In: Meyer JS, Lechner H, Reivich M, Ott E, Aranibar A, eds. Cerebrovascular Disease 2. 9' Salzburg Conference, September 27-30, Amsterdam/Oxford:Excerpta Medica, 1979:177-179.
476. Yamamoto M, Meyer JS, Sakai F, Yamaguchi F, Jacoby R, Shaw T. Mechanisms of
cerebral vasomotor responsiveness to carbon dioxide in health and disease. In: Meyer JS, Lechner H, Reivich M, Oft E, Aranibar A, eds. Cerebrovascular Disease 2. Vh Salzburg Conference, September 27-30, Amsterdam/Oxford:Excerpta Medica, 1979:280-286.
477. Yamaguchi F, Meyer JS, Sakai F, Yamamoto M. Behavioral activation testing in the
dementias. In: Meyer JS, Lechner H, Reivich M, Ott E, Aranibar A, eds. Cerebrovascular Disease 2. 9th Salzburg Conference, September 27-30, Amsterdam/Oxford:Excerpta Medica, 1979:121-132.
478. Stump DA, Cooke NA, Yonovitz A, Perez FI, Meyer JS. Selective regional cerebral
blood flow responses to auditory stimuli "white noise versus human voice". In: Meyer JS, Lechner H, Reivich M, Ott E, Aranibar A, eds. Cerebrovascular Disease 2. 9' Salzburg Conference, September 27-30, Amsterdam/Oxford:Excerpta Medica, 1979.
479, Sakai F, Meyer JS. Abnormal cerebrovascular reactivity in patients with migraine
and cluster headache. Headache 1979;19:257-266. 14th Harold G. Wolff Award Winner.
43
480. Yamamoto M, Meyer JS, Sakai F, Yamaguchi F, Shaw T. Cerebral vasomotor responsiveness to changes in C02 compared in patients with cerebrovascular disease and control subjects. Stroke 1979;10:486.
481. Yamaguchi F, Meyer JS, Yamamoto M, Sakai F, Shaw TG. Regional cerebral blood
flow (rCBF) in normal aging compared to multi-infarct and related dementias. Stroke 1979;10:488.
482. Shaw TG, Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Birken MAV, Cutaia M.
Controlled clinical trial of long-term oral papaverine therapy in patients with chronic cerebral ischemia. Stroke 1979;10:489.
483. Yamamoto M, Meyer JS, Naritomi H, Sakai F, Yamaguchi F, Shaw T. Non-invasive
measurement of cerebral vasospasm in patients with subarachnoid hemorrhage. J Neurol Sci 1979;43:301-311.
484. Meyer JS, Sakai F, Yamamoto M, Hayman L. High resolution three-dimensional
cerebral blood flow by brief stable xenon inhalation and computerized tomography. Ann Neurol 1979;6:151.
485. Meyer JS, Deshmukh VD, Ishihara N. Steal syndrome. In: Lechner H, Ladurner G,
Oft E, eds. Die zerebralen trans itori sch-i scham i sche n attaken. Verlag Hans Huber Bern:Stuttgart, Wien, 1979:48-57.
486. Yamaguchi F, Meyer JS, Sakai F, Yamamoto M. Normal human aging and cerebral
vasoconstrictive responses to hypocapnia. J Neurol Sci 1979;44:87-94 487. Ishihara N, Welch KMA, Meyer JS, Chabi E, Naritomi H, Wang TPF, Nell JH, Hsu
MC, Miyakawa Y. Influence of cerebral embolism on brain monoamines. J Neurol Neurosurg Psychol 1979;42:847-853.
488. Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Shaw T. Regional changes in
cerebral blood flow during standard behavioral activation in patients with disorders of speech and mentation compared to normal volunteers. Brain and Language 1980;9:61-67.
489. Yamaguchi F, Meyer JS, Sakai F, Yamamoto M. Case reports of three dysphasic
patients to illustrate rCBF responses during behavioral activation. Brain and Language 1980;9:145-148.
490. Tamura S, Karacan 1, Dervent A, Williams R, Meyer JS. Sleep disturbances in
vascular brain stem lesions. In: Third International Congress of Sleep Research. Tokyo Japan, 1979:275.
491. Karacan 1, Derman S, Meyer JS, Sakai F. Regional cerebral blood flow in sleep
apnea. In: Third International Congress of Sleep Research. Tokyo, Japan, 1979:211.
44
492. Karacan 1, Hirshkowitz M, Tamura K, Thornby JI, Ware JC, Williams R, Meyer JS. Prognostic indicators of sleep EEG patterns in cerebrovascular disease. Part Il: Relationship of clinical outcome to "micro sleep parameters". In: Third International Congress of Sleep Research. Tokyo, Japan, 1979:226.
493. Karacan 1, Tamura K, Ware JC, Dervent A, Williams R, Meyer JS. Prognostic
indicators of sleep EEG patterns in cerebrovascular disease. Part 1: Relationship of clinical outcome to "macro sleep parameters". In: Third International Congress of Sleep Research. Tokyo, Japan, 1979:110.
494. Derman S, Karacan 1, Meyer JS, Sakai F. Regional cerebral blood flow of normal
volunteers during sleep. In: Third International Congress of Sleep Research. Tokyo,Japan, 1979:49.
495. Meyer JS. Non-invasive regional cerebral blood flow measurements in subarachnoid
hemorrhage. In: Pia HW, Langmaid C, Zierski J, eds. Cerebral Aneurysms. Advances in Diagnosis and Therapy. Berlin: Springer-Verlag, 1979:133-143.
496. Yamamoto M, Meyer JS, Sakai F, Yamaguchi F. Aging and cerebral vasomotor
responses to hypercarbia. Responses in normal aging and in persons with risk factors for stroke. Arch Neurol 1980;37:489-496.
497. Mathew RJ, Largen JS, Dobbins K, Meyer JS, Sakai F, Claghorn JL. Biofeedback
control of skin temperature and cerebral blood flow in migraine. Headache 1980;20:19-28.
498. Sakai F, Meyer JS, Karacan 1, Derman S, Yamamoto M. Normal human sleep:
Regional cerebral hemodynamics. Ann Neurol 1980;7:471-478. 499. Meyer JS, Sakai F, Karacan 1, Derman S, Yamamoto M. Sleep apnea, narcolepsy,
and dreaming: Regional cerebral hemodynamics. Ann Neurol 1980;7-.479-485. 500. Meyer JS, Hayman LA, Yamamoto M, Sakai F, Nakajima S. Local cerebral blood
flow measured by CT after stable xenon inhalation. Am J Neuroradiol 1980;1:213-225.
501, Meyer JS, Hayman LA, Nakajima S, Yamamoto M, Harati Y. Three-dimensional
localized human cerebral blood flow measured in normals and cerebrovascular disorders by CT scanning during stable xenon inhalation. Neurol 1980;30:445.
502 Yamamoto M, Meyer JS. Hemicranial disorder of vasomotor adrenoceptors in
migraine and cluster headache (abstract). Headache 1980;20:155. 503. Meyer JS. Effects of normal aging versus disease on cerebral vasomotor
responsiveness. In: Bes A, Geraud G, eds. Cerebral circulation and neurotransmitters, International Congress Series 507. Amsterdam: Excerpta Medica, 1980:133-138.
45
504. Hayman LA, Sakai F, Meyer JS, Armstrong D, Hinck VC. Iodine enhanced CT patterns after cerebral arterial embolization in baboons. Am J Neuroradiol 180;1:233-238.
505. Mathew RJ, Meyer JS, Semchuk KM, Francis DJ, Mortel K, Claghorn JL: Cerebral
blood flow in depression. Lancet 1980;14:1308. 506. Yamaguchi F, Meyer JS, Yamamoto M, Sakai F, Shaw T. Non-invasive regional
cerebral blood flow measurements in dementia. Arch Neurol 1980;37:410-418. 507. Meyer JS, Hayman LA, Nakajima S, Amano T, Derman S, Lauzon P, Karacan 1.
Sleep apnea: Local cerebral blood flow changes during sleep and activation measured by xenon CT scans. Ann Neurol 1980;8:100.
508. Meyer JS, Yamamoto M, Hayman LA, Sakai F, Nakajima S, Armstrong D. Cerebral
embolism - local CBF and edema measured by CT scanning and Xenon inhalation. Neurol Res 1980;2:101-120.
509. Yamamoto M, Meyer JS, Sakai F, Yamaguchi F. Brainstem-cerebellar and
hemispheric blood flow in stupor and impaired states of responsiveness with and without intracranial hypertension. In: Shulman K, Marmarun A, Miller JD, Beckar DP, Hochwald GM, Broch M, eds. Intracranial Pressure IV. Berlin: SpringerVerlag, 1980:177-179.
510. Meyer JS, Hayman LA, Sakai F, Yamamoto F, Nakajima S, Armstrong D. High
resolution three dimensional measurement of localized cerebral blood flow by CT scanning and stable xenon clearance: Effect of cerebral infarction and ischemia. In: Trans American Neurological Association, Volume 104. New York: Springer Publishing Company, 1979:85-89.
511. Yamamoto M, Meyer JS, Sakai F, Jacoby R. Effect of differential spinal cord section
on human cerebral blood flow. J Neurol Sci 1980;47:395-406. 512. Meyer JS. Headache Research Center, Veterans Administration Medical Center,
Houston, Texas. In: Texas Headache Clinics, Volume 1, Number 4, 1980. 513. Welch KMA, Meyer JS. Neurochemical alterations in cerebrospinal fluid in cerebral
ischemia and stroke. In: Wood A ed. Neurobiology of Cerebrospinal Fluid. Plenum Press, 1980:325-336.
514. Yamamoto M, Meyer JS. Hemicranial disorder of vasomotor adrenoceptors in
migraine and cluster headache. Headache 1980;20:321-335. 515. Largen JW, Jr, Shaw T, Mortel K, Cutaia M, Meyer JS, Scheer D. Activation of
cerebral blood flow in association with Raven's progressive matrices in early putative Alzheimer's disease. INS Bull 1981;33-34.
516. Meyer JS. Summary of the 1 Oth World Federation of Neurology International
Conference on Cerebrovascular Disease. Stroke 1981; 12:147-153.
46
517. Meyer JS, Hayman LA, Nakajima S, Amano T, Lauzon P, Derman S, Karacan 1,
Harati Y. Local human rCBF measured by CT scanning in normals, brain tumors, stroke, epilepsy, sleep and activation. In: Cerebrovascular Disease 3, 10 th Salzburg Conference, International congress Series 532. Amsterdam: Excerpta Medica, 1981:130-135.
518. Shaw TG, Cutaia MM, Mortel KF, Meyer JS, Nakajima S, Amano T. Prospective
measurements of cerebral blood flow in normal and abnormal aging. Neurol 1981;31(3):102.
519. Nakajima S, Meyer Js, Amano T, Shaw TG, Mortel KF, Cutaia MM. Redistribution of
rCBF after STA-MCA bypass in patients with hemispheric ischemia. Neurol 1981;31(3):107.
520. Meyer JS. Application of studies of cerebral blood flow (CBF) to ischemic
cerebrovascular disease rCBF measured by "'Xe inhalation and external probes compared with LCBF measured by stable xenon inhalation and CT scanning. In: Moosy J, ed. Cerebrovascular Diseases, 12"' Research Conference. New York:Raven Press, 1981.
521. Meyer JS. Medical and surgical therapy in cerebrovascular disease. In: Loeb C, Italia
M, eds. Studies in Cerebrovascular Disease. Milano, 1981:195-206. 522. Nakajima S, Meyer JS, Yamamoto M, Amano T, Trompler A, Mortel K, Shaw T,
Cutaia M. Effects of normal aging and cerebral infarction on cerebral vasoconstrictor-responsiveness to 100% oxygen inhalation. In: Cerebral Vascular Disease 3, 10'h Salzburg Conference, International Congress Series 532. Amsterdam: Excerpta Medica, 1981:145-151.
523. Shaw TG, Cutaia MM, Meyer JS, Mortel KF, Yamamoto M, Nakajima S, Karacan 1,
Derman S: Age-related changes in regional cerebral blood flow during sleep in normals, sleep apneics and narcoleptics. In: Cerebral Vascular Disease 3, 10 th
Salzburg Conference. International Congress Series 532, Excerpta Medica, Amsterdam, 166-171, 1981.
524. Meyer JS, Lechner L, Reivich M, Ott EO, Aranibar A, eds. Cerebral Vascular
Disease 3, 10' Salzburg Conference. International Congress Series 532, Excerpta Medica Amsterdam, 351 pages, 1981.
525. Amano T, Meyer JS. Prostaglandins and human CBF control: Effect of aspirin and
Indomethacin. J Cerebral Blood Flow and Metabolism 1981; 1 (1):403-404. 526. Amano T, Meyer JS, Karacan 1, Derman S, Hartse K, Nakajima S, Hayman LA,
Shaw T. Changes in LCBF measured by CT scan during REM and non-REM sleep. J CBF & Metab 1981; 1 (1):464-466.
47
527. Meyer JS, Hayman LA, Nakajima S, Amano T, Lauzon P. Local cerebral blood flow and tissue solubility measured by stable xenon-enhanced computerized tomography. In: Advances in Neurology, Vol. 30, Diagnosis and Treatment of Brain Ischemia. New York:Raven Press, 1981:73-84.
528. Meyer JS, Amano T, Shaw T. Local cerebral blood flow measurements. AJNR
1981;2:376-377. 529. Meyer JS. Application of studies of cerebral blood flow: ischemic cerebrovascular
disease. In: Moosy J, Reinmuth OM, eds. Cerebrovascular Disease, 12t" Research Conference. New York:Raven Press, 1981:123-139.
530. Mathew RJ, Meyer JS, Francis DJK, Schoolar JC, Weinman M, Mortel KF. Regional
cerebral blood flow in schizophrenia: A preliminary report. Am J Psychiat 1981:138(l):112-113.
531. Largen JS, Shaw T, Weinman M, Meyer JS. Order effects and responsiveness of
regional cerebral blood flow in early putative Alzheimer's Disease. J CBF & Metab 1981;1(1):483-484.
532. Meyer JS, Hayman LA, Amano T, Nakajima S, Shaw T, Lauzon P, Derman S,
Karacan 1, Harati Y. Mapping local blood flow of human brain by CT scanning during stable xenon inhalation. Stroke 1981; 12:426-436.
533. Meyer JS. Diagnosis: Headache. Hospital Medicine 1981;August: 19-24. 534. Shaw T, Meyer JS. Aging and cerebrovascular disease in diagnosis and
management of stroke and TlAs. Addison Wesley Publishing Co., 1982:1-247. 535. Meyer JS, Shaw T. Diagnosis and management of stroke and TlAs. Cal
ifornia:Addison-Wesley Publishing Co., 1982:318 pages. 536. Meyer JS: Course prognosis and medical management of patients with acute stroke.
In: Meyer JS, Shaw TG, eds. Diagnosis and Management of Stroke and TlAs. California:Addison-Wesley Publishing Co., 1982:155-172. 537. Shaw TG, Cutaia MM, Mortel KF, Meyer JS, Nakajima S, Amano T. Prospective
measurements of cerebral blood flow in normal and abnormal aging. Neurol 1981;31:102.
538. Meyer JS. Clinical applications of non-invasive measurements of cerebral blood flow.
In: Slade WIR, ed. Geriatric Neurology. New York:Futura Publishing Co., 1981:25-43.
539. Meyer JS. Measurements of regional cerebral blood flow (rCBF) and their application
to migraine research. In: Mathew R, ed. Treatment of Migraine. Spectrum Publications, Inc., 1981:1-8.
48
540. Meyer JS. 133Xe and stable xenon inhalation measurements of cerebral blood flow in health and disease. Progress in Nuclear Medicine 1981;7:95-110.
541. Meyer JS. Current concepts of management of women with migraine headaches.
The Female Patient 1982;7:19-28. 542. Meyer JS, Amano T, Karacan 1, Derman S, Hartse K, Nakajima S, Hayman L,
Lauzon P, McCracken J. Sleep apnea and narcolepsy: LCBF changes during sleep, wakefulness and activation compared to normals. Trans Am Neurol Assoc 1980; 105:1-4.
543. Meyer JS. Strategies for drug development in multi-infarct dementia. In: Crook T,
Gershon S, eds. Strategies for the Development of Effective Treatment for Senile Dementia. Connecticut: Powley Associates, Inc., 1981:209-214.
544. Brinkman SD, Smith RC, Meyer JS, Vroulis G, Shaw T, Gordon JR, Allen RH.
Lecithin and memory training in suspected Alzheimer's disease. J Geront 1982;37:4-9.
545. Meyer JS, Bushong SC, Amano T, Okabe T, Shaw TG, Centeno R, Hayman LA.
Methodological advantages and disadvantages of Xenon CT-CBF. Stroke 1982;13:261-262.
546. Amano T, Meyer JS. Prostaglandin inhibition and cerebrovascular control in patients
with headache. Headache 1982;22:52-59. 547. Meyer JS. Stroke (Vascular Disease of the Brain). In: Better Homes and Gardens,
New Family Medical Guide. lowa:Meredith Corporation, 1982:236-244. 548. Amano T, Meyer JS, Okabe T, Shaw T, Mortel KF. Stable xenon CT-CBF
measurements computed by a single compartment-double integration model in normal aging and dementia. J Computer Asst Tomog 1982;6-.923-932.
549. Meyer JS, Amano T. Aspirin and Indomethacin: Cerebral hemodynamics effects of
prostacyclin inhibition in patients with headache. In: Kudrow L, Appenzeller 0, eds. Prostaglandins, Platelets and Salicylates: Basic and Clinical Aspects. New York: Postgraduate Medicine Communications, 1982:81-87.
550. Meyer JS. Strokes and coronary events during sleep. Physician and Patient
1982;1:41-42. 551. Amano T, Meyer JS. Cerebrovascular changes in patients with headache during anti
seroton i nerg ic treatment. Headache 1982;22:249-255. 552. Meyer JS, Nakajima S, Okabe T, Amano T, Centeno R, Lee YY, Levine J, Levinthal
R, Rose J. Redistribution of cerebral blood flow following STA-MCA bypass in patients with hemispheric ischemia. Stroke 1982;13:774-784.
49
553. Goukirmizi E, Meyer JS, Okabe T, Amano T, Mortel K, Karacan 1. Cerebral blood flow during paroxysmal EEG activation induced by sleep in patients with complex partial seizures. Sleep 1982;5:339-342.
554. Meyer JS. Changes in local CBF and lambda values following regional cerebral
infarction in the baboon. Advances in the Biosciences 1982;43:153-165. 555. Meyer JS, Shaw TG, Okayasu H, Tachibana H. Methodological considerations of
Xenon CT-CBF methods. J CBF & Metab 1983;3:136-138. 556. Okabe T, Meyer JS, Amano T, Okayasu H, Mortel K. Prostaglandin inhibition and
cerebrovascular hemodynamics in normal and ischemic human brain. J CBF & Metab 1983;3:115-121.
557. Meyer JS, Okayasu H, Tachibana H, Shaw T, Mortel K. Xenon contrast CT scanning
differentiates between normal aging, multi-infarct dementia, and senile dementia of Alzheimer type. Neurol 1983;33(4):208.
558. Meyer JS, Lechner H, Reivich M, Ott EO. Cerebral Vascular Disease 4. World
Federation of Neurology, 1 1th International Salzburg Conference. Amsterdam: Excerpta Medica, 1983:185-193.
559. Shaw TG, Mortel KF, Meyer JS, Hardenberg J, Okabe T, Okayasu H. Four year
longitudinal prospective analysis of age related changes in cerebral blood flow measured in normal healthy and risk factored volunteers. In: Meyer JS, Lechner H, Reivich M, Oft E, eds. Cerebral Vascular Disease 4. International Congress Series 616. Amsterdam: Excerpta Medica, 1983:15-21.
560. Okabe T, Meyer JS, Okayasu H, Harper R, Rose J, Grossman R, Centeno R, Lee
YY. Xenon enhanced CT scanning before and after excision of cerebral AVMs. Contribution to pathogenesis and treatment. In: Meyer JS, Lechner H, Reivich M, Ott E, eds. Cerebral Vascular Disease 4. International Congress Series 616. Amsterdam: Excerpta Medica, 1983:185-193.
561. Amano T, Meyer JS, Okabe T, Shaw T, Mortel K. Measurements of local cerebral
blood flow and xenon partition coefficients in Alzheimer's disease versus normal aging. In: Meyer JS, Lechner H, Reivich M, Oft E, eds. Cerebral Vascular.Disease 4. International Congress Series 616. Amsterdam: Excerpta Medica, 1983:244-249.
562. Nakajima S, Meyer JS, Amano T, Shaw T, Okabe T, Mortel KF. Cerebral vasomotor
responsiveness during 100% oxygen inhalation in cerebral ischemia. Arch Neurol 1983;40:271-276.
563. Amano T, Meyer JS, Okabe T, Shaw T, Mortel KF. Cerebral vasomotor
responsiveness during oxygen inhalation. Results in normal aging and dementia. Arch Neurol 1983;40:277-282.
564. Meyer JS. Summary of the World Federation of Neurology International Conference
on Cerebrovascular Disease, Salzburg, Austria, Stroke 1983,14:402412.
50
565. Meyer JS, Shaw TG, Okayasu H, Tachibana H: Multi-infarct and Alzheimer
dementias differentiated from normal aging by Xenon contrast CT measurements. J CBF & Metab 1983;3(l):506-507.
566o Tamura K, Karacan 1, Williams RC, Meyer JS. Disturbances of the sleep-waking
cycle in patients with vascular brain stem lesions. Clin EEG 1983;14:35-46. 567. Meyer JS. Regulation of cerebral hemodynamics in health and disease. Eur Neurol
1983;22(l):41-60. 568. Meyer JS, Shaw TG. Cerebral blood flow in aging, the dementias and depression. In:
Burrows GD, Kay DWK, eds. Handbook of Studies of Psychiatry and Old Age. Amsterdam: Elsevier Press, 1984-439-454.
569. Rogers R, Meyer JS, Shaw TG, Mortel KF. Reductions in regional cerebral blood flow associated with chronic alcohol consumption. JAGS 1985;31:540-543. 570. Rogers R, Meyer JS, Shaw TG, Mortel KF, Hardenberg JP, Zaid RR. Cigarette
smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA 1983;250:2796-2800. Reprinted in Year Book of Family Practice 1985.
571. Meyer JS, Hardenberg J. Clinical effectiveness of calcium entry blockers in
prophylactic treatment of migraine and cluster headaches. Headache 1983;23:266-277.
572. Meyer JS, Okayasu H, Tachibana H, Okabe T. Stable xenon CT-CBF measurement
in prevalent cerebrovascular disease (stroke). Stroke 1984; 15:80-90. 573. Okabe T, Meyer JS, Okayasu H, Harper R, Rose J, Grossman RG, Centeno R,
Tachibana H, Lee YY. Xenon enhanced CT-CBF measurements in cerebral AVMs before and after excision. J Neurosurg 1983;59:21-31.
574. Meyer JS, Largen JW, Shaw T, Mortel KF, Rogers R. Interactions of normal aging,
senile dementia, multi-infarct dementia and alcoholism in the elderly. In: Hartford JT, Samorajski T, eds. Alcoholism in the elderly. New York:Raven Press, 1984:227-251.
575. Tachibana H, Meyer JS, Okayasu H, Shaw TG, Kandula P. Cerebral blood flow and
partition coefficients measured in cerebral astrocytomas of different grades of malignancy. Surg Neurol 1984;21:125-131.
576. Meyer JS, Tachibana H, Hardenberg JP, Dowell RE, Kitagawa Y, Mortel KF. Normal
pressure hydrocephalus. Influences on cerebral hemodynamic and cerebrospinal fluid pressure chemical autoregulation. Surg Neurol 1984;21:195203.
577. Okayasu H, Meyer JS, Mathew NT, Amano T, Hardenberg J. Lithium carbonate has
no measurable effect on cerebral hemodynamics in cluster headaches. Headache 1984;24:1-4.
51
578. Tachibana H, Meyer JS, Okayasu H, Kandula P. Changing topographic patterns of human cerebral blood flow with age measured by Xenon CT. AJNR 1984;5:139146.
579. Meyer JS, Tachibana H, Kitagawa Y, Kandula P. Xenon contrast CT-CBF
measurements in Parkinsonism. Neurol 1984;34(l):207. 580. Tachibana A, Meyer JS, Kitagawa Y, Rogers R, Okayasu H, Mortel KF. Effects of
aging on cerebral blood flow in dementia compared to normals. JAGS 1984;32:114-120.
581. Meyer JS, Shaw TG. Cerebral blood flow in aging. In: Albert MIL (Ed). Clinical
Neurology of Aging. New York:Oxford University Press, 1984:178-196. 582. Meyer JS. Review: Computer-aided electromyography. In: Desmedt JE, ed. J
Neurosurg 1984;61:197. 583. Meyer JS. Review. Biological aspects of Alzheimers disease. In: Katzman R, ed. J
Gerontol 1984;39:630. 584. Shaw TG, Mortel KF, Meyer JS, Rogers R, Hardenberg J, Cutaia MM. Cerebral
blood flow changes in benign aging and cerebrovascular disease. Neurol 1984;34:855-862.
585. Rogers R, Meyer JS, Shaw TG, Mortel KF, Thornby J. The effects of chronic
cigarette smoking on cerebrovascular responsiveness to 5% C02 and 100% 02 inhalation. JAGS 1984;32:415-420.
586. Meyer JS. Calcium antagonists and the prophylactic treatment of migraine and
cluster headache. In: Progress in Pathophysiology and Therapy of Cerebrovascular Disease: Calcium Antagonists. Amsterdam: Excerpta Medica, 1984:85-110.
587. Meyer JS, Dowell R, Walker M. Calcium antagonists are effective in prophylactic
treatment of all types of vascular headache. Ann Neurol 1984;16:112-114. 588. Meyer JS, Kitagawa Y, Tanahashi N, Kandula P, Cech DA, Rose JE, Grossman R.
Pathogenesis and treatment of normal pressure hydrocephalus. Ann Neurol 1984;16:135-136.
589. Meyer JS, Rogers R, Mortel KF. Progressive cerebral ischemia antedates
cerebrovascular symptoms by two years. Ann Neurol 1984; 16:305-313. 590. Meyer JS. Women and vascular headache. The Women's Fund Bull, Winter
1984;3-4. 591. Tachibana H, Meyer JS, Okayasu H, Shaw TG, Kandula P. Xenon contrast CTCBF
scanning of the brain differentiates normal age related changes from multiinfarct dementia and SDAT. J Gerontology 1984;39:415-423.
52
592. Meyer JS, Dowell R, Walker ML. Calcium antagonists. A promising new approach to migraine headache. The Female Patient 1984;9:63-70.
593. Meyer JS, Dowell R, Mathew NT, Hardenberg J. Clinical and hemodynamic effects
during treatment of vascular headaches with verapamil. Headache 1984;24:313321. 594. Kitagawa Y, Meyer JS, Tachibana H, Mortel KF, Rogers R. CT-CBF correlations of
cognitive deficits in multi-infarct dementia. Stroke 1984;15:1000-1008. 595. Tanahashi N, Meyer JS, Rogers R, Kitagawa Y, Mortel KF, Kandula P, Levinthal R,
Rose J. Long-term assessment of cerebral perfusion following STA-MCA bypass in patients. Stroke 1985;16:85-91.
596. Meyer JS, Walker M, Nance M, Dowell R. Calcium antagonists appear to be
effective in prophylactic treatment of all types of vascular headaches. VA Practitioner 1985;2:42-51.
597. Meyer JS, Ktagawa Y, Tanahashi N, Tachibana H, Kandula P, Cech DA, Rose JE,
Grossman RG. Pathogenesis of normal pressure hydrocephalus - preliminary observations. Surg Neurol 1985;23:121-133. Reprinted in Year Book of Nuclear Medicine 1985.
598. Rogers R, Meyer JS, Mortel KF, Mahurin RK, Thornby J. Age-related reductions in
cerebral vasomotor reactivity and the law of initial values. A 4-year prospective longitudinal study. J CBF & Metab 1985;5:79-85.
599. Meyer JS. Editorial: Calcium channel blockers for the prophylactic treatment of
vascular headaches. Ann Int Med 1985; 102:395-397. 600. Meyer JS, Gozukirmizi E, Karacan 1. Sleep activated EEG and CBF measured in
patients with complex partial seizures. In: Baldy-Moulinier M, -Ingvar DH, Meldrum BS, eds. Current Problems in Epilepsy. London:John Libbey, 1985:180-184.
6011 Meyer JS, Kitagawa Y, Tanahashi N, Tachibana H, Kandula P, Cech DA, Clifton GL,
Rose JE. Evaluation of treatment of normal-pressure hydrocephalus. J Neurosurg 1985;62:513-521. Abstracted in Annual Review of Hydrocephalus 1986.
602. Rogers R, Meyer JS, Judd BW, Mortel KF. Abstention from cigarette smoking
improves cerebral perfusion among elderly chronic smokers. JAMA 1985;253:2970-2974. Abstracted in Mod Med of Canada 1985. Abstracted in JAMA, French Edition, 1985;10:947-950. Reported in JAMA, German Edition, 1985;5:702-709. Translated and published in JAMA, Southeast Asia Edition, 1986;2:31-36. Translated and published in JAMA, Jugoslavian Edition, 1985-1:199-200.
603. Meyer JS. Nimodipine is effective in prophylactic treatment of migraine and cluster
headaches. In: Betz E, Deck K, Hoffmeister F, eds. Nimodipine, Pharmacological and Clinical properties. New York-Stuttgart:Springer-Veriag, 1985:421-441.
53
604. Tachibana H, Meyer JS, Kitagawa Y, Tanahashi N, Kandula P, Rogers R. Xenon contrast CT-CBF measurements in Parkinsonism and normal aging. JAGS 1985;33:413-421.
605. Meyer JS. Cerebral blood flow and metabolism in ischemic brain disease. Fifth Southeast European Neuropsychiatric Conference, Graz, Austria. Greece: University Studies Press, 1983:227-241.
606. Meyer JS, Tanahashi N, Ishikawa Y, Kandula P, Mortel KF, Rogers R. Reversibility
of cerebral hypoperfusion and brain atrophy in Wernicke-Korsakoff's syndrome. Ann Neurol 1985; 18:142-143.
607. Meyer JS. Summary: Twelfth Salzburg Conference on Cerebrovascular Disease.
World Neurology, Newsletter No. 4, July 15:4-6, 1985. 608. Meyer JS. Measurement of cerebral blood flow by stable xenon contrast
computerized tomography. In: Hartmann A, Hoyer S, eds. Cerebral Blood Flow and Metabolism Measurement. Berlin: Springer-Verlag, 1985:315-327.
609. Meyer JS, Kitagawa Y, Tanahashi N, Kandula P, Rose JE, Grossman RG. Dementia
associated with normal pressure hydrocephalus. J Neurol 1985;232:122. 610. Meyer JS, Tanahashi N, Ishikawa Y, Hata T, Velez M, Fann WE, Kandula P, Mortel
KF, Rogers R. Cerebral atrophy and hypoperfusion improve during treatment of Wernicke-Korsakoff Syndrome. J CBF & Metab 1985;5:376-385.
611. Meyer JS, Tanahashi N, Ktagawa Y. Clinical value and costs of technical medicine
in diagnosis and therapy of cerebrovascular disease - methods for measuring cerebral blood flow. In: Cerebral Vascular Disease 5. World Federation of Neurology, Twelfth Salzburg Conference, International Congress Series 687. Amsterdam: Excerpta Medica, 1985:3-22.
612. Meyer JS, Kitagawa Y, Tanahashi N, Tachibana H, Mortel KF, Roger R. CT-CBF
correlates of cognitive deficits in multi-infarct dementia. In: Cerebral Vascular Disease 5. World Federation of Neurology, Twelfth Salzburg Conference, International Congress Series 687. Amsterdam: Excerpta Medica, 1985:271-277.
613. Meyer JS. Calcium channel blockers in the treatment of vascular headaches.
Rational Drug Therapy 1985; 19:1-4. 614. Meyer JS, Nance M, Walker M, Zetusky WJ, Dowell RE. Migraine and headache
treatment with calcium antagonists supports as vascular pathogenesis. Headache 1985;25:358-371.
615. Nath RG, Coleman L, Meyer JS, McCalden TA. Short-term hypercholesterolemia
and the baboon cerebral circulation. Proc Western Pharm Soc 1985;28:69-71. 616. Tanahashi N, Meyer JS, Ishikawa Y, Kandula P, Mortel KF, Rogers R, Ghandi S,
Walker M. Cerebral blood flow and cognitive testing correlate in Huntington's disease. Arch Neurol 1985;42:1169-1175.
54
617. Meyer JS, Hata T, Imai A, Zetusky WJ. Migraine and intracranial swelling. Letter to
the Editor, Lancet 1985;2:1308-1309. 618. Meyer JS, Rogers R, Mortel KF Prospective analysis of long-term control of mild
hypertension on cerebral blood flow. Stroke 1985; 16:985-989. 619. Rogers R, Meyer JS, Mortel KIF, Mahurin RK Judd BW. Decreased cerebral blood
flow precedes multi-infarct dementia, but follows senile dementia of Alzheimer's type. Neurol 1986;36:1-6.
620. Meyer JS. Cerebral function, blood flow and metabolism: A new vista in psychiatry.
Integrated Psychiatry 1985;3:224-225. 621. Ishikawa Y, Meyer JS, Tanahashi N, Hata T, Velez M, Fann WE, Kandula P, Mortel
KF, Rogers R. Abstinence improves cerebral perfusion and brain volume in alcoholic neurotoxicity without Wernicke-Korsakoff syndrome. J CBF & Metab 1986;6:86-94.
622. Kitagawa Y, Meyer JS, Tanahashi N, Rogers R, Tachibana H, Kandula P, Dowell
RIF, Mortel KF Cerebral blood flow and brain atrophy correlated by Xenon contract CT scanning. Comp Radiol 1985;9:331-340.
623. Solomon S, Meyer JS, Raskin N. Migraine: are you choosing the most effective
agent. Data Centrum 1986;3:19-27. 624. Meyer JS. Brain imaging and brain function. Sokolof L (Ed). Book Review J
Neurosurg 1985;17:864-865. 625. Meyer JS, Judd BW, Rogers R. Cognitive performance fluctuates in multi-infarct
dementia. Neurol 1986;1(1):36. 626. Judd BW, Meyer JS, Rogers R, Gandhi S, Tanahashi N, Mortel KF, Tawakina T.
Cognitive performance correlates with cerebrovascular impairments in multi-infarct dementia. JAGS 1986;34:355-360. Abstracted in Geriatrics Digest 1986;7:19-20.
627. Meyer JS, Hata T, Imai A, Sakai F. Xenon CT helps reveal blood flow disorders.
Diagnostic Imaging 1986;8:92-96. 628. Rivera VM, Meyer JS, Hata T, Ishikawa Y, Imai A. Narcolepsy following cerebral
hypoxic ischemia. Ann Neurol 1986; 19:505-508. 629. McCalden TA, Tanahashi N, Nath RG, Coleman L, Meyer JS. In vivo actions of a
calcium channel blocker (Nimodipine) in the cerebrovascular response to infused 5-hydroxytryptamine. J Pharm Exp Therap 1986;237:36-39. Reprinted in Focus on Stroke - Nimodipine Review 1984-1989. Reprinted in American Heart Association, Dallas, Texas 1989:49.
630. Meyer JS, Hata T, Imai A, Sakai F. Three-dimensional mapping of local cerebral
perfusion in two distinct types of alcoholic encephalopathy. Ann Neurol 1986;20:155.
55
631. Meyer JS, Judd BW, Rogers R, Mortel KF. Improved cognition after control of risk
factors in multi-infarct dementia. Ann Neurol 1986;20:158. 632. Okyre JG, Ktonas PY, Meyer JS. Quantification of the alpha EEG modulation and its
relation to cerebral blood flow. IEEE Trans Biomed Engineer 1986;33:690-696. 633. Meyer JS. Headache: An illustrated practitioner's guide. Hosp Med 1986;22:146170. 634. Meyer JS, Zetusky W, Jonsdottir M, Mortel KF. Cephalic hyperemia during migraine
headaches. A prospective study. Headache 1986;28:388-397. 635. Meyer JS. Recent advances in measuring cerebral blood flow and metabolism in
human aging, cerebrovascular disease, dementia, sleep and the epilepsies. In: Lechner H, Meyer JS, Oft E, eds. Cerebrovascular Disease: Research and Clinical Management, Volume 1, Part 1: Review Articles. Amsterdam-New YorkOxford: Elsevier, 1986:67-86.
636. Meyer JS. Cerebral blood flow and metabolism in multi-infarct dementia: relationship
to cognitive deficits. In: Lechner H, Meyer JS, Ott E, eds. Cerebrovascular Disease: Research and Clinical Management, Volume 1, Part I.: ReviewArticles. Amsterdam-New York-Oxford: Elsevier, 1986:173-181.
637. Meyer JS. Clinical value and costs of technical medicine in diagnosis and therapy of
cerebrovascular disease: cerebral embolism. In: Lechner H, Meyer JS, Ott E, eds. Cerebrovascular Disease: Research and Management, Volume 1, Part 11: Winston-Salem Conference on clinical value of diagnostic testing for the evaluation of patients with stroke. Amsterdam-New York-Oxford: Elsevier, 1986:245-249.
638. Meyer JS. Clinical value and costs for diagnostic testing for evaluation of patients
with stroke: methods for measuring cerebral blood flow. In: Lechner H, Meyer JS, Oft E, eds. Cerebrovascular Disease: Research and Clinical Management, Volume 1, Part [I. Amsterdam-NewYork-Oxford: Elsevier, 1986:307-312.
639. Meyer JS. Vascular pharmacology of migraine therapy. VA Prac 1986;3:50-62. 640. Meyer JS, Judd BW, Tawakina T, Rogers R, Mortel KF. Improved cognition after
control of risk factors for multi-infarct dementia. JAMA 1986;265:2203-2209. Abstracted in International Synopses 1986. Abstracted in JAMA, French Edition, Neuro-Psychiatrie 1986; 1 l(l):27-34.
641. Meyer JS, Judd BW, Rogers R, Mortel KF. Cognition fluctuates in multi-infarct
dementia. Stroke 1987;18:297. (Abstract) 642. Fann WE, Hayre HS, Meyer JS. Voice-based detection of tardive dyskinesia. Clin
Pharmacol Ther 1987;2:206. (Abstract)
56
643. Hata T, Meyer JS, Tanahashi N, et al. Three-dimensional mapping of local cerebral perfusion in alcoholic encephalopathy with and without Wernicke-Korsakoff syndrome. J CBF & Metab 1987;7:35-44.
644. Meyer JS. CBF and common migraine. Letter to the Editor, Headache
1987;27:107-108. 64-5. Oravez WT, Meyer JS, Imai A, Shinohara T, Timpe G, DeVille T. Technical
optimization for determining local cerebral blood flow (LCBF) using dynamic quantitative CT and Xes/02(g) contrast method. Radiol 1987;161:345. (Abstract)
646. Meyer JS, Rogers R, Mortel KF, Judd BW. Hyperlipidemia is a risk factor for
decreased cerebral perfusion and stroke. Arch Neurol 1987;44:418-422. 647. Rogers R, Meyer JS, Mortel KF. Additional predisposing risk factors for
atherothrombotic cerebrovascular disease among treated hypertensive volunteers. Stroke 1987; 18:335-34 1.
648. Meyer JS, Imai A, Shinohara T, Sakai F, Timpe G, DeVille T, Oravez WT. Improved
methodology for inhalation of stable Xenon during CBF measurements by computerized tomography. J CBF & Metab 1987;7(l):566. (Abstract)
649. Meyer JS, Rogers R, Mortel KF. Letter to the Editor - Multi-infarct dementia. JAMA
1987;257:1049. 650. McCalden TA, Tanahashi N, Nath RG, Coleman L, Meyer JS. In-vivo action of a
calcium channel blocker (Nimodipine) on the cerebrovascular response to infused 5-hydroxytryptamine. J Pharmacol and Exp Therap 1987;237:34-36.
651. Meyer JS, Rogers FL, Mortel KF. Letter to the Editor - Cerebral blood flow in
dementia. Neurol 1986;36:1542-1543. 652. Meyer JS, Hata T, Imai A. Clinical and experimental studies of diaschisis. In: Wood
JH, ed. Cerebral Blood Flow. New York: McGraw-Hill Inc, 1987:481-502. 653. Jonsdottir M, Meyer JS, Rogers R. Efficacy, side effects and tolerance compared
during headache treatment with three different calcium blockers. Headache 1987;27:364-369.
654. Meyer JS, Ishikawa Y, Hata T, Karacan IL. Cerebral blood flow in normal and
abnormal sleep and dreaming. Brain and Cognition 1987;6:266-295. 655. Meyer JS. Requested Editorial Comment - Migraine headache and epilepsy:
coincidental or related? JAMA 1987;258:1820. 656. Meyer JS. Cerebral blood flow in aging, stroke and dementia. J Cardiovasc
Ultrasonog 1987;6:220. (Abstract)
57
657. Meyer JS, Dalessio DJ. Toxic vascular headache. In: Dalessio DJ, ed. Wolffs Headache and Other Head Pain, Fifty Edition. New York:Oxford University Press, 1987:136-171.
658. Meyer JS, Ktagawa Y, Tanahashi N, Tachibana H, Kandula P, Cech D, Clifton G,
Rose J. Evaluation of treatment of normal-pressure hydrocephalus. ln:Matsumoto S, ed. Annual Review of Hydrocephalus. Tokyo: Neuron Publishing Co, 1986:215218.
659. Meyer JS. Controlled clinical trials of cerebral thrombolysis: a voice from the past. In:
Powers WJ, Raichle ME, eds. Cerebrovascular Diseases. Fifteenth Princeton) Conference. New York: Raven Press, 1986:343-347.
660. Meyer JS, Rogers R, Judd BW, Mortel KF. Cognitive performance and cerebral
blood flow fluctuate in multi-infarct dementia. 112th Annual Meeting of the American Neurological Association, 1987:37. (Abstract)
661. Meyer JS, Shinohara T, Imai A, Kobari M, Sakai F, Hata T, Oravez WT, Solomon E,
Timpe G. Improved methods for mapping local cerebral blood flow by 27% to 30% Xenon-enhanced computed tomography. 112th Annual Meeting of the American Neurological Association, 1987:59. (Abstract)
662. Meyer JS, Judd BW, Rogers R, Mortel KF. Control of hypertension, abstention from
smoking and surgical revascularization procedures improve cognition in different categories of multi-infarct dementia. In: Meyer JS, Lechner H, Ott E, Reivich M, eds. Cerebral Vascular Disease 6. Amsterdam: Elsevier Science Publishers, 1987:89-96.
663. Rogers R, Meyer JS. Computerized dementia screening questionnaire (DSQ) for
identifying multi-infarct dementia and other common causes of dementia. In: Meyer JS, Lechner H, Ott E, Reivich M, eds. Cerebral Vascular Diseases 6, World Federation of Neurology 13th Salzburg Conference, International Conference Series 736. Amsterdam: Excerpta Medica, 1987:135-147.
664. Meyer JS, Hata T, Imai A. Evidence supporting a vascular pathogenesis of migraine
and cluster headache. In: Blau JN, ed. Migraine, Clinical, Therapeutic Conceptual and Research Aspects. London: Chapman-Hall Publishers, 1987:265302.
665. Rogers R, Meyer JS. Computerized history and self-assessment questionnaire for
diagnostic screening among patients with dementia. JAGS 1988;36:13-21. 666. Meyer JS, Rogers R, Mortel KF. Controlled clinical trial of daily aspirin therapy in
multi-infarct dementia. Stroke 1988; 19:148. (Abstract)
667. Meyer JS, Rogers R, Judd BW, Mortel KF, Sims P. Cognition and cerebral blood flow fluctuate together in multi-infarct dementia. Stroke 1988; 19:163-169. 668. Meyer JS. The nature of reduced cerebral perfusion in vascular and multi-infarct
dementia. In: Meyer JS, Lechner H, Marshall J, Toole J, eds. Vascular and Multi-Infarct Dementia. New York: Futura Publishing Co, 1988:113-27.
58
669. Meyer JS, Lechner H, Marshall J, Toole J, eds. Vascular and Multi-Infarct Dementia. New York:Futura Publishing Co, 1988:1-276.
670. Meyer JS, McClintic K, Sims P, Rogers R, Mortel KF. Etiology, prevention and
treatment of vascular and multi-infarct dementia. In: Meyer JS, Lechner H, Marshall J, Toole JF, eds. Vascular and Multi-Infarct Dementia. New York: Futura Publishing Co, 1988:129-148.
671. Kobari M, Meyer JS, Imai A, Oravez WT, Ichijo M. Cross-sectional imaging of
cerebral blood flow during migraine headaches. (Abstract) Headache 1988;23:295. 672. Meyer JS. Approche hemodynamique. Cerebral hemodynamic studies of normal
aging. In: Maloine SA, ed. Le Vieillissement Cerebral Normal et Pathologique, 4th Colloque. Paris: Foundation Nationale De Gerontologie, 1987:176-189.
673. Meyer JS, Shinohara T, Imai A, Kobari M, Sakai F, Hata T, Oravez WT, Timpe GM,
Deville T, Solomon E. Imaging cerebral blood flow by xenon enhanced computed tomography. Technical optimization procedures. Neuroradiol 1988;30:283-292.
674. Rogers R, Meyer JS, Mortel KF. Gemfibrozil improves cognitive performance and
cerebral perfusion in elderly hypertriglyceridemic patients. (Abstract) Ann Neuro 1988;24:125.
675. Meyer JS, Kobari M, Ichijo M, Imai A, Oravez W. Solubility of xenon gas in human
brain increases during normal aging: pathological implications. Ann Neurol 1988;24:133-134.
676. Meyer JS, Rogers R, Mortel KF. Multi-infarct dementia: Demography, risk factors
and therapy. In: Ginsberg MD, Dietrich WD, eds. Cerebrovascular Diseases, 16 1h
Princeton Conference. New York: Raven Press, 1989:199-206. 677. Meyer JS, McClintic KL, Rogers R, Sims P, Mortel KF. Aetiological considerations
and risk factors for multi-infarct dementia. J Neurol Neurosurg and Psych 1988;51:1489-1497. Abstracted in Year Book of Geriatrics and Gerontology 1990. Reprinted in Geriatrics International 1990.
678. Ichijo M, Meyer JS, Kobari M, Oravez WT. Reversible cerebral ischemia revealed by
xenon contract CT scanning in multi-infarct dementia. Stroke 1989;20:157. (Abstract).
679. Meyer JS, Imai A, Shinohara T. Causes of cerebral ischemia and infarction. In:
Vinken PJ, Bruyn GW, Kawans HL, ed. Handbook of Clinical Neurology, Vascular Diseases, Part 1, Volume 53/9. 1989:155-173.
680. Imai A, Meyer JS, Kobari M, Ichijo M, Shinohara T, Oravez WT. LCBF values decline
while LA values increase during normal human aging measured by stable xenon-enhanced computed tomography. Neuroradiol 1988;30:463-472.
59
681. Lotfi J, Meyer JS. Cerebral hemodynamics and metabolic effects of chronic alcoholism. In: Cerebrovascular and Brain Metabolism Rev. New York:Raven Press, 1989:2-25.
682. Rogers R, Meyer JS, McClintic K, Mortel KF. Reducing hypertriglyceridemia in
elderly patients with cerebrovascular disease stabilizes or improves cognition and cerebral perfusion. Angiol 1989;40:260-269. Abstracted in Modern Medicine 1989.
683. Kobari M, Meyer JS, Ichijo M, Oravez WT. Hyperperfusion of cerebral cortex,
thalamus and basal ganglia during spontaneously occurring migraine headaches. Headache 1989;29:282-289.
684. Meyer JS, Rogers R, McClintic K, Mortel KF, Lotfi J. Randomized clinical trial of daily
aspirin therapy in multi-infarct dementia. JAGS 1989;37:549-555. Abstracted in JAMA ~989;262:3054. Abstracted in Abstracts International 1989. Abstracted in Year Book of Geriatrics and Gerontology 1990.
685. Kobari M, Meyer JS, Ichijo M, Oravez WT. Subcortical hyperperfusion during
migraine and cluster headaches. J CBF & Metab 1989;9(l):S719. (Abstract) 686. Meyer JS, Ichijo M, Kobari M, Oravez WT. Cerebral perfusion patterns among
different types of vascular dementia. J CBF & Metab 1989;9(l):S542. (Abstract) 687. Meyer JS, Kobari M, Ichijo M, Oravez W. Computed tomographic leuko-araiosis,
cerebral ischemia and cognitive performance. Ann Neurol 1989;26:134. (Abstract) 688. Meyer JS, McClintic KL, Rogers R, Sims P, Mortel KF. Incidence of risk factors and
types of stroke in patients with multi-infarct dementia. In: Meyer JS, Lechner H, Reivich M, Toole JF, eds. Cerebral Vascular Disease 7, World Federation of Neurology 14' Salzburg Conference, International Congress Series, 858. Amsterdam: Excerpta Medica, 1989:7-11.
689. Meyer JS, Lotfi J. Vascular and multi-infarct dementia: Demography, risk factors,
prevention and treatment. In: Bartko D, Gerstenbrand F, Turcan P, eds. Neurology in Europe. London:John Libbey & Co, 1989:109-114.
690. Meyer JS, Lotfi J, Kobari M. Treatment of migraine and cluster headache with
calcium antagonists. In: Hartmann A, Kuschinsky W, eds. Cerebral Ischemia and Calcium. Berlin: Springer-Verlag, 1989:410-418.
691. Rogers R, Meyer JS, Mortel KF. After reaching retirement age physical activity
sustains cerebral perfusion and cognition. JAGS 1990;38:123-128. 692. Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy and cerebral
perfusion in normal aging. Arch Neurol 1990;47:161-165. 693. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leuko-araiosis: correlation of MR and CT
findings with blood flow, atrophy and cognition. AJNR 1990;11:372-382.
60
694. Kobari M, Meyer JS, Ichijo M. Cerebral hemodynamic changes during migraine and cluster headache - Pharmacological implications. Head Quar 1990;1:23-27.
695. Meyer JS. Differential diagnosis, etiology, pathophysiology and treatment of multi-
infarct dementia. Proceedings of the Send international Symposium on Vascular Dementia. Recent Adv Cardiovasc Dis 1990;11(1):83-89.
696. Funk JL, Mortel KF, Meyer JS. Estrogen replacement therapy helps maintain
cognition in elderly women. Neurol 1990;40(1):418. 697. Kobari M, Meyer JS, Ichijo M, Oravez VVT. Cortical and subcortical hyperperfusion
during migraine and cluster headache. Neuroradiol 1990;32:4-11. 698. Meyer JS, Kawamura J, lchijo M. Clinical studies of cluster headache. Head Rev
1990;3:5. 699. Meyer JS, Kawamura J, Ichijo M, Kobari M, Terayama Y. Leuko-araiosis, cerebral
atrophy and blood flow in elderly patients with dementia. Ann Neurol 1990;28:234. 700. Mortel KF, Meyer JS, Sims PA, McClintic K. Diabetes mellitus as a risk factor for
stroke. South Med J 1990; 83:904-911. 701 Meyer JS. Effects of Aging, Risk Factors for Stroke and Dementia on Cerebral Blood
Flow. In: Bes A, Geraud G, eds. Current Problems in Neurology 12: Circulations Cerebrale et Vieillissement. London/Paris: John Libbey, Eurotext, 1990:17-30.
702. Meyer JS, Lotfi J, Martinez G, Caroselli JS, Mortel KF, Thornby Ji. Effects of medical
and surgical treatment on cerebral perfusion and cognition in patients with chronic cerebral ischemia. Surg Neurol 1990;34:301-308.
703. Kawamura J, Meyer JS, lchijo M, Kobari M, Terayama Y. Leuko-araiosis, cerebral
atrophy and blood flow in elderly patients with dementia. Proceedings of the 15" Annual Meeting of the American Neurological Association. 1990:53.
704. Meyer JS, Kawamura J, Terayama Y, Weathers S. Diagnosis of multi-infarct
dementia by non-spectroscopic methods. In: Miller BIL, ed. Silent Vascular Disease, Dementia and Spectroscopy. Bull Clin Neurosciences 1990:55, 71-80.
705. Gallagher RM, Meyer JS, Ichijo M, Kobari M, Lotfi J, Rose FC, Davis OTG, Solomon
GD. Prophylactic treatment of migraine. In: Gallagher RM, ed. Drug Therapy For Headache. Marcel Dekker Inc, 1991:65-94.
706. Gallagher RM, Meyer JS, Ichijo M, Kobari M, Lotfi J. Pharmacologic treatment of
cluster headache. In: Gallagher RM, ed. Drug Therapy For Headache. Marcel Dekker Inc, 1991:131-150.
707. Reed KM, Rogers R, Meyer JS. Cerebral magnetic resonance imaging compared in
Alzheimer's and multi-infarct dementia. J Neuropsych and Clin Neurosci 1991;3:51-57.
61
708. Terayama Y, Meyer JS, Kawamura J, Weathers S. After severe head injury, damage
to thalamus, putamen and white matter impairs cognitive recovery (abstract). Neurol 1991;41(1):176-177.
709. Meyer JS, Ichijo M, Kawamura J, Terayama Y. Cerebral ischemia correlates better
with cognitive impairments in mild to moderate multi-infarct dementia than infarcted brain volume. In: Hartmann A, Kuschinski W, Hoyer S, eds. Cerebral Ischemia and Dementia. Berlin: Springer-Verlag, 1991:287-295.
710. Meyer JS. Does diaschisis have clinical correlates? Editorial, Mayo Clin. Proc.
1991;66:430-432. 711. Kawamura J, Meyer JS, Terayama Y, Weathers S. Cerebral hyperemia during
spontaneous cluster headaches with excessive cerebral vasoconstriction to hyperoxia. Headache 1991;31:222-227.
712. Mortel KF, Funk JL, Meyer JS, Vanek L. Cerebral perfusion and cognitive effects of
aspirin versus ticlopidine in patients with cerebral ischemia. Drug Invest 1991;3:61-68.
713. Kawamura J, Meyer JS. Headaches due to cerebrovascular disease. Med Clin North
Amer 1991;75:617-630. 714. Kawamura J, Meyer JS, Terayama Y, Weathers S. Excessive cerebral
vasoconstrictive response to oxygen inhalation is a biological marker of cluster headache. (Abstract) Cephalalgial991;11(11):264-265.
715. Terayama Y, Meyer JS, Kawamura J, Weathers S. Cerebral blood flow and cognitive
testing correlated longitudinally for ten years after severe head injury. (Abstract) J CBF & Metab 1991; 11(2):830.
716. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and LCBF
reductions among patients with vascular dementia. (Abstract) J CBF & Metab 199 1; 11 (2):800.
717. Meyer JS, Kawamura J, Terayama Y, Weathers S. Cluster headache patients show
excessive cerebral vasoconstrictive responses to oxygen inhalation. J CBF & Metab 1991; 11(2):87.
718. Terayama Y, Meyer JS, Kawamura J, Weathers S, Mortel KF. White matter ischemia
and cognitive performance after different types of strokes. (Abstract) Ann Neurol 1991;30:249.
719. Mortel KF, Lotfi J, Meyer JS, Funk JL. Long-term clinical outcome in normal
volunteers and patients with cerebral transient ischemic attacks. (Abstract) Ann Neurol 1991;30:245-246.
62
720. Funk JL, Mortel KF, Meyer JS, Kawamura J, Terayama Y. Leuko-araiosis and depression in multi-infarct dementia. (Abstract) Ann Neurol 1991;30:251.
721. Mortel KF, Wood S, Pavoi M, Meyer JS, Funk JL. Cerebral perfusion and cognitive
outcomes compared longitudinally among Alzheimer and multi-infarct dementia patients. (Abstract) Ann Neurol 1991;30:251.
722. Mortel KF, Pavol M, Wood S, Meyer JS, Funk JL. Personal and familial risk factors
for stroke and dementia among Alzheimer and vascular dementia patients. (Abstract) Ann Neurol 1991;30:289.
723. Terayama Y, Meyer JS, Kawamura J, Weathers S. Role of thalamus and white
matter in cognitive outcome after head injury. J CBF & Metab 1991;11:852-860. 724. Meyer JS, Moskowitz MA. Discussion: Mechanisms of migraine with aura. In: Olesen
J, ed. Migraine and Other Headaches: The Vascular Mechanisms. New York:Raven Press, 1991:195-196.
725. Meyer JS, Kawamura J, Terayama Y. Stable xenon CT-CBF methodology for
studying vascular headache. In: Olesen J, ed. Migraine and Other Headaches: The Vascular Mechanisms. New York: Raven Press, 1991:29-34.
726. Meyer JS, Kawamura J, Terayama Y. Xenon 133 cerebral blood flow measurements
in migraine with aura. In: Olesen J, ed. Migraine and Other Headaches: The Vascular Mechanisms. New York: Raven Press, 1991:115-119.
727. Meyer JS, Kawamura J, Terayama Y. CT-CBF and 133 Xe inhalation cerebral blood
flow studies in cluster headache. In: Olesen J, ed. Migraine and Other Headaches: The Vascular Mechanisms. New York:Raven Press, 1991:305-310.
728. Meyer JS, Kawamura J, Terayama Y. CT-CBF and 133Xe CBF studies in migraine
without aura. In: Olesen J, ed. Migraine and Other Headaches: The Vascular Mechanisms. New York: Raven Press, 1991:227-235.
729. Meyer JS, Kawamura J, Ichijo M, Kobari M, Terayama Y. Leuko-araiosis, aging and
dementia. In: Cerebral Vascular Disease 8, World Federation of Neurology 15 th
Salzburg Conference, International Congress Series 975. Amsterdam: Excerpta Medica, 1991:45-50.
730. Terayama Y, Meyer JS, Kawamura J. Cognitive recovery correlates with long-term
increases of cerebral perfusion after head injury. Surg Neurol 1991;36:335-342. 731. Fife, CE, Meyer JS. Hyperbaric oxygen treatment of acute migraine headache. Head
Quar 1991;2:301-306. 732. Kawamura J, Meyer JS, Terayama Y, Weathers S. Longitudinal measurement of
cerebral perfusion in patients with multi-infarct dementia. J Stroke Cerebrovasc Dis 1991;1:196-202.
63
733. Funk JL, Mortel KF, Meyer JS. Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women. Dementia 1991;2:268272.
734. Kawamura J, Meyer JS, Terayama Y, Weathers S. Cerebral white matter perfusion
in dementia of the Alzheimer's type. Alz Dis & Assoc Disorders 1991;5:231-239. 735. Kawamura J, Meyer JS, Terayama Y, Weathers S. Cerebral hypoperfusion
correlates with mild and parenchymal loss with severe multi-infarct dementia. J Neurol Sci 1991;102:32-38. Reprinted in Current Opinion in Neurobiology 1992.
736. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leukoaraiosis correlates with
cerebral hypoperfusion in vascular dementia. Stroke 1991;22:609-614. Reprinted in Geriatrics International 1992;3:1-5.
737. Meyer JS, Imai A, Ichijo M, Kobari M, Kawamura J, Terayama Y. Local cerebral
blood flow and local lambda values change with normal advancing age. In: Yonas H, ed. Cerebral Blood Flow Measurements With Stable Xenon-Enhanced Computed Tomography. New York: Raven Press, 1992;89-113.
738. Kobari M, Meyer JS, Ichijo M, Kawamura J. Xenon contrast CT-CBF measurements
in senile dementia of Alzheimer type. Neuropsychiat Neuropsychol Behavior Neurol 1992;5:37-45.
739. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y. Leuko-araiosis, cerebral
ischemia and cognitive performance correlated by xenon CT-CBF. In: Yonas H, ed. Cerebral Blood Flow Measurements With Stable Xenon-Enhanced Computed Tomography. New York:Raven Press, 1992:110-113.
740. Meyer JS, Kawamura J, Ichijo M. Cerebrovascular disease and headache. In:
Diamond S, Dalessio DJ, eds. The Practicing Physician's Approach to Headache, 5th Edition. Baltimore: Williams & Wilkins, 1992:162-173.
741. Grotta JC, Norris JW, Kamm B, Meyer JS. Prevention of stroke with Ticlopidine@:
who benefits most? Neurol 1992;42:111-115. 742. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and cerebral
hypoperfusion compared in elderly normals and Alzheimer's dementia. JAGS 1992;375-380.
743. Meyer JS, Terayama Y, Takashima S, Mortel KF. Cerebral autoregulation among
elderly normal volunteers, Alzheimer's and Multi-Infarct Dementias. Stroke 1992;23(3).
744. Terayama Y, Meyer JS, Kawamura J, Weathers S, Mortel KF. Patterns of cerebral
hypoperfusion compared among demented and non-demented patients with stroke. Stroke 1992;23(5):686-692.
745. Meyer JS, Kawamura J, Terayama Y. White matter lesions in the elderly. J Neurol
Sci 1992; 110: 1 -7.
64
746. Terayama Y, Meyer JS, Kawamura J, Takashima S, Mortel KF. Cerebral
autoregulation among elderly normal volunteers, Alzheimer's and multi-infarct dementia. Stroke 1992;23:463.
747. Meyer JS, Terayama Y, Takashima S, Mortel KF. Cerebral autoregulation among
elderly normal volunteers, Alzheimers and Multi-infarct dementias. Proceedings of Second World Congress of Stroke. J Stroke Cerebrovasc Dis 1992;S40(l).
748. Terayama Y, Meyer JS, Takashima S, Weathers S. CT densitometric comparisons
of normal and abnormal cerebral gray and white matter compartments and perfusion in multi-infarct versus Alzheimer's dementia. Proceedings of Second World Congress of Stroke. J Stroke Cerebrovasc Dis 1992;2(l):S43.
749. Takashima S, Meyer JS, Terayama Y, Weathers S. CT densitometric changes in
cerebral gray and white matter compartments and their perfusion values in normal aging. Proceedings of Second World Congress of Stroke. J Stroke Cerebrovasc Dis 1992;2(l):S66.
750. Meyer JS, Terayama Y, Kawamura J, Takashima S, Weathers S. Longitudinal
outcome of patients with ischemic vascular dementia. (Bertha Memorial Lecture) Proceedings of Second World Congress of Stroke. J Stroke Cerebrovasc Dis 1992;S151(1).
751. Kawamura J, Meyer JS, Terayama Y, Weathers S. Leuko-araiosis and cerebral
hypoperfusion compared between patients with ischemic vascular dementia and normal elderly volunteers. J Stroke Cerebrovasc Dis 1992;2:180-188.
752. Meyer JS, Terayama Y, Takashima S, Kawamura J, Weathers S. Long-term follow-
up of patients with vascular dementia. Bertha Memorial Lecture. J Stroke Cerebrovasc Dis 1992;2:244-248.
753. Meyer JS, Terayama Y, Takashima S. CT-CBF compared in normal aging, ischemic
vascular dementia and Alzheimer's disease (abstract). Proceedings of the 2 d
International Meeting of Xenon/CT-CBF, Fukuoka, Japan, S.L.G. 1992. 754. Fife CE, Meyer JS, Berry JM, Sulton TE. Hyperbaric oxygen and acute migraine
pain. Preliminary results of a randomized blinded trial. Undersea Biomed Res 1992;19(l):106.
755. Meyer JS. Current concepts of headache and its treatment in the People's Republic
of China. Headache Quar 1992;4:2. 756. Kawamura J, Meyer JS, Ichijo M, Kobari M, Terayama Y, Weathers S. Correlations
of leuko-araiosis with cerebral atrophy and perfusion in elderly normals and dements. J Neurol Neurosurg & Psychiat 1993;56:182-187.
65
757. Mortel KF, Meyer JS. Reduced education as a risk factor for dementia of the Alzheimer and ischemic vascular types. (Abstract) J Exp Clin Neuropsych 1993; 15:32.
758. Meyer JS, Terayama Y, Takashima S, Obara K, Weathers S. Densitometric
comparisons of polio-araiosis and leuko-araiosis among patients with ischemic vascular dementia and normal volunteers. Proceedings of the V1, International Symposium on Cerebral Hemodynamics Transcranial Doppler and Other Modalities. Stroke 1993;24:511.
759. Takashima S, Meyer JS, Terayama Y, Obara K, Weathers S. Densitometric changes
indicating polio-araiosis and leuko-ariosis of cerebral gray and white matter in normal aging. Proceedings of 16th Annual Meeting of the American Society of Neuroimaging 8, 1993. J Neuroimaging 1993;3:71.
760. Meyer JS, Terayama Y, Takashima S, Mortel KF. Longitudinal outcome among
patients with ischemic vascular dementia. J Stroke and Cerebrovasc Dis 1993;3:90-101.
761. Takashima S, Meyer JS, Terayama Y, Obara K, Mortel KF, Weathers S. CT
morphological changes associated with normal aging of the human brain. (Abstract) Neurol 1993;43(2):A379. J CBF & Metab 1993;13(l):S406.
762. Terayama Y, Meyer JS, Kawamura J, Weathers S. Cognitive recovery correlates
with white matter restitution after head injury. Surg Neurol 1993;39:177-186. 763. Meyer JS, Terayama Y, Takashima S. Cerebral circulation in the elderly.
Cerebrovasc and Brain Metab Rev 1993;5:122-146. 764. Kawamura J, Meyer JS, Terayama Y, Takashima S, Obara K, Mortel KF, Pavol MK,
Weathers S. Leuko-Araiosis and cerebral perfusion in normal aging. Exp Aging Res 1993;19:225-240.
765. Meyer JS, Terayama T, Takashima S, Obara K. Cerebral circulatory changes during
migraine with aura. Rev Neurosci 1993;4:305-319. 766. Fife CE, Hanson S, Meyer JS, Maklad N. Transcranial Doppler evaluation of cerebral
vessels during hyperbaric oxygenation. Undersea Biomed Res 1993;20(1):14. 767. Mortel KF, Meyer JS. Case control studies of levels of education and types of
occupation as risk factors for Alzheimer's and ischemic vascular dementia. (Abstract) Ann Neurol 1993;34:259-260.
768. Obara K, Meyer JS, Takashima S, Muramatsu K. Patients with small lacunes have
decreased cerebral perfusion which correlates well with cognitive performance. (Abstract) Ann Neurol 1993;34:284.
66
769. Mortel KF, Wood S, Pavol MA, Meyer JS, Rexer JL. Analysis of familial and individual risk factors among patients with ischemic vascular dementia and Alzheimer's disease. Angiology 1993;44:599-606. Abstracted in Clinical Digest Series-Parkinson/Alzheimer Digest 1994. Abstracted in Focus on Parkinsons' Disease 1994;6(2):44-45.
770. Meyer JS, Dalessio DJ. Headache associated with chemicals, toxins, systemic
infection and metabolic disorders (Toxic Vascular Headache). In: Dalessio DJ, Silberstein SD, eds. Wolff s headache and other head pain, sixth edition. New York, Oxford:Oxford University Press, 1993:209-234.
771. Meyer J, Takashima S, Terayama Y. Calcium channel blockers prevent delayed
cerebral ischemia after intracranial aneurysmal subarachnoid hemorrhage. In: Hartmann A, Kuschinsky W, Hoyer S, eds. Cerebral Ischemia and Basic Mechanisms. Berlin: SpringerVerlag, 1993:113-124.
772. Meyer JS, Takashima S, Obara K. Wolff s vascular theory of headache 50 years
later. Headache Quarterly 1993;4(3):202-215. 773. Terayama Y, Meyer JS, Takashima S, Weathers S. Comparisons of polio-araiosis
and leuko-araiosis in dementias of the ischemic vascular and Alzheimer types. J Stroke & Cerebrovasc Dis 1993;3:267-275.
774. Meyer JS. In: Garcia J, Welch KMA, eds. Discussion of intracerebral hemorrhage in
cerebrovascular disease. Proceedings of the 16'h Princeton Conference. Stroke 1993;24(l):107.
775. Meyer JS, Obara K, Muramatsu K. Diaschisis. Neurol Res 1993; 15:362-366. 776. Meyer JS, Kawamura J, Terayama Y. Cerebral blood flow and metabolism in normal
and abnormal aging. In: Albert M, Knoefel J, eds. Clinical Neurology of Aging, Second Edition. Oxford University Press, 1994:214-234.
777. Meyer JS, Takashima S, Terayama Y, Obara K. Xenon contrast CT measurements
of zero and low flow predict later thrombo-embolic cerebral infarction among patients and stroke models. In: Tomita M, ed. Excerpta Medica International Congress Series, Symposium on Microcirculatory Stasis in the Brain. Elsevier: Amsterdam, 1993:491-496.
778. Meyer JS, Obara K, Muramatsu K. Migrainous infarction. Neurobase 1994; published on computer disc, 1994. 779. Meyer JS, Muramatsu K, Obara K. Late-life migrainous accompaniments.
Neurobase 1994; published on computer disc, 1994. 780. Elkind AH, Javamilla J, Dalessio DJ, Gallagher RM, Kunkel RS, Meyer JS, Ziegler D.
Therapeutic guide of National Headache Foundation. Silent Partners, Inc.:Austin, Texas. 1993.
67
781. Mortel KF, Pavol MA, Wood S, Meyer JS, Terayama Y, Rexer JL, Herod B. Prospective studies of cerebral perfusion and cognitive testing among elderly normal volunteers and patients with ischemic vascular dementia and Alzheimer's disease. Angiology 1994;45:171-180.
782. Mortel KF, Meyer JS. Estrogen replacement therapy and risk of dementia. (Abstract)
Neurology 1994;44(2):A20. 783. Obara K, Meyer JS, Muramatsu K, Mortel KF. Lacune-associated cerebral
hypoperfusion correlates with cognitive testing. J Stroke and Cerebrovascular Disease 1994;4:121-129.
784. Meyer JS, Terayama Y, Takashima S, Weathers S. CT changes associated with
normal aging of the human brain. J Neurol Sci 1994;123:200-208. 785. Meyer JS, Takashima S, Obara K, Muramatsu K, Mortel KF. Longitudinal outcome
following treatment of hypertension among patients with ischemic vascular dementia. Hypertension Research 1994;17(Sl):S89-S96.
786. Meyer JS, Terayama Y, Obara K, Muramatsu K, Mortel KF. Problems encountered
with longitudinal neurologic psychometric and cerebral CT imaging among Stroke Data Bank patients with dementia. Neuroepidemiology 1994;13:340-344.
787. Meyer JS, Takashima S, Terayama Y. Diaschisis: Epiphenomenon or clinical entity.
J Stroke and Cerebrovasc Dis 1994:4(l):S95-S99. 788. Obara K, Meyer JS, Muramatsu K. Cognitive declines correlate with decreased
cortical volume and perfusion in dementia of Alzheimer's type. J Neurol Sci 1994;127:96-102.
789. Meyer JS, Takashima S, Obara K. "Silent cerebrovascular lesions" occur among
elderly "normal" volunteers besides patients with previous symptomatic strokes. J Stroke and Cerebrovasc Dis 1994;4:229-234.
790. Pavol MA, Massman PJ, Mortel KF, Marriotto MJ, Meyer JS. The effect of leuko-
araiosis on frontal lobe functioning in non-demented elderly subjects. JINS 1995;1:168.
791. Mortel KF, Meyer JS, Herod B, Thornby J. Education and occupation as risk factors
for dementias of the Alzheimer and ischemic vascular types. Dementia 1995;6:5562. 792. Meyer JS. Dementia correlates with cerebral ischemia not atrophy after small
strokes. Stroke 1995;26:730. 793. Fife CE, Powell MG, Sulton TS, Housen S, Meyer JS. TCD evaluation of the middle
cerebral artery (MIA) during hyperbaric oxygenation. 1994 Symposium on Cerebral Hemodynamics, TCD, CBF and Other Modalities. Stroke 1995;26:731.
68
794. Meyer JS, Muramatsu K, Shirai T, Mortel KF. Prospective CT confirms differences between vascular versus Alzheimer's dementia. Stroke 1995;26:735-742.
795. Meyer JS, Muramatsu K, Shirai T, Mortel KF. Cerebral CT changes during normal
human aging. (Abstract) J Cerebral Blood Flow and Metabolism 1995;15(l):S596. 796. Terayama Y, Katsumata H, Ishihara N, Meyer JS. CT densitometric changes of
cerebral gray and white matter compartments among hemodialysis patients 3 years after initiation of hemodialysis. J Cerebral Blood Flow and Metabolism 1995; 1 5(l):S81 1.
797. Meyer JS, Shirai T, Muramatsu K, Mortel KF. Effects of chronic cigarette smoking
and abstention on cerebral perfusion among neurologically normal volunteers. In: Domino EF, ed. Brain imaging of nicotine and tobacco smoking. Ann Arbor, Michigan.-NPP Books, 1995:137-151.
798, Meyer JS, Terayama Y, Takashima S, Obara K. Computed tomography cerebral
blood flow values compared in normal aging, ischemic vascular dementia and Alzheimer's disease. In: Tomonaga M, Tanaka A, Yonas H, eds. Quantitative cerebral blood flow measurements using stable xenon/CT: Clinical applications. Futura Publishing Co Inc:Armonk, New York, 1995:321-329.
799. Meyer JS. Silent cerebral infarction and lacunes. Introductory remarks. J Stroke and
Cerebrovasc Dis 1994;4:S43. 800. Mortel KF, Meyer JS. Lack of postmenopausal estrogen replacement and the risk of
dementia. J Neuropsychiatry and Clinical Neurosciences 1995;7:334-337. Reprinted in Menopause Digest 1996.
801. Muramatsu K, Meyer JS, Obara K, Shirai T. Prospective measures of cerebral
atrophy and perfusion among cognitively intact stroke patients. J Stroke and Cerebrovasc Dis 1995;5-.129-138.
802. Meyer JS, Mortel KF. Functional brain imaging. J Neurol Neurosurg Psychiatry
1995;59:454. 803. Obara K, Meyer JS, Muramatsu K, Mortel KF: Cerebral density and perfusion
measured among heart disease patients with and without stroke. Neurological Research 1995;17:377-383.
804. Meyer JS, Obara K, Muramatsu K, Mortel KF. Cognitive performance after small
strokes correlates with ischemia not atrophy of the brain. Dementia 1995;6:312-322. 805. Meyer JS, Shirai T, Akiyama H. Neuroimaging for differentiating vascular from
Alzheimer's dementia. Cerebrovascular and Brain Metabolism Reviews 1996;8:1 -10. Reprinted in Parkinson/Alzheimer's Digest, 1996. 5: 21-24.
806. Meyer JS, Muramatsu K, Shirai T. Headache associated with metabolic disorders.
Neurobase 1996 (revised, published on computer disc).
69
807. Meyer JS, Shirai T, Muramatsu K. Headache associated with arterial hypertension.
Neurobase 1996 (revised, published on computer disc). 808. Mortel KF, Meyer JS. Prospective study of vascular events and cerebral perfusional
changes following transient ischemic attacks. Angiology 1996;47(3):215-224. 809. Meyer JS, Muramatsu K, Shirai T. Cerebral embolism as a cause of stroke and
Transient Ischemic Attack. Echocardiography: A Journel of Cardiovascular Ultrasound and Allied Techniques. 1996, 199 13 513-517.
810. Meyer JS, Shirai T, Mortel KF,Muramatsu K, Akiyama H: Testing Xe/CT-CBF cerebrovascular reserve for identifying migraine and differentiating Alzheimer's from vascular dementia. Acta Neurologica Scandinavia. 1996; Suppl., 93: 148-149.
811. Meyer JS, Shirai T, Akiyama H, Mortel KF, Wills PM. Acetazolamide as a
confirmatory test for migraine headaches. Proceedings of 11 th Migraine Trust International Symposium, London UK. Cephalalgia 1996; 16, 14-15.
812. Meyer JS, Shirai T, Akiyama H, Mortel KF, Classification of Vascular Dementia
Subtypes Confirmed By Acetazolamide (Diamox@) Testing. Cerebrovascular Dis. 1996 (Suppl 2) P 362-71.
813. Meyer JS, Shirai T, Akiyama H, Konno S, Mortel KF, Wills PM. Acetazolamide
challenge confirms vascular versus tension headaches. Annals Neurology, 1996; 40:507.
814. Meyer JS, Akiyama H, Shirai T. Cerebral CT changes correlate with cognitive
declines and identify dementia of Alzheimer's type in Alzheimer Disease, Facts Research and interventions in Gerontology. B. Vellas, Editor, Serdi Publishing Co., 1996; 28-38.
815. Meyer JS, Muramatsu K, Shirai T, Obara K, and Mortel KF. Prospective CT identifies
vascular and Alzheimer's dementias from normal aging. Proceedings of the World Federation of Neurology, Salzburg Conference, Nikko, Japan. J. . Stroke and Cerebrovascular Disease. 1996; 6 Supplement 1: 122-126.
816. Meyer JS. Headaches due to subarachnoid bleeding. National Headache
Foundation Newsletter. Headlines 98: 7; 1996. 817. Gallagher RM, Meyer JS, for the DHE working group. Acute treatment of migraine
with dihydroergotamine nasal spray. Arch Neurol 1996; 53, 1285-1291. 818. Meyer JS. A new diagnostic test for migraine and cluster headache. National
Headache Foundation Newsletter. Fall 1996; 96,7.
70
819. Meyer JS, Shirai T, Akiyama H, Mortel KF, Wills PM. Acetazolamide Testing of Cerebral Vasodilator Capacity Provokes "Vascular" but not Tension Headaches. Headache 1996; 36, 589-594.
820. Loeb C, Meyer JS. Vascular Dementia: Still a debatable entity? Journal of
Neurological Sciences 1996; 143, 31-40. 821. Meyer JS, Akiyama H, Konno S, Mortel KF, Margishvili G. Risk Factors for Cerebral
Atrophy during Human Aging. Neurology 1997, 48 A 206 (Suppi 2). 822. Meyer JS. Headache due to bleeding within the brain. National Headache Society,
Headlines 99, 5-6, 1997. 823. Meyer JS, Akiyama H, Konno S. Migrainous infarctions Neurobase updated version.
1997. Published on computer disk. 824. Meyer JS, Shirai T, Akiyama H. Vascular dementias. In: Primer on Cerebrovascular
Disease (Welch KMA, Caplan L, Reis D, Siesjo B, Weir B (eds). Chapter 101, 364-366, 1997.
825. Meyer JS, Margishvili GM, Terayama Y, Konno S. Headache associated
with arterial hypertension. Neurobase updated version. 1997. 826. Shirai T, Meyer JS, Akiyama H. Management of acute stroke with
hyperosmolar agents. In: Primer on Cerebrovascular Disease (Welch KMA, Caplan L, Reis D, Siesjo B, Weir B (eds). Chapter 180, 737-739, 1997.
827. Akiyama H, Meyer JS, Mortel KF, Terayama Y, Konno S, Margishvili GM.
Risk factors for cerebral atrophy and cognitive declines. (abstract) J. CBF and Metabolism. 17, Suppl. 1,5625, 1997.
828. Meyer JS, Konno S, Terayama Y, Margishvili GM. Migrainous Infarction.
Neurobase updated version. 1997. 829. Meyer JS, Terayama Y, Konno S, Margishvili GM. Late-Life Migrainous
Accompaniments. Neurobase updated version. 1997. 830. Meyer JS, Akiyama H, Terayama Y, Konno S, Mortel KF, Margishvili GM.
Aging, Risk Factors for Cerebral CT Changes and Risk of Dementia (abstract). International Psychogeriatric Association Meeting, Jerusalem, Israel. 1997.
831. Meyer JS, Terayama Y, Konno S, Akiyama H, Mortel KF, Margishvili GM,
Wills PM. Cerebrovascular Disease Alters the Symptomatic course of Migraine. (abstract). Headache, 1997, 37, 323-324.
832. Meyer JS, Akiyama H, Konno S, Mortel KF, Margishvili G. Human Aging:
Risk Factors for Cerebral Atrophy. In: Cerebrovascular Pathology in Alzheimer's Disease. (J.C. de la Torre and V. Hachinski, Eds). Ann N Y Acad Sci, 1997, 826, 483-489.
71
833. Meyer JS, Terayama Y, Konno S, Akiyama H, Mortel KF, Margishvili GM.
Aging and Risk Factors for Cognitive Declines (abstract), 122nd Annual Meeting, American Neurological Association, page 35, 1997, Annals Neurology.
834. Meyer JS, Terayama Y, Konno S, Akiyama H, Mortel KF, Margishvili GM.
Classification of the Vascular Dementias Validated (abstract). Proceedings of Salzburg Conference, Buenos Aires. J. Stroke and CVD, 6,452,1997.
835. Meyer JS, Shirai T, Akiyama H, Konno S, Mortel KF, Wills PM.
Acetazolamide challenges identify vascular versus tension headaches. Ann. Neurol. 1996; 40, 407.
836. Meyer JS, Shirai T, Akiyama H, Muramatsu K, Mortel KF, Wills PM.
Acetazolamide challenges show abnormal cerebral vasomotor capacitance among migraine patients. Stroke, 1996, 27, 797.
837. Meyer JS, Terayama Y, Konno S, Akiyama H, Mortel KF, Margishvili GM.
Cerebral Degenerative Changes during Aging with Cognitive Declines (abstract). Fourth International Xenon CT-CBF Meeting, J. Stroke and Cerebrovascular Disease, 6, 439, 1997.
838. Konno S, Meyer JS, Terayama Y, Margishvili GM, Mortel KF.
Classification, Diagnosis and Treatment of vascular Dementia, Drugs and Aging. 11, 361-373, 1997.
839. Akiyama H, Meyer JS, Mortel KF, Terayama Y, Thornby J, Konno S.
Normal Human Aging: Factors contributing to cerebral atrophy. J. Neurol. Sciences, 152, 39-49, 1997.
840. Meyer JS, Cerebral Aging. Synapse Newsletter, Adis International
Publishers, Chester, England, 3, 2-7, 1998. 841. Meyer JS, Terayama Y, Konno S, Akiyama H, Margishvili GM, Mortel KF.
Cardiovascular and related risk factors for vascular dementia. European J. Neurol. 5 (Suppl 1), S4, 1998.
842. Meyer JS, Terayama Y, Konno S, Akiyama H, Margishvili GM, Mortel KF.
Risk factors for cerebral degenerative changes and dementia. European Neurol. 39 (Suppl 1) 7-16, 1998.
843. Meyer JS, Wang XD. Preface Shanghai Symposium on "Cerebrovascular
Aging, Challenge at the Dawn of the 21st Century: Therapeutic Value of Duxil, European Neurol. 39: S1-3, 1998.
844. Meyer JS, Terayama Y, Konno S, Margishvili GM, Akiyama H, Rauch RA,
Mortel KF, Wills PM. Age-related Cerebrovascular Disease alters the Symptomatic Course of Migraine. Cephalalgia, 18 (4), pp. 202-208, 1998.
72
845. Fife C, Meyer JS, Margishvili GM. The use of hyperbaric oxygen in the treatment of headache - Hyperbare Oxygenationstherapie - Intensivinedizin, Kopfschmerz, Schlaganfall. Interdisziplinares Symposium zur hyperbaren Oxygenationtherapie, Gottingen, pages 41-52, Archimedes Verlags GmbH 1998.
846. Meyer JS, Konno S, Margishvili GM, Terayama Y. Vasodilator response to
acetazolamide tested in subtypes of vascular dementia. J. Stroke and Cerebrovascular Disease, 7 (5), pp. 323-329, 1998.
847. Meyer JS, Konno S, Margishvili GM, Haque Md. A. Transformed Migraine as a cause of
chronic daily headache. Proceedings XII Migraine Trust International Symposium, London, England, pp. 14-15, 1998.
848. Meyer JS, Rauch GM. Editorial. Gender differences in cerebral perfusion. J. Neurol.
Sciences, 162:133, 1999. 849. Konno S, Meyer JS, Margishvili GM, Rauch RA, Haque A. Transformed migraine is a
cause of chronic daily headaches. Headache, 39:95-100, 1999. 850. Meyer JS, Rauch GM, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion,
cognitive decline and dementia. In Hemodynamics and cerebral perfusion: new evidence in the pathology of AD. International Business Communications Conference Symposium, 225 Turnpike Road, Southborough, MA 1772-1749. 1999.
851. Meyer JS, Rauch GM, Haque A, Rauch RA. Cardiovascular and other risk factors for
Alzheimer's Disease and Vascular dementia (abstracts). In Vascular Factors in Alzheimer's Disease. Alzheimer's Reports 1999 S5 1, Editorial Office, Department of Medicine, Box 157, Addenbrook's Hospital, Hills Road, Cambridge, CB2 2QQ UK.
852. Mortel KF, Meyer JS, Rauch GM, Rauch RA, Haque Md.A. Factors influencing survival
among patients with Vascular dementia and Alzheimer's disease. J. Stroke and Cerebrovascular Disease. 1999;8:57-65.
853. Rauch GM, Meyer JS, Haque A, Rauch RA. Aging, risk factors for cognitive decline and
dementia. J. Cerebral Blood Flow and Metabolism. 1999 19: Suppl. 1 S15.
854. Meyer JS, Rauch GM, Rauch RA, Haque A. Risk factors contributing to dementias of vascular and Alzehimer’s type. In 1st International Congress of Vascular Dementia (Koreyn, A.D., ED.) Monduzzi Editore, Bologna, Itraly, 1999;67-70.
855. Meyer JS, Editorial Commentary on “Xenon CT Cerebral Blood Flow Measurements in
Acute Cerebral Ischemia: Review of 56 cases” J. Stroke and Cerebrovascular Disease, 8, 01, 1999.
856. Meyer JS, Rauch GM, Rauch RA, Haque MA. Risk factors for mild cognitive decline
and dementia of the vascular and Alzheimer’s Type. Stroke, 2000;31,319.
73
857. Meyer JS, Rauch GM, Crawford K, Rauch RA, Konno S, Akiyama H, Terayama Y,
Haque A. Risk Factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int’l. J. Geriat. Psychiatry, 1999 14:1050-1061.
858. Meyer JS, Margishvile Gaiane, Haque A, Rauch RA, Terayama Y, Konno S, Akiyama H.
Risk factors for cerebral degeration and dementia. Acta Neurologica Taiwonica, 2000, 8: 199-200.
859. Meyer JS, Rauch GM. Why emergency XeCT-CBF should become routine in acute
ischemic stroke before thrombolytic therapy. Keio J. of Med., 2000, 49, Supplement 1, A25-A28.
860. Meyer JS, Rauch GM, Haque A, Crawford K. XeCT-CBF changes during normative
aging, cognitive decline and dementia. Keio J. Med., 2000, A95-A97. 861. Meyer JS, Rauch GM, Mortel KF, Rauch RA, Haque A, Akiyama H, Konno S, Terayama
Y. Risk factors for vascular dementia. J. Stroke amd Cerebralvascular Disease 2000, 9 Supplement 1, 37-38.
862. Kobari M, Meyer JS, Ichijo M, Kawamura S. Distinguishing patients with Senile
Dementia of Alzheimer’s type and normal elderly subjects utilizing Xenon CT-CBF and multivariate analysis. Keio J. Med, 2000, A101-104.
863. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford KM. Cardiovascular and other
risk factors for Alzheimer’s Disease and vascular dementia in Vascular Factors in Alzheimer’s Disease (Kalaria, RN and Ince P. Eds) in Annals N.Y. Acad. Sci. 2000. 903,411-423.
864. Meyer JS, Rauch GM, Rauch RA, Haque MA. Risk factors for cerebral hypoperfusion
mild cognitive impairment and dementia in Vascular Pathophysiology in Alzheimer’s Disease. Neurobiology of Aging. 2000, 221,161-169.
865. Loeb C, Meyer JS. Criteria for diagnosis of vascular dementia. Arch. Neurol. 2000.
57,1382-1383. 866. Meyer JS, Thornby J, Crawford K, Rauch GM, Li Y-S. Migraine and cluster headaches
cause temporary cognitive impairements. Cephalagia, 2000, 20, 381. 867. Meyer JS, Thornby J, Crawford K, Rauch GM. Reversible cognitive decline
accompainies miagraine and cluster headaches. Headache 2000, 40,638-646. 868. Meyer JS, Thornby J, Crawford K, Rauch GM. Reversible cognitive decline accompanies
migraine and cluster headaches (abstract). Annals Neurol. 2000, 41.
74
869. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds): Vascular Dementia (Text- book) Futura Publishing Co., Inc. Armonk, New York, 2001.
870. Haque MA, Meyer JS, Rauch GM. Epidemotory of Vascular dementia. Chapter 1 in
Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co. Armonk, N.Y., 2001, 1-8.
871. Meyer JS, Rauch GM, Rauch RA. Cardiovascular risk factors contributing to cerebral
degenerative changes, cognitive decline and dementia. Chapter 2 in Vascular Dementia, Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, NY., 2001, 19-39.
872. Rauch GM, Meyer JS. Clinical features of patients with Vascular dementia versus
Alzheimer’s disease. Chapter 7 in Vascular Dementia, Meyer Js, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 119-129.
873. Loeb C, Meyer JS, Rauch GM. Criteria for diagnosis of vascular dementia, Chapter 10, in
Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 181-202.
874. Meyer JS, Rauch GM. Classification of subtypes of vascular dementia. Chapter 11 in
Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 203-219.
875. Meyer JS, Rauch GM, Rauch RA. Neuroimaging in vascular dementia. Chapter 12 in
Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 221-233.
876. Meyer JS, Rauch GM. Prevention and treatment of vascular dementia. Chapter 14 in
Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 251-262.
877. Rauch GM, Meyer JS. Estrogen therapy for prevention of dementia in post-menopausal
women. Chapter 16 in Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001, 279-288.
878. Meyer JS, Rauch GM. Factors influencing long-term survival among patients with
vascular dementia versus Alzheimer’s disease. Chapter 17 in Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001: 289-306.
879. Haque MA, Meyer JS, Rauch GM. Neuropsychological assessments for cognitive
decline. Chapter 8 in Vascular Dementia. Meyer JS, Rauch GM, Lechner H, Loeb C, Toole JF (Eds) Futura Publishing Co., Armonk, N.Y., 2001: 131-154.
75
880. Meyer JS, Li Y-S, Rauch GM, Haque A. Risk factors for accelerated cerebral degenerative changes and cognitive decline. Research and Practice in Alzheimer’s disease and other dementias. 2001: 5, 27-30.
881. Meyer JS, Thornby J, Li Y-S, Rauch GM. Migraine cluster and chronic daily headaches
often accompanied by cognitive decline. In new and emerging therapies in the treatment of migraine. (Brian Mondell ED). In John Hopkins University Advanced Studies in Medicine. 2001: 1, 97-100.
882. Meyer JS, Li Y-S, Thornby J. Cross-validating mini-mental status, cognitive capacity
screening and Hamilton depression scales among subjects with vascular headache. Int’l. J. Geriatric Psychiat. 2001:16, 430-435.
883. Meyer JS. Treatment of VAD with cholinesterase inhibitors. Published in “Dementia in
Developing Countries”. Publication of the Institute for the Health of the Elderly. University of New Castle. 2001:18.
884. Li YanSheng, Meyer John S, Thornby, John. Longitudinal follow-up of depressive
symptoms among normal versus cognitively impaired elderly subjects. Int’l. J. Geriatric Psychiat. 2001, 16:718-727.
885. Meyer JS, Li Y-S. Longitudinal outcome of depressive symptoms among vascular
dementia patients. J. Neurol. Sciences. 187 Suppl. 1. S64, 2001. 886. Li Y-S, Meyer JS, Thornby J, Hinh P. Transient domains of cognitive impairments
during intervals of migraine headache. Headache Quarterly. 2001. 12:21-26. 887. Li Y-S, Meyer JS, Thornby J. Depressive symptoms among cognitively normal versus
cognitively impaired elderly subjects. Int’l. J. Geriatric Psychiat. 2001, 16:455-461. 888. Meyer JS, Rauch GM. Before thrombolytic therapy for acute stroke xenon inhalation
contrast CTCBF imaging is recommended. Proceedings of 4th World Stroke Congress, Melbourne, Australia, November 25-29, 2001.
889. Li Y-S, Meyer JS, Haque A, Chowdhury M, Hinh P, Quach M. Feasibility of vascular
dementia treatment with cholinesterase inhibitors. Int. J. Geriatric Psych. 2002, 17;193-196.
890. Meyer JS, Chowdhury M, Xu G, Li Y-S, Quach M. Diagnosis and cholinesterase
inhibitor treatment of vascular dementia. Proceedings of the 3rd International Neurology Conference of the Egyptian Society of Neurology, Psychiatry and Neurosurgery. Cairo, Egypt, 67-69, 2002.
891. Meyer JS, Li Y-S, Chowdhury M, Quach M, Xu G. Motivational depressive symptoms
as risk factors for vascular dementia. Proceedings of 27th International Stroke Conference. Stroke. 2002, 33-418.
76
892. Meyer JS, Li Y-S. Importance of depressive symptoms as a risk factor for vascular
dementia. Proceedings of Second International Congress on Vascular Dementia. 2002, A.D. Korczyn Ed. Monduzzi Editore, International Proceedings Division, Bologna, Italy, 119-122.
893. Meyer JS, Chowdhury M, Xu G, Quach M. Treatment of vascular dementia with daily
aspirin. Proceedings of Second International Congress on Vascular Dementia, 2002, A.D. Korcyn Ed. Monduzzi Editore, International Proceedings Division, Bologna, Italy, 215-220.
894. Meyer JS, Li Y-S, Xu G, Chowdhury M, Quach M. Feasibility of treatment of mild cognitive impairment with cholinesterase inhibitors. Proceedings of Second International Congress on Vascular Dementia, 2002, A.D. Korcyn Ed. Monduzzi Editore, International Proceedings Division, Bologna, Italy, 221-226.
895. Meyer JS, Li Y-S, Thornby J, Chowdhury M, Quach M. Feasibility of treating mild
cognitive impairment with cholinesterase inhibitors. Int’l J. Geriatric Psychiat. 2002, 17:1-3.
896. Meyer JS, Li Y-S. Review of gender issues and oestrogen replacement in common
cognitive disorders. Chapter XV. D’haenen H, Den Doer JA, Willner P. (Eds) John Wiley & Sons Ltd., Publishers. Biological Psychiatry, 387-392,2002.
897. Meyer JS Collaborator, Antithrombotic Trialists (ATT) Collaboration. Prevention of
death, myocardial infarction and stroke by anti-platelet therapy. Collaborative meta-analysis of 266 trials involving 200,000 patients at high risk of occlusive vascular events. British Medical Journal. 2001.
77
PUBLICATIONS IN PRESS
1. Meyer JS, Li Y-S. Clinical experience with first quantitative stroke scale. In Stroke Scales
Symposium. Gotoh F. Editor. J. Stroke and Cerebrovascular Disease, in press. 2. Meyer JS, Li Y-S. Cerebral blood flow methods with results in health and disease. In
Encyclopedia of Neurological Sciences, KMA Welch (Ed.). Academic Press, San Diego, California. In press, 2002.
3. Meyer JS, Chowdhury M, Quach M. Treatment of vascular dementia with daily oral 325mg
aspirin. Proceedings of Second International Congress on Vascular Dementia. J. Neurol. Science. In press, 2002.
4. Meyer JS, Chowdhury M, Xu G, Quach M. Cholinesterase inhibitor treated vascular
dementia. Proceeding of the Third World Congress on Vascular Factors In Alzheimer’s Disease, Kyoto, Japan; April 7-10, 2002.
5. Meyer JS, Chowdhury M, Xu G, Li Y-S, Quach M. Donepezal treatment of vascular
dementia. Annals of N.Y. Acad. of Sciences. In press, 2002. 6. Meyer JS, Xu G, Li Y-S, Chowdhury M, Quach M. Is mild cognitive impairment (MCI)
prodromal for vascular dementia like Alzheimers? Stroke. In press, 2002. 7. Meyer JS, Xu G, Li Y-S, Chowdhury M, Quach M. Longitudinal analysis of abnormal
spectral domains comprising mild cognitive impairment (MCI) during aging. Journal of Neurological Sciences. In press 5/28/02.
78
MANUSCRIPTS SUBMITTED
1. Abudiab M, Meyer JS, Khalil M. Statistical analysis for the methodological approach to evaluation of 1,3-butadiene neurotoxicity. CNS Drug Reviews. Submitted October 25, 2000.
2. Xu G, Meyer JS, Thornby J, Chowdhury M, Quach M. Screening for mild cognitive
impairment (MCI) utilizing combined mini-mental - cognitive capacity examintations for dementia prodromes. Int’l J. Geriatric Psychiatry. To be submitted 2002.
3. Meyer JS, El-Gengaihy A, Xu G, Chowdhury M, Quach M. Magnetic resonance imaging
(MRI) in mild cognitive impairment (MCI). To be submitted to Stroke, 2002.